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Summary 
Bovine mastitis still remains a major problem to the dairy industry world wide although 
there are mastitis control strategies in place. In the last few decades there has been a 
change in the predominant pathogens causing mastitis. Streptococcus uberis is now the 
leading cause of bovine mastitis. Accurate and cost effective methods for identification of 
S. uberis by diagnostic laboratories would assist farm management to reduce the infection. 
One common practice to control mastitis is the use of antimicrobial agents. Long term 
antibiotic use can cause antibiotic resistance and there is concern that resistant bacteria 
could be transferred to humans. Knowledge of current antibiotic susceptibility test patterns 
for mastitis pathogens could improve therapy protocols for particular dairy farms. An 
alternative way to eliminate mastitis pathogens is biological control. Recent evidence has 
shown that non-pathogenic coagulase-negative staphylococci have the ability to produce 
antibacterial proteins (bacteriocins) that are active against some mastitis pathogens.  
 
One hundred and fifteen isolates of esculin hydrolyzing streptococci from intramammary 
infections in dairy cows, which are commonly categorized as S. uberis, were further 
identified using four additional biochemical tests (hippurate hydrolysis, fermentation of 
inulin and mannitol and growth in 6.5% NaCl). 16S rRNA sequencing was used as a gold 
standard for species identification. The additional biochemical tests generated seven 
different patterns. All isolates belonging to pattern 1 (hippurate hydrolysis positive, inulin 
and mannitol fermentation positive and negative for growth in 6.5% NaCl) were identified 
by 16S rRNA sequencing as S. uberis (91%) or S. parauberis (9%). Half of the isolates 
displaying pattern 2 which differed from pattern 1 only in inulin fermentation (negative) were 
also identified as S. uberis (33%) or S. parauberis (17%) by 16S rRNA sequencing. 
Differentiation of S. uberis and S. parauberis required genotypic examination. Use of these 
additional biochemical tests (hippurate hydrolysis, inulin and mannitol fermentation and 
growth in 6.5% NaCl) resulted in relatively low numbers of misidentification (8.6%). These 
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tests represent an affordable cost and can therefore be considered an adequate method for 
veterinary diagnostic laboratories for identifying S. uberis isolated from bovine mastitis.  
 
The susceptibility of S. uberis to nine antimicrobial agents was determined by the broth 
dilution method. The minimal inhibitory concentrations (MICs) at which 90% of isolates 
were inhibited (MIC90s) for each of ampicillin, penicillin, oxacillin, erythromycin, tetracycline, 
novobiocin, cephalothin, vancomycin and gentamicin was 1.0, 0.06, 0.25, 0.5, 0.5, 4.0, 
0.25, 0.5 and 8.0 µg/mL respectively. No isolates showed resistance to those antibiotics.  
However the continuous monitoring of antibiotic resistance is essential, as the emergence 
of resistance strains has become a concern. 
 
A bacteriocin-producing bacterium, Macrococcus caseolyticus (formerly Staphylococcus 
caseolyticus) was isolated from a cow’s milk sample in Victoria from a farm with a “uberis” 
problem; i.e. an unacceptable prevalence of clinical and sibclinical cases of mastitis. The 
bacteriocin was heat stable and remained active over a wide range of pH, with highly 
specific activity against the genus Streptococcus. Purification of the bacteriocin, included 
ammonium sulphate precipitation, gel filtration, cation exchange chromatography, 
extraction from polyacrylamide gel and reverse phase high performance liquid 
chromatography. The results showed two components which were independently active 
and the mass spectrometry showed the mass of both was less than 3000 Da. Scanning 
and transmission electron microscopy showed damage of target cells. It is suggested that 
the use of bacteriocins could provide effective control and prevention of bovine mastitis 
caused by S. uberis.     
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Chapter 1 General introduction 
1.1 Bovine mastitis  
Bovine mastitis is an inflammatory condition of the mammary gland in dairy cattle and is 
associated with chemical, physical and usually bacteriological changes in milk (Radostits, 
et al., 1994). Clinical findings in mastitis are classified according to severity of disease. 
Clinical mastitis is defined as obvious inflammation of the udder (Smith, et al., 1985b, 
Radostits, et al., 1994). The symptoms include redness, swelling, heat and pain. There is 
decreased milk production, changes in composition of the milk and changes in milk 
appearance, such as discoloration, the presence of flakes, clots or a watery secretion and 
the presence of numerous leukocytes. Subclinical mastitis is defined as an inflammation of 
the mammary gland that is not visible and requires diagnostic tests for detection (Radostits, 
et al., 1994). Subclinical mastitis is the most prevalent type of inflammation of the 
mammary gland in dairy cows. During subclinical mastitis, microorganisms are present in 
milk, the leukocyte content is elevated and milk quality is reduced. This type of mastitis 
causes the greatest economic loss (Smith, et al., 1985b, Radostits, et al., 1994). Chronic 
mastitis may persist in subclinical form for months or years (Radostits, et al., 1994).  
 
Diagnosis of clinical mastitis is based on abnormal appearance of the udder or milk, which 
can be determined by farmers or veterinarians. Milk may present colour changes from 
slightly yellow, yellow to bloody, bloody or have the appearance of serum (watery). 
Abnormal milk may also contain a varying amount of clots. Signs of udder abnormalities 
such as swelling, severity of pain and the overall appearance indicate the severity of 
infection and serve as a guide for the course of treatment (Radostits, et al., 1994).   
 
Diagnosis of subclinical infection is more problematic since the milk appears normal. 
Analysis of subclinical mastitis is usually based upon some indicators of inflammation 
which can be made in several ways, including direct measurement of the somatic cell count 
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(SCC) level or indirect methods by performing a California Mastitis Test (CMT) on 
suspected quarters or measurement related to increased vascular permeability which 
results in alterations in the chemistry of the milk. For routine milk analysis a combination of 
the above methods should be an ongoing part of any mastitis control program. Milk culture 
will definitively identify the presence of mastitis pathogens.  
 
The cells found in milk (somatic cells) consist of white blood cells or leukocytes and 
epithelial cells (Radostits, et al., 1994). Leukocyte numbers increase in response to 
bacterial infection. The epithelial cells originate from udder secretory tissue and increase as 
a result of injury or infection. An increase in somatic cell numbers is largely a result of an 
increase in the number of leucocytes. The concentration of somatic cells serves as a 
measurement of the level of infection in the cow’s mammary gland.  
 
Individual cow somatic cell count (SCC) will provide a determination of the prevalence of 
infection within the herd. Bulk tank somatic cell counts (BTSCC) are performed routinely as 
a indication of milk quality but the BTSCC can also be used to monitor the level of udder 
health by monitoring the bulk tank scores over time (Radostits, et al., 1994). Normal 
quarters show less than 150,000 cells/mL while quarters with SCC over 250,000 cells/mL  
are considered to be infected (Brightling, et al., 1998, Leigh, 1999). The Australian 
guidelines (Countdown Downunder) suggest Australian dairy farms supply milk with a cell 
count of less than 250,000 cells/mL to ensure the production of high-quality milk (Brightling, 
et al., 1998). Most farmers are willing to act on farm management practices (five-point plan 
and Countdown Downunder) to obtain a low SCC  (Brightling, et al., 1998).  
The SCC is determined in a mastitis examination usually by electronic cell-counting 
machines (Miller, et al., 1986, Radostits, et al., 1994). An indirect measurement of somatic 
cell count in milk could be determined by California Mastitis Test (CMT) (Dingwell, et al., 
2003). The test is based upon the amount of cellular nuclear protein present in the milk 
sample. CMT is a simple, inexpensive, rapid screening test for mastitis and can be 
performed by milkers. The test is appropriate for cow-side evaluation of udder health. 
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Electrical conductivity of milk increases during mastitis due to increases in Na+ and Cl- and 
decreases in K+ and lactose. Changes in conductivity can be easily detected by hand-held 
devices (Seguya & Mansell, 2000). However, treatment of mastitis works best if there is 
some information on the particular bacterium causing the problem. Therefore, 
bacteriological culturing of milk samples is essential (Radostits, et al., 1994).      
 
Due to the successful control of mastitis by modern dairy management, bulk milk somatic 
cell counts have been reduced but mastitis still remain in herds with low BTSCC. In nine 
well managed herds in the USA with low SCCs, 82.3% of clinical cases were caused by 
coliforms and environmental streptococci which were difficult to control (Hogan, et al., 
1989b). A situation in three dairy herds from UK showed that either very low (less than 
21,000 cells/mL) or high quarter SCCs (greater than 200,000 cells/mL) have been 
associated with an increase in the incidence of clinical mastitis incidence which was mainly 
caused by environmental pathogens (Peeler, et al., 2003).   
 
Bovine mastitis causes a major economic loss in the dairy industry worldwide (Beck, et al., 
1992, Seegers, et al., 2003, Petrovski, et al., 2006). The dairy industry is Australia’s third 
largest rural industry, with a farmgate value of $3.17 billion in 2004/05. It is the largest 
value-added food industry, increasing value more than three-fold through processing and 
marketing to contribute $9 billion to the nation’s economy. Dairy exports amount to about 
one million tonnes of product to 130 countries and generates an estimated $3 billion in 
export income each year. Victoria is a state that contributes most to Australian milk 
production (65.7%) (Dairy Australia, 2007). Reduction in milk production and milk quality, 
drugs, discarded milk, veterinarian expenses, labour cost, antibiotic uses, and culling 
chronically infected cows contribute to the economic loss from mastititis (Østerås, 2000). The 
costs of mastitis control are not difficult to calculate but loss from reduced production and 
quality are more difficult to evaluate accurately. The average cost per case of clinical 
mastitis is estimated to be €277 in The Netherlands and £203 in the UK (Østerås, 2000). The 
annual cost is estimated to be £300 million in the UK (Hillerton & Berry, 2005).  
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After a calf is born, the cow will continue to produce milk for approximately 300 days. This 
stage is called the lactation period. Subsequently, cessation of regular milking (dry period) 
is recommended for at least 2 months prior to calving again (Dais & Allaire, 1982). The dry 
period benefits the dairy cow in several ways. The change in diet to lower energy and 
higher fibre content allows liver lesions and rumen ulcers to heal and increases rumen 
muscle tone. Replenishment of the energy reverses of cows during the dry period by 
increasing the dietary energy density might increase milk production. Also during this time, 
the secretory cells in the mammary gland involute, regress, and then multiply again. A short 
or absent dry period greatly reduces the numbers of secretory cells which are a major 
factor affecting milk yield (Beever, 2006). In addition, cows are most susceptible to 
environmental mastitis infections during the dry period (Eberhart, 1986). To reduce the risk 
of new infections and cure existing cases, all quarters of all cows are treated with an 
approved long-lasting antibiotic product at drying-off (Hillerton & Kliem, 2002, Hillerton & 
Berry, 2005).   
 
Mastitis is almost always caused by bacterial infection (Radostits, et al., 1994). Mastitis can 
be classified according to the source of infectious organisms, either contagious mastitis or 
environmental mastitis. Causes of contagious mastitis include Staphylococcus aureus, 
Streptococcus dysgalactiae and Streptococcus agalactiae (Radostits, et al., 1994, Leigh, 
1999). Contagious mastitis indicates that the infection is spread from cow to cow. The 
bacteria can be transmitted during the milking process by milking hands, milking equipment 
and other objects. Organisms causing environmental mastitis include Streptococcus uberis 
and coliform bacteria (Smith, et al., 1985b, Radostits, et al., 1994).  The primary source of 
environmental pathogens is the surroundings in which a cow lives. Teats of cows can also 
be colonized by harmless bacteria such as Corynebacterium sp., Bacillus sp., Aerococcus 
sp., Micrococcus sp. and coagulase negative staphylococci (CoNS) (Woodward, et al., 
1988, White, et al., 1989, Vliegher, et al., 2004). 
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Over the past 30 years a great reduction of mastitis, particularly in the UK and USA has 
been achieved due to the five-point plan (Leigh, 1999). The five-point plan for controlling 
mastitis was launched by The National Institute for Research in Dairying (NIRD) and the 
Central Veterinary Laboratory, UK. The plan aimed at reducing exposure, duration and 
transmission of intramammary infections which consists of: 
 
1. Keeping well designed milking machines maintained and functioning properly  
2. Cleaning and drying teats before milking and using a teat dip afterwards 
3. Dry cow treatment of every quarter of every cow with a long lasting antibiotic 
4. Recognizing clinical mastitis cases early and treating them promptly 
5. Culling chronically infected cows 
 
The Countdown Downunder program for mastitis control in Australia is another consistent 
set of "best practice" mastitis control measures and milk quality guidelines (Brightling, et al., 
1998). The guidelines cover periods of calving, lactation, late lactation, drying-off and the 
dry period. For each period of the cow’s milking year, Countdown Downunder provides a 
set of guidelines about what has to be done, why it should be done, how to do it and how to 
check that it has been achieved. The goal of the Countdown Downunder program is to 
reduce the BTSCC of at least 90% of Australian dairy farms supplying milk to less than 
250,000 cells/mL and to reduce the cell count of 100% of Australian dairy farms supplying 
milk to a cell count of less than 400,000 cells/mL in all milk supply periods. In 2005, about 
400 dairy herds across Australia had an average BTSCC exceeding 400,000 cells/mL, but 
another 1000 herds had levels between 300,000 and 400,000 cells/mL (DairyAustralia, 
2007). 
 
Since good management of mastitis has been used, the species of bacteria causing 
mastitis has changed.  The reduction of contagious mastitis has been remarkably 
successful but there has been little effect on the incidence of mastitis due to bacteria which 
infect the gland from environmental sources (Leigh, 1999, Bradley, 2002). Environmental 
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mastitis pathogens have become a major problem in dairy herds worldwide. Fifty dairy 
herds in Ohio, USA reported that the most common clinical isolates were CoNS (14.6%) 
and E. coli (14.6%) (Bartlett, et al., 1992). A one year study on three dairy herds in the UK 
reported clinical mastitis incidence rates of 25.4, 55.2 and 67.6 quarter-cases per 100 cows 
per year respectively. S. uberis and E. coli caused approximately 50% of clinical cases 
(Peeler, et al., 2003). A study of five herds in New Zealand reported that S. uberis (63.2%) 
was the most prevalent pathogen isolated from clinical mastitis cases followed by CoNS 
(11.5%) (McDougall, et al., 2004). Moreover, the majority of S. uberis infections are 
subclinical (Zadoks, et al., 2003). In subclinical mastitis, decreased milk production results 
in the greatest loss, representing about 75% of the total loss (DeGraves & Fetrow, 1993). It 
is likely that inadequacies of current mastitis control strategies will lead to a changing 
aetiology of mastitis. The search for additional understanding and procedures to control the 
environmental bacteria is essential.   
1.2 Streptococcus uberis 
Bergey’s manual of systemic bacteriology lists seven genera of facultative anaerobic Gram-
positive coccci (GPC); Aerococcus, Leuconostoc, Micrococcus, Pediococcus, 
Staphylococcus, Streptococcus and Stomatococcus (Schleifer, 1986). A review written in 
1995 listed additional new genera which included Globicatella, Enterococcus, Lactococcus, 
Vagococcus, Allolococcus, Gemella, Tetragenococcus, and Helcococcus (Facklam & 
Elliott, 1995). Streptococci are non-motile Gram-positive cocci, spherical or ovoid in shape, 
which are arranged in pairs or chains. The genus Streptococcus consists of non-sporing, 
catalase negative facultative anaerobic bacteria. Streptococci have complex nutritional 
requirements and form mainly lactic acid or lactic, acetic and formic acids and ethanol and 
CO2 from carbohydrates (Holt, et al., 1994). They are important in the dairy industry and as 
human and animal pathogens (Jones, 1978). Jones (1978) reviewed several classifications 
of streptococci. Most notable classifications are based on cultural characteristics (such as 
hemolytic reaction when cultured on blood containing agar), and use of carbohydrate 
fermentation reactions together with physiological and morphological tests. Serological 
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grouping, which was established by Lancefield in 1933, has played an important role in the 
identification of streptococci (Lancefield, 1933). Serological or Lancefield grouping 
differentiates streptococci according to antigenic characteristics of the group specific 
carbohydrate reactions using the precipitation technique.  
 
Identification of S. uberis is important to therapeutic decision-making and development of 
methods to control mastitis. According to Jones (1978) and Holt, et al. (1994) the taxonomy 
of S. uberis appears to be unsatisfactory. The species is biochemically and serologically 
heterogeneous (Lammler, 1991, Khan, et al., 2003, Odierno, et al., 2006). One of the most 
widely used methods for streptococci identification are commercial kits such as API 20 
Strep (Odierno, et al., 2006), however, newly recognized species such as S. parauberis is 
not included in the identification database. It is now becoming clear that identification of S. 
uberis requires the use of both conventional and molecular methods. Current classification 
of S. uberis relies on genotypic strategies. On the basis of DNA-DNA hybridization, Gravie 
and Bramly (1979) demonstrated genetic heterogeneity of S. uberis and differentiated two 
genotypes, designated as types I and II. After comparison of 16S rRNA nucleotide 
sequences of S. uberis types I and II, Williams and Collins (1990) suggested type II as a 
new species “Streptococcus parauberis”.     
 
Streptococcus uberis is commonly described as an environmental mastitis pathogen 
because it has an ability to survive and multiply in extramammary sites. It has been isolated 
from various anatomical sites of cows and from the cow’s environment. These include 
bovine lips, skin, udder surface, belly, teats, urogenital tract, tonsil, rectum, rumen, nostrils, 
eyes and vulva (Cullen, 1966, Mundt, 1982, Bramley, et al., 1984). In addition, the 
organism can be isolated from water, soil, plant matter, bedding materials, flies, fecal 
samples and hay (Bramley, et al., 1984, Hogan, et al., 1989a, Hogan et al., 1990, Zadoks, 
et al., 2005). With the increasing focus on the control of environmental bacteria, particularly 
S. uberis, it is necessary to understand the epidemiology of the pathogen.  
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The most widely used method for sub-species differentiation is pulse-field gel 
electrophoresis (PFGE). DNA macrorestriction analysis by PFGE appears to be the most 
promising, useful, and reproducible typing system for epidemiological investigation which 
makes it useful for comparison of strains between laboratories (Smith & Cantor, 1987, 
Baseggio, et al., 1997, Wang, et al., 1999, Phuektes, et al., 2001, Khan, et al., 2003). 
PFGE has been used successfully to investigate genomic diversity among strains of S. 
uberis. Epidemiological studies of S. uberis with differing PFGE patterns indicated that the 
main route of transmission appeared to be from environmental sources (Baseggio, et al., 
1997, Phuektes, et al., 2001, Khan, et al., 2003). For example, three studies of 
epidemiological typing of bovine S. uberis in Victoria, Australia showed (i) 74 distinct PFGE 
profiles from 130 isolates from 73 cows on three farms (Wang, et al., 1999), (ii) 17 different 
PFGE patterns  from 21 isolates from ten herds (Baseggio, et al., 1997) and (iii) 62 different 
strains  amonst 138 isolates from four herds (Phuektes, et al., 2001). The epidemiological 
study of 69 S. uberis isolates from 57 cows on 26 farms in Germany also showed 55 
different PFGE patterns (Khan, et al., 2003). However, the above epidemiological studies 
have also showed some identical PFGE patterns indicating cow to cow transmission of S. 
uberis could occur (Baseggio, et al., 1997, Wang, et al., 1999, Phuektes, et al., 2001, 
Khan, et al., 2003). For example, Wang et al. (1999) found five strains of the same PFGE 
pattern of S. uberis isolated from different cows on the same farm. An identical strain of S. 
uberis (C2) was the most prevalent in one herd, accounting for 40% of isolates. (Phuektes, 
et al., 2001). In an earlier study by the same group, identical isolates of S. uberis (isolates 
P3 and P9, R2 and R3) were found from different cows within the same herds (Baseggio, 
et al., 1997). 
 
Streptococcus uberis infects cows through the teat canal. During infection of mammary 
glands, the tissue damage could be caused by the bacteria or their products, including cell 
wall material, toxins and other extracellular products. The organism attaches, proliferates 
and induces an influx of neutrophils into the secretory acini of the teat canal within 24 
hours. Subsequently septal edema, vacuolation of secretory cells, necrosis of alveoli and 
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infiltration of septa by lymphocytes is observed. As the disease progresses, there is 
hypertrophy of ductular epithelium, involution of glandular tissue, and early stage fibrosis. 
S. uberis is found within macrophages and neutrophils, alveolar lumina, lymphatic vessels, 
lymph nodes and attached to ductular epithelium (Thomas, et al., 1994, Pedersen, et al., 
2003). Mammary tissue damage during bovine mastitis reduces the number and activity of 
epithelial cells and could lead to death of these cells (Zhao & Lacasse, 2007). Some strains 
of S. uberis can survive and persist within mammary epithelial cells without affecting the 
host cell viability (Almeida, et al., 2005). Polymerase chain reaction-based DNA 
fingerprinting showed that infection with S. uberis persists in dairy cows (Oliver, et al., 
1998). Persistently infected cows are at greater risk of being culled in the next lactation 
(McDougall, et al., 2004, Green, et al., 2005). All of these events contribute to a decrease 
in milk production and account for approximately 70% of the total cost of mastitis (Zhao & 
Lacasse, 2007).  
1.3 Host-parasite interactions in Streptococcus uberis infection 
Bovine mastitis caused by S. uberis is influenced by the host status, the environment and 
the pathogen itself.  
1.3.1 Host  
Infection with S. uberis may occur in lactating and non-lactating cows (Todhunter, et al., 
1995, Dingwell, et al., 2002, McDougall, et al., 2004). Both contagious and environmental 
mastitis pathogens cause new dry period infection. Exposure to contagious pathogens 
probably decreases with cessation of regular milking but exposure to environmental 
pathogens continues throughout the dry period (Eberhart, 1986).  Therefore, many studies 
have reported a high rate of environmental streptococcal infection in the dry period (Smith, 
et al., 1985a Todhunter, et al., 1995, Jayarao, et al., 1999, McDougall, et al., 2004, Green, 
et al., 2005). Studies of bovine mastitis in England and Wales demonstrated that S. uberis 
is a predominant cause of clinical mastitis in the late dry period (Francis, et al., 1986). 
Recent studies indicate that the clinical cases of streptococcal mastitis that occur during 
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the subsequent lactation were caused by infections acquired during the preceding dry 
period (McDougall, et al., 2004, Green, et al., 2005).   
The incidence of intramammary infection caused by streptococci (including S. uberis) is 
influenced by the age of cows. The rate of infection is higher in older cows (Smith, et al., 
1985a, Todhunter, et al., 1995, Jayarao, et al., 1999, Busato, et al., 2000).  Moreover, 
McDougall et al. (2004) showed that cows over two years of age had a longer duration of 
infection than younger cows. The importance of leukocytes has been established in 
defense against E. coli (Hill, et al., 1978, Burvenich, et al., 2004) and S. aureus infection of 
the bovine mastitis glands (Schalm, et al., 1976) but the pathogenesis of S. uberis infection 
remains unclear. Postmilking teat disinfection in low BTSCC herds (less than 150000 
cells/mL) can increase the risk of E. coli mastitis (Schukken, et al., 1990, Peeler, et al., 
2000). A similar occurrence was reported in low cell count herds in the UK where 50% of 
clinical cases were caused by E. coli and S. uberis (Peeler, et al., 2003). The authors 
suggested that removal of minor pathogens such as Corynebacterium spp. and CoNS 
caused the removal of a protective effect that these bacteria may provide. No information 
exists on the role of leukocytes in controlling the incidence of S. uberis, however, after 
challenging with S. uberis, an increase in milk leukocyte recruitment into mammary glands 
was prompt and significant (Rambeaud, et al., 2003).    
1.3.2 Environment  
The rate of mastitis is also influenced by season, with most streptococcal infections 
occurring during summer (Smith, et al., 1985a). The authors suggested that the 
environmental conditions during summer such as humidity and high temperature favor 
bacterial growth. The farm environment was reported to be a major source of S. uberis 
infection (Zadoks, et al., 2005). Streptococcus uberis can also survive and multiply in 
environmental sites such as fecal and soil samples which appear to be a natural niche for 
the bacteria (Zadoks, et al., 2005). A finding that faecal carriage of S. uberis was highest 
during summer was consistent with the increase in S. uberis infections in summer (Zadoks, 
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et al., 2005). The finding that no S. uberis was isolated from non-farm soil indicated that the 
presence of cattle may be important for maintenance of S. uberis in the dairy environment.   
1.3.3 Streptococcus uberis strain 
It is possible that emergence of strains of S. uberis of certain genotypes are associated with 
increased virulence. A report on strain variation showed that one PFGE pattern of S. uberis 
was more commonly associated with clinical mastitis than other PFGE types (Phuektes, et 
al., 2001). It was suggested that the predominant strain had enhanced virulence. Multilocus 
Sequence Typing (MLST) is another approach to study bacterial epidemiology. MLST is an 
unambiguous procedure for characterising isolates of bacterial species using the sequences 
of internal fragments of seven house-keeping genes. Approximately 450-500 bp internal 
fragments of each gene are used, as these can be accurately sequenced on both strands using 
an automated DNA sequencer. For each house-keeping gene, the different sequences present 
within a bacterial species are assigned as distinct alleles and, for each isolate, the alleles at 
each of the seven loci define the allelic profile or sequence type (ST). STs are grouped into 
clonal complexes (CC) by similarity to a central allelic profile (genotype). A recent 
publication from our laboratory on S. uberis MLST which compared STs and CCs of 
isolates from different countries (Australia, New Zealand and UK) indicated that specific 
groups of genotypes (GCC ST5 and ST143) were found predominantly in clinical and 
subclinical mastitis, suggesting that these types could have enhanced virulence (Tomita, et 
al., 2008).   
1.4 Control of mastitis caused by Streptococcus uberis 
1.4.1 Antibiotic treatment 
Intramammary infection caused by S. uberis can occur during the lactating and non-
lactating period. The successful control of S. uberis mastitis relies on antibiotic treatment, 
that is practical, prompt and effective (Hillerton & Kliem, 2002, Hillerton & Berry, 2005). Dry 
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cow therapy with antibiotics given by the intramammary route is now a part of dairy farm 
management systems (Five-point plan and Countdown Downunder) recommended to 
reduce the level of intramammary infection. The aim of antibiotic treatment is not only to 
eliminate present infection but to reduce new intramammary infection. Antibiotic treatment 
remains necessary to cure the intramammary infection caused by S. uberis. A UK study of 
54 lactating cows reported that antibiotic treatment was successful in an experimental herd 
(Hillerton & Kliem, 2002).  Intramammary antibiotic treatment with Leo Yellow (Leo Animal 
Health, Princes Risborough, UK which contains penethemate hydroiodide, 
dihydrostreptomycin sulphate, framycetin sulphate, and prednisolone) achieved 70% 
clinical cure in three days and 100% cure within 6 days (Hillerton & Kliem, 2002). A study 
was conducted in four British herds (two herds at the Institute for Animal Health (IAH) and 
two commercial herds undergoing conversion to organic status) on the effect of antibiotic 
dry cow treatment with Cepravin Dry Cow intramammary infusion (contains cephalonium, 
first generation of cephalosporin) and Orbenin Extra (contains cloxacillin)  (Berry & 
Hillerton, 2002b, Hillerton & Kliem, 2002). No cases of clinical mastitis were detected 
during the dry period in the treated quarters in any of the herds (443 quarters from IAH 
herds and 144 quarters from organic herds). Significantly more quarters in the untreated 
groups were found to have clinical mastitis in the dry period in both the IAH and the organic 
herds (7 of 499 quarters, P = 0.012 and 7 out of 172 quarters, P = 0.05, respectively). Dry 
cow therapy also remains important in controlling infection by S. uberis at calving. There 
were significantly more new intramammary infections in the untreated (58 of 433 quarters) 
than treated groups (19 of 424 quarters) for the IAH herds (P < 0.001). A similar situation, 
of more new intramammary infection at calving in the untreated quarters (38 of 134) but no 
new infection in the treated group (144 quarters) was reported for the organic herds (P < 
0.0001). Dry cow therapy appeared to be advantageous for control of environmental 
streptococcal infection during the early dry period but not late dry period (Smith, et al., 
1985). Moreover, another advance has been the demonstration experimentally that earlier 
antibiotic treatment before visible signs of disease was effective against bovine mastitis 
caused by S. uberis (Milner, et al., 1997). 
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There has been criticism of excessive use of antibiotics in animals, including dairy cattle 
(Joint Expert Advisory Committee on Antibiotic Resistance, 1999, Gustafson & Bowen, 
1997). Also there is greater concern about use of antibiotics, related to increased trends of 
organic food consumption (National Mastitis Council, 2004) and the increasing concern 
about the presence of antibiotic residues in milk (McEwen, et al., 1992, Cui, et al., 2007). In 
the case of regular antibiotic use in animal production, it is of great importance to 
administer antibiotics with appropriate regimes to prevent increases in the incidence of 
resistance genes. This is particularly for the case for classes of antibiotic that could result in 
transmission of antibiotic-resistant strains of bacteria to humans (McEwen, et al., 1992, 
Gustafson & Bowen, 1997, National Mastitis Council, 2004).  Therefore, to assist in solving 
these problems and for improved surveillance of the prudent use of antibiotics, 
understanding the current prevalence of antibiotic-resistance in microorganisms isolated 
from infected cows in particular geographic areas is required. The antibiotics used in 
veterinary therapy are usually based on previous information on antibiotic susceptibility 
trends. It becomes necessary at regular intervals to monitor mastitis pathogens for changes 
in antibiotic resistance patterns. In addition, antibiotic treatment of S. uberis to control 
mastitis has not been completely effective. Smith, et al. (1985b) reported that dry cow 
therapy reduced the rate of streptococcal infection during the early dry period but was 
without effect during the prepartum period. Therefore, additional methods and antibiotic 
agents to control this infection are required.    
 
1.4.2 Reduction of pathogen exposure 
An alternative method of control of environmental mastitis could be achieved by decreasing 
exposure of teat ends to the pathogen. The procedures could involve reduction of the 
pathogen load in the environment, use of teat disinfectants, and prevention of exposure of 
teats by the use of barriers.  
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In the USA and the UK where cows are kept in housing systems during winter, a high 
incidence of S. uberis mastitis has often been associated with the use of organic bedding 
material, particularly straw, which is a good substrate for S. uberis replication (Rendos, et 
al., 1975, Ward, et al., 2002). These authors recommended choosing appropriate bedding 
material and frequent replacement of bedding to reduce the exposure of the bacteria to the 
cow teats. There is no report on contaminated bedding materials in Australia since cows 
live outdoors at all times. Cleaning the farm environment, such as the calving area, was 
suggested to reduce the prevalence of S. uberis infection (Brightling, et al., 1998) because 
the pathogen is able to infect via the teat canal after parturition (McDougall, et al., 2004).  
 
Iodine teat dips are the most common form of teat disinfection in Australia and other places 
such as in the USA (Galton, et al., 1986, Brightling, et al., 1998). The Countdown 
Downunder guideline recommends the use of post-milking teat disinfection to reduce 
contamination during lactation (Brightling, et al., 1998). Postmilking teat dip is not highly 
effective in preventing new S. uberis infection; for example, chlorous acid and chlorine 
dioxide reduced only 27.8% of S. uberis infections (Oliver, et al., 1989). Predipping and 
postdipping with a mixture of sodium chlorite and lactic acid, (4XLA®; Alcide Corp., 
Norwalk, CT) resulted in a significant reduction in new intramammary infection by S. uberis 
and S. aureus  compared with quarters with teats postdipped only (Oliver, et al., 1993). The 
advantage of predipping is to reduce the incidence and chance of bacteria entering the bulk 
milk tank. No chapping or irritation of teats was observed in this study. A nisin (a 
bacteriocin of Lactococcus lactis)-based germicidal formulation was evaluated in vivo as a 
teat dip (Sears, et al., 1992). The bactericidal activity of nisin (AMBICIN N®) against five 
mastitis pathogens (S. aureus, S. agalactiae. S. uberis, K. pneumoniae and E. coli) 
suggested the product could be used for prevention of mastitis. This product caused 
greater than three logs reduction in viable count of these pathogens after only one min 
exposure. The inhibitory activity was similar to that exhibited by 1% iodophor teat dip but 
greater than diluted iodophor or 0.5% chlohexidine. The teat dip containing nisin showed a 
lower skin irritation compared to iodophor and chlorine. This indicated that it should be 
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evaluated further for efficacy as a teat sanitizer to reduce new intramammary infection. 
Nisin is known as a broad spectrum agent with activity against Gram-positve bacteria. 
Other ingredients present in AMBICIN N® could contribute to the spectrum of activity 
(Stevens et al., 1991, Stevens et al., 1992). AMBICIN N® contains nisin in combination with 
a chelator, disodium EDTA, facilitated inhibitory activity against Gram-negative bacteria 
(several Salmonella species, Enterobacter aerogenes, Shigella flexneri, Citrobacter freundii 
and Escherichia coli). These authors suggested that the chelator bound magnesium ions in 
the lipopolysaccharide layer of Gram-negative bacteria, producing cells with increased 
susceptibility to antibiotics. Therefore, their results indicated that the inhibitory activity of 
nisin can be extended to Gram-negative bacteria when the outer cell membrane is altered 
with the chelator.  
 
A physical teat barrier could protect intramammary infection by limiting exposure of the 
teats to bacterial invasion. It has been suggested to use teat seals in the non-lactating 
period (Ryan, et al., 1998, Ryan et al., 1999, Berry & Hillerton, 2002a). Teat Seal (Osmond 
Teat Seal, Cross Vetpharm Group Ltd., Dublin, Ireland) is an inert internal teat barrier 
made from bismuth sub-nitrate (an inert salt) in a paraffin base (Berry & Hillerton, 2002a). 
Teat Seal can be used alone or combined with an antibacterial substance such as an 
antibiotic or bacteriocin. Teat Seal in combination with cloxacillin is available in Ireland 
(Berry & Hillerton, 2002a). A formulation of Teat Seal without antibiotics is available in New 
Zealand (Berry & Hillerton, 2002a). Many studies reported success in reducing 
intramammary infection using Teat Seal. A study of seven dairy herds in the UK reported 
no cases of clinical mastitis observed in cows (n = 197) treated with Teat Seal plus 
cloxacillin, while 204 cows with clinical mastitis were observed in the untreated group 
during dry period (Berry & Hillerton, 2002a). This study also found that Teat Seal reduced 
cases of new infection caused by S. aureus (70%) and S. uberis (80%) at calving and 
reduced subsequencet cases of clinical mastitis compared with no treatment (Berry & 
Hillerton, 2002a). In addition, the use of teat sealant plus antibiotic was reported to have a 
better effect on mastitis control than antibiotic alone. Reduction in the incidence of new 
 18
intramammary infection caused by S. uberis in the early dry period, late dry period and at 
calving was greater for internal teat sealant combined with long-acting antibiotic 
(cefalonium) compared to the same antibiotic alone (Berry & Hillerton, 2007). Cows 
receiving teat seal plus antibiotic were less likely to become infected with S. uberis or 
CoNS than cows receiving antibiotic alone (Berry & Hillerton, 2007). Teat seal can also be 
used in combination with a bacteriocin. Ryan et al. (1998) conducted a study in which a 
bacteriocin from Lactococcus lactis, lacticin 3147, produced by a food grade organism, was 
incorporated into a commercial teat seal (antibiotic free). Lacticin 3147 is a broad spectrum 
bacteriocin with bactericidal activity against Streptococcus and Staphylococcus. Using the 
agar diffusion assay, the teat seal containing lacticin 3147 showed zones of inhibition 
against, S. agalactiae, S. dysgalactiae, S. uberis and S. aureus, whereas no zones were 
produced by teat seal alone. The teat seal combination was not irritating to cows. Later, the 
same group of researchers conducted an in vivo study using a teat seal containing lacticin 
3147. In an experiment in which cows were challenged with S. dysgalactiae (Ryan, et al., 
1999) or S. aureus (Twomey, et al., 2000), a significant reduction in clinical mastitis due to 
both pathogens was shown. These studies showed that the teat seal containing the 
bacteriocin not only provides a physical barrier but the bacteriocin can also inhibit the 
growth of pathogens that have potential to invade the teat.  Therefore, this non-antibiotic 
teat sealant could be used as an alternative treatment of dry cow therapy.  It would be 
possible to use teat sealants with other bacteriocins that have an inhibitory effect on other 
mastitis pathogens.  
1.4.3 Interaction of bovine streptococci and minor mastitis pathogens 
The presence of minor pathogens or normal teat flora was reported to influence the 
incidence of streptococcal mastitis. A French study showed that colonization of the teat 
canal by Corynebacterium bovis may prevent infection with major pathogens (S. aureus 
and Streptococcus) (Rainard & Poutrel, 1988). A recent study conducted in six well 
managed commercial dairy herds in the UK, similarly showed a significant reduction in the 
number of S. uberis in milk samples in the presence of Corynebacterium species (normal 
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teat flora) (Green, et al., 2005). The mechanism of the effect of naturally occurring teat 
microflora on the inhibition of S. uberis is not clearly understood. However, a number of 
contributing effects have been postulated including immune stimulation, increased somatic 
cell count (Peeler, et al., 2000), competition for nutrients or attachment sites (Rainard & 
Poutrel, 1988) or the production of an inhibitory substance by the minor bacteria that are 
active against pathogens (Vliegher, et al., 2004, Nascimento, et al., 2005). 
 
The use of minor pathogens, such as CoNS, that have an inhibitory reaction against the 
major mastitis pathogens also shows promise as a method of environmental mastitis 
control. Using an in vitro cross-streaking method, 25% of teat skin normal flora showed 
inhibition against the growth of mastitis pathogens (Woodward, et al., 1987). Species of 
normal flora or contaminants that were able to inhibit Gram-positive mastitis pathogens 
were Corynebacterium spp., Bacillus spp., Aerococcus spp. and Staphylococcus spp. 
Among those bacteria, S. hominis was a predominant species that was able to colonize 
newborn calves and dry cow teats longer than other bacteria and the use of S. hominis was 
suggested as a competitive culture for controlling mastitis (Woodward, et al., 1988). 
Another similar study showed that Staphylococcus chromogenes was predominant in pre-
partum dairy heifers (Devriese, et al., 2002). The bacteria were not associated with 
intramammary infection but protected quarters against elevated SCC in the early post-
partum period (Vliegher, et al., 2003). Two out of ten isolates of S. chromogenes showed 
an  in vitro inhibitory effect against S. aureus, S. dysgalactiae and S. uberis but not E. coli 
(Vliegher, et al., 2004). A recent study from Brazil (Nascimento, et al., 2005) showed 6.4% 
of CoNS involved in bovine mastitis presented in vitro antagonistic activity against Listeria 
monocytogenes (food-borne pathogen) and several stains of S. agalactiae associated with 
bovine mastitis. The CoNS species that showed this activity were S. epidermidis, S. 
simulans, S. saprophyticus, S. hominis and S. arlettae. The inhibitory substances were 
later demonstrated to be bacteriocins. In addition, three strains (one strain of S. arlettae 
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and two strains of S. saprophyticus) were shown to produce a bacteriocin identical to 
aureocin A70, a bacteriocin isolated from S. aureus. 
 
Elevated SCCs and the presence of a large number of bacteria in milk is not a desirable 
outcome for the dairy industry. The use of normal flora as a competitor to pathogens or a 
stimulator of the immune response in cows is a complicated procedure to ensure effective 
control. In addition, Corynebacterium spp. and CoNS are considered to be minor bovine 
mastitis  pathogens (Radostits, et al., 1994, Haltia, et al., 2006). For these reasons, the use 
of an inhibitory substance like a bacteriocin is a better alternative for mastitis control than 
colonizing teats with harmless bacteria or low-grade pathogens.  
1.4.4 Cows immune system 
Another approach to control mastitis is to increase resistance of cows to infection by 
increasing immunity by vaccination, altering the diet or breeding.  
 
Studies on live vaccines against S. uberis have been conducted in the UK with some 
success. In 1988, 17 lactating cows which had experienced a previous intramammary 
infection with S. uberis 0140J demonstrated a reduction (from 87 to 32%) in clinical mastitis 
following subsequent experimental challenge (Hill, 1988).  Later, a study in which cows 
were immunized with a subcutaneous preparation of live S. uberis (0140J) plus an 
intramammary booster with bacterial surface extract derived from the same strain, showed 
that protection could be achieved against experimental challenge with the same strain (only 
12.5% of challenged quarters developed clinical mastitis) (Hill, et al., 1994). In addition, a 
study of a killed S. uberis product showed protection from clinical mastitis by the same 
strain (Finch, et al., 1994). However, the live vaccine did not protect against challenge with 
a different strain, S. uberis C221 (Finch, et al., 1997).    
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Recent advances in molecular biology have lead to progress in more efficient vaccines 
against S. uberis. New vaccines are based on the use of a bacterial extract which contains 
antigen from the most common bacterial serotypes or from purified antigens which may or 
may not be conjugated to carriers in order to increase immunological efficiency. One 
possible method of protection from S. uberis infection is to reduce the rate of bacterial 
growth in the mammary gland. Plasminogen activator, PauA, converts plasminogen in 
bovine milk to the serine protease, plasmin which is required for growth of S. uberis (Ward 
& Leigh, 2004). A concentrated culture filtrate containing PauA and purified PauA were 
combined with either Freund's incomplete adjuvant (FIA) or a veterinary adjuvant, SB62, 
and used to vaccinate dairy cows by the subcutaneous route (Leigh, et al., 1999). 
Immunisation of four animals with purified PauA combined with FIA conferred no protection 
to mastitis following intramammary challenge with S. uberis 0140J. However, immunisation 
of two groups of four animals with the total antigen (PauA) combined with either FIA or 
SB62 induced protection in 3 out of 8 and 5 out of 8 similarly challenged quarters, 
respectively. Vaccinated, protected cattle generated serum antibody responses that 
inhibited plasminogen activation by PauA, which was important in preventing colonisation 
of the infection caused by S. uberis.  This vaccine has not yet lead to commercial 
production but further study on this efficacious vaccine is continuing (McVey, et al., 2005).  
 
Dietary control can have a beneficial effect on the incidence of clinical mastitis. Vitamin E is 
a fat-soluble vitamin which is located in membranes. Dietary levels of vitamin E may be 
reduced during the winter housing period or in zero-grazing systems when the cows are fed 
mainly on stored feedstuffs which may have a low vitamin E content (Ndiweni & Finch, 
1995). Selenium is a co-factor of the cytosolic enzyme glutathione peroxidase, which is 
essential for the detoxification of hydrogen and lipid peroxides. The selenium status of dairy 
cows may be compromised in animals reared in areas in which soil is defecient in selenium 
content and fed mainly on locally grown feedstuffs (Ndiweni & Finch, 1995). A low vitamin 
E/selenium status has been associated with increased bovine mastitis (Atroshi, et al., 
1987). A study in the USA on supplementation with vitamin E showed 37% reduction of 
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clinical mastitis and reduction in the duration of clinical signs in a selenium-injected group 
(Smith, et al., 1984). Since leucocytes provide the major cellular defense mechanism within 
the mammary gland, the effect of in vitro supplementation with vitamin E and selenium on 
the function of these cells was investigated. In vitro supplementation with vitamin E and 
selenium was found to stimulate the number and function of bovine mammary gland 
macrophages and lymphocyte (Ndiweni & Finch, 1995), enhance migration of 
polymorphonuclear leukocytes and enhance the phagocytosis of opsonised S. aureus by 
polymorphonuclear leukocytes (Ndiweni & Finch, 1996). 
 
Breeding for resistance to mastitis pathogens is another approach for sustainable mastitis 
control (Detilleux, 2002). There are many criteria for resistance trait selection, such as low 
susceptiblility to pathogens, adequate somatic cell count or udder and teat conformation. 
Selection of trait resistance can be conducted by phenotypic and genotypic strategies. 
Information can be collected on clinical cases of the number and function of leukocytes 
from milk and presence of particular genes affecting resistance relating to immune function 
such as CD18 and tumor necrosis factor-α (TNF-α) (Detilleux, 2002). Cows with a suitable 
combination of characteristics can be selected and used as parents for the next generation. 
Breeding improvement is not designed for curing the infection at present; it does not 
guarantee resistance in all environments and is very complex, time consuming and could 
take several generations to show any effect.       
1.5 Bacteriocins 
Bacteriocins are ribosomally synthesized bactericidal proteins produced by many species 
of bacteria. These proteins demonstrate a quite narrow spectrum of antibiotic activity, 
generally against bacteria closely related to the producer strain (Tagg, et al., 1976). They 
include a diversity of proteins in terms of size, microbial targets, modes of action and 
immunity mechanisms. Many bacteriocins have successfully achieved widespread 
application, mainly in food preservation (Coventry, et al., 1997, Wan, et al., 1997, 
Aymerich, et al., 2000, Ayad, et al., 2002). As the overuse of antibiotics in human and 
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veterinary medical practice has led to the development of antibiotic-resistant strains, there 
is increased interest in the application of bacteriocins to the management of bacterial 
infections of humans and animals (Grave, et al., 1999, Erskine, et al., 2002, Catry, et al., 
2003). Introducing benign bacteriocin-producing bacteria into the indigenous microbial 
population to control the emergence of pathogens has been suggested by some authors 
(Woodward, et al., 1987, Oliveira, et al., 1988, Woodward, et al., 1988, Vliegher, et al., 
2003, Vliegher, et al., 2004). 
 
Tagg et al. (1976) reviewed the discovery of the first bacteriocin, colicin, which was found 
in a strain of Escherichia coli. The term bacteriocin usually refers to colicins, which are 
generally restricted to strains of Enterobacteriaceae. The authors summarized six criteria in 
defining bacteriocins “(i) a narrow inhibitory spectrum of activity centered about the 
homologous species; (ii) the presence of an essential, biologically active protein moiety; (iii) 
a bactericidal mode of action; (iv) attachment to specific cell receptors; (v) plasmid-borne 
genetic determinants of bacteriocin production of host cell bacteriocin immunity; (vi) 
production by lethal biosynthesis.” However, most of the bacteriocins produced by Gram-
positive bacteria do not fit into this definition, meeting only criteria (i) and (iii). Moreover, 
there is no universally accepted definition of bacteriocins and many bacteriocins have not 
been sufficiently characterized (Cladera-Olivera, et al., 2004). Some researchers prefer to 
use the term “bacteriocin-like substances” (Tagg, et al., 1976).  
 
Many of the genetic determinants of bacteriocins are encoded in plasmids. Plasmid-
encoded bacteriocins include aureocin from S. aureus A70 (Nascimento, et al., 2002), 
aureocin A53 from S. aureus A53 (Netz, et al., 2002a) and nukacin ISK-1 from S. warneri 
ISK-1 (Aso, et al., 2005b). Transposons are mobile genetic elements with the capacity to 
jump to new target DNA (McGregor, 2003). Nisin from Lactococcus lactis was shown to be 
transposon associated (Li & O’Sullivan, 2002, Stentz, et al., 2004). 
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The mode of action of many bacteriocins has not been completely investigated; however, 
colicins have been investigated in great detail. Some reviewers (Riley, 1993, Daw & 
Falkiner, 1996) have classified the four killing mechanisms of colicins: destruction of cell 
permeability by damaging the cytoplasmic membrane, degradation of DNA, inhibition of 
protein synthesis and cell lysis by inhibition of peptidoglycan synthesis. The mode of action 
of bacteriocins may vary from one type to another. A bacteriocin produced by S. 
epidermidis 1580, staphylococcin 1580, inhibited simultaneously the syntheses of DNA, 
ribonucleic acid, and protein. (Jetten & Vogels, 1972a). A bacteriocin from S. aureus, 
aureocin A53, with bactericidal activity against S. simulans 22 stopped biosynthesis of 
DNA, polysaccharides, and protein (Netz, et al., 2002b). Lysostaphin from S. simulans 
cleaved peptidoglycans of S. aureus target cells (Baba & Schneewind, 1996). Lactocin 27 
produced by a Lactobacillus helveticus strain had a bacteriostatic effect on the indicator, 
Lactobacillus helveticus strain LS18. It inhibited primarily protein synthesis without affecting 
DNA and RNA synthesis or adenosine 5′-triphosphate levels (Upreti & Hinsdill, 1975).   
 
Most work on bacteriocin production by Gram-positive bacteria has focused on lactic acid 
bacteria in fermented food (Klaenhammer, 1993) and in food preservation (Coventry, et al., 
1997, Wan, et al., 1997, Aymerich, et al., 2000, Ayad, et al., 2002). Klaenhammer (1993) 
classified the bacteriocins produced by lactic acid bacteria into four distinct classes. Class I 
bacteriocins, lantibiotics, are small peptides with a molecular weight of less than five kDa, 
containing the unusual amino acid, lanthionine. Class II bacteriocins are non-lanthionine 
containing, small (less than 10 kDa), heat-stable peptides that act by membrane 
permeabilization of susceptible microorganisms. Class II bacteriocins are further divided 
into three subgroups: subclass IIa are Listeria-active peptides, subclass IIb contains two 
peptides that act synergically and subclass IIc are thiol-activated peptides. Class III 
bacteriocins are large (more than 30 kDa)  heat-labile proteins (Nilsen, et al., 2003). Class 
IV bacteriocins are complex, consisting of proteins associated with a lipid or carbohydrate 
moiety that is required for activity.     
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1.5.1 General properties of bacteriocins from staphylococci  
Most bacteriocins are released into surrounding media and therefore they can be detected 
in the supernate (Hale & Hinsdill, 1973, Nakamura, et al., 1983, Sahl, 1994, Netz, et al., 
2002a). In cases where no bacteriocin was released into broth media, it may be possible to 
extract the bacteriocin from an agar medium (Tagg, et al., 1973, Villani, et al., 2001). Some 
bacteriocins remain associated with producer cells and the bacteriocins can be extracted 
from the cell pellets (Yang, et al., 1992, Mota-Meira, et al., 1997). 
 
Bacteriocins are proteinaceous compounds of varying amino acid sequences. Many of the 
bacteriocins belong to class I and II which are small peptides (Klaenhammer, 1993). 
Bacteriocins produced from staphylococci (Table1.1) are normally less than 10 kDa in size 
with some exceptions, such as Bac 201 (41000 Da). The proteineacious nature of 
bacteriocins can be confirmed by proteolytic enzyme digestion (Coventry, et al., 1996, 
Villani, et al., 2001, Hechard, et al., 2005, Nascimento, et al., 2005).  
 
 
 
 
 
 
 
 
 
 
Table 1.1 Bacteriocins from the genus Staphylococcus  
Bacteriocin Organism Molecular 
weight 
(Da) 
Reference 
No designated name  Staphylococcus aureus strain 5,000 (Nakamura, et al., 1983) 
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IYS2 
Staphylococcin 462 Staphylococcus aureus 462 9,000 (Hale & Hinsdill, 1973) 
Staphyloeoccin Au-26 Staphylococcus aureus 26 2,700 (Scott, et al., 1992) 
Staphylococcin 1580 Staphylococcus epidermidis 
1580 
2,000 (Sahl, 1994) 
Staphylococcin 
BacR1 
Staphylococcus aureus UT0007 3,338 (Crupper, et al., 1997) 
Bac 201 Staphylococcus aureus AB201 41,000 (Iqbal, et al., 1999) 
Staphylococcins 
C55α 
Staphylococcins 
C55β 
Staphylococcus aureus C55 
Staphylococcus aureus C55 
3,339 
2,993
(Navaratna, et al., 1998) 
(Navaratna, et al., 1998) 
Micrococcin P1 Staphylococcus equorum WS 
2733 
1,143 (Carnio, et al., 2000) 
Aureocin A70 Staphylococcus aureus A70 NA (Netz, et al., 2001) 
Aureocin A53 Staphylococcus aureus A53 6,012.5 (Netz, et al., 2002a)  
Staphylococcin 188 Staphylococcus aureus 188 NA (Saeed, et al., 2004) 
Nukacin ISK-1 Staphylococcus warneri ISK-1 2,960 (Aso, et al., 2005a)   
Warnericin RB4 Staphylococcus warneri RB4 2,958.2 (Minamikawa, et al., 
2005) 
Epilancin 15X Staphylococcus epidermidis 3172.75 (Ekkelenkamp, et al., 
2005) 
No designated name Staphylococcus warneri RK 2,613.8 
and 
2,449.4
(Hechard, et al., 2005) 
  
 
NA: not available   
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A number of bacteriocins from Gram positive bacteria have a relatively wide spectrum 
compared to bacteriocins from Gram negative bacteria, for example, colicins (Jack, et al., 
1995). Some inhibitory peptides from Staphylococcus spp. are active against a wide range 
of Gram positive bacteria and interestingly those bacteriocins also have a broad spectrum 
of activity against Gram-negative organisms. For example, bacteriocins from 
Staphylococcus aureus; Staphylococcin 462 (Hale & Hinsdill, 1975), Bac 1829 (Crupper & 
Iandolo, 1996), Staphylococcin BacR1 (Crupper, et al., 1997) and Bac201 (Iqbal, et al., 
1999) exhibited broad spectrum activity against a variety of species of bacteria. In contrast, 
some bacteriocins from Staphylococcus spp. have a spectrum that is very specific to Gram 
negative bacteria. For example, an antibacterial peptide from Staphylococcus warneri has 
a spectrum of activity directed toward the genus Legionella (Hechard et al., 2005). Another 
strain of Staphylococcus warneri RB4 produced an anti-Alicyclobacillus bacteriocin, 
warnericin RB4 (Minamikawa, et al., 2005).   
1.5.2 Assay of bacteriocins  
1.5.2.1 Detection of bacteriocin producer strains 
The most commonly used procedure for detecting bacteriocin-producer strains is the spot 
on lawn method. Pure cultures of the test organisms are spotted on an appropriate agar 
medium and the plate is incubated for sufficient time to develop inhibitory activity. The plate 
is then overlaid with a semisolid agar seeded with an indicator strain. Inhibition zones 
around the culture after incubation of the overlaid culture indicate the presence of inhibitory 
activity (Harting, et al., 1972) 
 
A slightly modified spot on lawn assay has also been described as suitable for screening 
mixed cultures for bacteriocin production. A study of antagonistic activity of oral bacteria 
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towards the periodontopathic bacterium, Treponema denticola, used a modified method 
(Grenier, 1996). Subgingival plaque samples were plated directly on oral spirochete 
medium, which had been spread with the indicator strain. The putative bacteriocin producer 
strains were observed and isolated from the original plate. An Australian study for detection 
of bacteriocin producers from food was performed by a variation of the spot on lawn 
method in which samples contained mixed cultures (Coventry, et al., 1997). Food samples, 
including meats, chicken, milk, milk products, vegetables and seafood, were plated in de 
Man, Rogosa and Sharpe (MRS) agar and yeast extract lactate agar. After incubation 
under anaerobic conditions, the agar plates were overlaid with indicator strains. Clearing 
zones of growth inhibition were then observed and selected colonies suspected to be 
bacteriocin producers were isolated from within the agar. Villani and colleagues (2001) 
grew test organisms from fresh raw cow’s milk samples without isolating individual strains, 
before examining the activity against a variety of indicator strains including Listeria 
monocytogenes. After incubation of milk samples, the plates were overlaid with soft 
medium seeded with indicator strains.   
 
Another method, the agar inversion method, consists of streaking a culture of test strains 
across a plate in parallel lines, then incubating the plate to allow bacteriocin to be 
produced. Next the agar is inverted and the indicator strain is cross streaked on the 
inverted surface. Inhibition zones are observed after a standardized incubation time. This 
method has the benefit of distinguishing bacteriophage activity from bacteriocins since 
bacteriocins are able to diffuse through the agar, whereas phage cannot (Vliegher, et al., 
2004).     
1.5.2.2 Assay of bacteriocin activity  
The activity of bacteriocins from broth cultures is commonly measured by the diffusion 
method on agar plates with three alternative protocols in which the culture supernate is 
delivered in a well cut in the agar, spotted onto the surface or incorporated into a disc. Of 
these methods, the agar diffusion assay is the most common (Nakamura, et al., 1983, 
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Crupper & Iandolo, 1996, Crupper, et al., 1997, Crupper & Iandolo, 1997, Iqbal, et al., 
1999, Hechard, et al., 2005, Minamikawa, et al., 2005). The method involves cutting holes 
in agar plates seeded with indicator strains, and placing the culture supernate in the holes. 
After incubation, the inhibition zones are measured. For the spot protocol, a drop of cell-
free bacteriocin-containing solution is spotted on an agar plate. After the drop is allowed to 
dry, the plate is overlaid with a indicator strain and the inhibition zone measured after 
incubation for an appropriate period (Hale & Hinsdill, 1973, Wirawan, et al., 2006). For the 
disc diffusion method, a solution containing the bacteriocin is applied to a blank paper disc 
which is then placed on an agar medium containing the indicator strain. The size of the 
inhibition zone is observed after incubation (Bizani & Brandelli, 2002, Delgado, et al., 
2005). The agar diffusion assay is time consuming and laborious but it is simple, 
reproducible and no complicated equipment is required (Turcotte, et al., 2004). This assay 
is still the most widely used quantitative technique to measure antibiotic activity of 
bacteriocins.   
 
Bacteriocin activity can also be quantified by a liquid assay using photometric or turbidity 
measurement in a tube or microtiter plate assay (Parente, et al., 1995, Turcotte, et al., 
2004). Briefly, a bacteriocin in liquid form and a standardized indicator strain are incubated 
together in suitable conditions. The bacteriocin activity is measured by the reduction of 
turbidity of the indicator strain compared with a control sample without bacteriocin. The 
method requires optimization, depending on the type of bacteriocin and the sensitivity of 
the indicator organism. The limitations of this procedure are low reproducibility, since the 
assay is critically dependent on incubation time. Precise measurement of indicator strain 
concentration and growth phase are also critical in this assay. The method nevertheless is 
a rapid technique (Turcotte, et al., 2004).       
 
 
1.5.3 Exclusion of non-bacteriocin inhibitory agents 
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The screening methods for bacteriocin producers described in the previous sections give 
preliminary information. However, other causes of inhibitory activity, (bacteriophage, 
hydrogen peroxide and organic acids) need to be eliminated (Jack, et al., 1995). The 
inhibitory effect from bacteriophage can be ruled out by using the agar inversion method 
because bacteriophages are not able to pass through agar (Vliegher, et al., 2004). Ultra 
structure of bacteriophage visualized using electronmicroscopy can also distinguish phage 
from bacteriocin (Zink, et al., 1995). Increasing dilution of culture supernate is another 
method used to distinguish bacteriocin and bacteriophage. On dilution, bacteriophage 
shows a decreasing number of discrete phage plaques on agar plates seeded with an 
indicator strain but bacteriocin shows a diffuse thinning of growth becoming less marked 
with increasing dilution of the supernate (Mayr-Harting, et al., 1972). By-products of 
metabolism, such as hydrogen peroxide, are usually produced by Streptococcus sp. (Tagg, 
et al., 1976). Hydrogen peroxide production may be misinterpreted as an inhibitory effect 
caused by bacteriocins. The inhibitory activity of hydrogen peroxide can be eliminated by 
incubation of the bacteriocin producer strains on medium supplemented with catalase 
(Tagg, et al., 1976). In another method, peroxide production was ruled out by 
demonstration of a reduction in inhibitory activity after catalase was added to the crude 
bacteriocin solution to destroy peroxide in the solution (Ogunbanwo, et al., 2003, Aslim, et 
al., 2005). The inhibitory effect by organic acids was removed by culturing test strains in 
media with calcium carbonate as a buffer (Minamikawa, et al., 2005, Wirawan, et al., 2006) 
or by neutralizing the inhibitory substances with NaOH to pH 7.0 prior to examining for the 
bacteriocin activity (Ogunbanwo, et al., 2003, Aslim, et al., 2005, Nascimento, et al., 2005).   
 
 
1.5.4 Production of bacteriocins   
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Factors affecting bacteriocin production include both producer cells and environmental 
factors. Each bacteriocin is unique in its optimal conditions for production. Therefore, it is 
necessary to design experimental conditions specific for each bacteriocin-producing strain.  
1.5.4.1 Growth phase  
Bacteriocin production depends on the producer’s growth phase. Most bacteriocins are 
produced during the exponential growth phase with greatest production occurring during 
the beginning of the stationary phase (Iqbal, et al., 1999, Abriouel, et al., 2003, He, et al., 
2006). Bacteriocin levels decrease at the end of stationary phase due to degradation by 
proteases (Kim, et al., 2006) or binding of bacteriocins to producer cells (Houlihan & 
Russell, 2006). This feature of the bacteriocin production profile is common to almost all 
lactic acid bacteria and other organisms that produce bacteriocins, including 
Staphylococcus sp. For example, garviecin L1-5, produced by Lactococcus garvieae L1-5, 
was produced in the log phase of growth and maximum activity was reached at late log to 
early stationary phase of growth (Villani, et al., 2001). Activity of acidocin D20079, a 
bacteriocin produced by Lactobacillus acidophilus DSM20079, was observed during the 
transition from the exponential to the stationary phase. The activity were highest for a very 
short period at 11 to 13 h of incubation and then sharply decreased (Deraz, et al., 2005). 
Production of Bac1829 from Staphylococcus aureus KSI1829 began in the stationary 
phase of growth (Crupper & Iandolo, 1996). Staphylococcus aureus AB201 produced Bac 
201 during  exponential phase growth (Iqbal, et al., 1999). Warnericin RB4 by 
Staphylococcus warneri RB4 was produced in the exponential phase; the yield reached a 
maximum (1,280 AU/mL) at the end of the exponential growth phase (Minamikawa, et al., 
2005).  
 
 
1.5.4.2 Growth medium 
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Optimization of growth conditions and medium composition is required to obtain the 
maximum yields of bacteriocin to facilitate further investigations. Production of a bacteriocin 
by Lactobacillus brevis OG1 increased from 3200 to 6400 AU/mL with the addition of yeast 
extract (3.0%), NaCl (1.0-2.0%), glucose (1.0%) or Tween 80 (0.5%) to MRS medium 
(Ogunbanwo, et al., 2003). Methods for maximum production of four mutacins (A-CM7, B-
Ny266, C-7A and H-29B) by S. mutans were optimized (Nicolas, et al., 2004). Buffering 
substances, organic carbon sources and organic nitrogen sources were tested in order to 
improve bacteriocin production. The results showed that culture medium consisting of 
cheese whey permeate (6%), yeast extract (2%) and CaCO3 (1%) was both inexpensive 
and provided optimal growth conditions for production of the four mutacins. 
Supplementation of milk medium with yeast extract (0.3-1.0%) enhanced  production of 
bacteriocins by seven Lactobacillus strains (Avonts, et al., 2004). The yeast extract used in 
microbiological media has very reliable composition, however, that for industrial formulation 
may vary somewhat more. See John’s comments at the edge of the page.Defined medium 
may not assist in production of bacteriocins. Fifteen strains of S. mutans showed 
bacteriocin production with basal trypticase medium and brain heart infusion but no 
production was detected in a defined medium, M3, by the spot on lawn method (Rogers, 
1972). Production of bacteriocin from Bacteroides strain T1-1 showed a bacteriocin titer of 
32 to 64 in complex medium (Brain Heart Infusion) but only trace amounts were produced 
in a defined medium (Booth, et al., 1977).  
 
It has been reported that production of bacteriocins by lactic acid bacteria was enhanced 
by osmotic stress induced by increasing the NaCl concentration in the culture medium. 
Investigations into the production of amylovorin L471 from Lactobacillus amylovorus DCE 
471, isolated from Sudanese Kisra fermentations of sorghum flour, showed that addition of 
10 g/l of NaCl in a sourdough simulation medium gave maximum bacteriocin activity. NaCl 
also played an important role on the production of nukacin ISK-1 from Staphylococcus 
warneri ISK-1 isolated from fermented rice bran (Sashihara, et al., 2001). It was found that 
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not only addition of NaCl, but also KCl and sorbitol increased the production of this 
bacteriocin.  
 
A surfactant, Tween 80, added to culture medium was shown to promote the production of 
bacteriocins (Keren, et al., 2004). Moreover, a bacteriocin from S. bovis HC5, Bovicin HC5, 
was detected in higher concentration from medium containing Tween 80 than 
unsupplemented medium.  Cell free culture supernate with Tween 80 added also showed 
increased bacteriocin activity against Clostridium sticklandii SR. The authors concluded 
that Tween 80 enhanced bacteriocin activity by aiding insertion of bacteriocin into the target 
cells rather than by enhancing the release from producer cells.  In contrast, Houlihan and 
Russell (2006) reported that Tween 80 did not increase production of bacteriocins. 
1.5.4.3 pH   
Several studies on bacteriocin production by lactic acid bacteria have shown that 
maintaining a constant pH, usually around 5.0-7.0, enhances bacteriocin production. 
Maximum activity of a bacteriocin produced by Lactobacillus acidophilus DSM 20079, 
acidocin D20079, was obtained from a pH-controlled reactor with MRS broth at pH 6.0 
(Deraz, et al., 2005). In another study, the effect of pH on bacteriocin production from 
Lactococcus sp. GM005 was evaluated in pH-uncontrolled and pH-controlled cultures 
(Onda, et al., 2003). The pH of uncontrolled cultures dramatically changed from 7.0 to 4.4 
after 12 h of incubation with the maximum inhibitory activity at 1280 AU/mL. The 
antibacterial activity was eight times greater at 10,240 AU/mL with pH-controlled cultures at 
pH 6.0. In a similar study, enhanced production of enterocin AS-48 by Enterococcus 
faecalis A-48-32 was obtained when pH was regulated. The pH was maintained above 5.8 
and the maximum inhibitory activity was four times greater than uncontrolled pH culture 
(Abriouel, et al., 2003).   
1.5.4.4 Temperature  
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Optimal growth temperature (generaaly at 30-37°C) usually result in optimal bacteriocin 
production (Kim, et al., 2006). However, a few studies have reported maximal yield of 
bacteriocins at suboptimal growth temperatures. Production of brevicin 286 by 
Lactobacillus brevis VB286 was optimal at 20°C while optimal cell growth occurred 
between 25 and 37°C (Coventry, et al., 1996). For Lacticin RM, maximal activity was 
obtained at 10°C, whereas the optimal growth temperature of the producer, Lactococcus 
lactis subsp. lactis EZ26, was 30°C (Keren, et al., 2004).    
1.5.4.5 Agitation  
The effect of agitation was examined in a few reports. Of the  four mutacins (A-CM7, B-
Ny266, C-7A and H-29B) produced by four strains of S. mutans, agitation only reduced the 
titre of mutacin A-CM7  (Nicolas, et al., 2004). Production of brevicin 286 by Lactobacillus 
brevis VB286 was similar when grown under agitation or non-agitation (Coventry, et al., 
1996). The reduction in bacteriocin activity was thought to be due to degradation by 
protease contained in the culture (Nicolas, et al. 2004). 
1.5.4.6 Other factors 
Recently, an investigation of the influence of sub-inhibitory concentrations of an antibiotic, 
ciprofloxacin, on bacteriocin production in Escherichia coli was reported (Jerman, et al., 
2005). The results of the agar diffusion assay showed that medium containing sub-lethal 
concentrations of ciprofloxacin yielded more colicin (more than 30 fold increase) than 
medium without ciprofloxacin. It was suggested that the antibiotic interferes with DNA 
replication as well as cell wall synthesis, and induced an SOS response which induced 
bacteriocin synthesis. 
1.5.5 Estimation of bacteriocin molecular mass 
Molecular mass can be estimated by different methods, including gel electrophoresis and 
mass spectrometry. Gel electrophoresis is a common procedure to estimate protein size in 
the course of purification of bacteriocins. Mass spectrometry is able to present more 
accurate results from a purified sample.  
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Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) is a method to 
separate proteins by size (Bollag & Edelstein, 1991). SDS associates with the proteins and 
denatures them and gives an overall negative charge enabling separation based on 
molecular weight (Hames, 1998). SDS-PAGE is also a cheap, reproducible and rapid 
method for characterizing proteins. After crude protein separation, the gel is left in a 
mixture of isopropanol and acetic acid to fix the separated proteins and then soaked with 
distilled water. A suitable indicator strain is overlaid on the washed gel, and any zone of 
inhibition is measured after incubation. The position of the inhibition zone is used to 
determine the molecular weight of the bacteriocin  (Crupper, et al., 1997, Iqbal, et al., 
1999).   
 
Mass spectrometry (MS) is an analytical tool used for measuring the molecular mass of a 
sample (Hames, 1998). It is known as an accurate technique for protein size determination. 
The instrument used for MS is divided into three parts; ionization source, analyzer and 
detector. The sample is introduced into the ionization source and the sample molecules are 
ionized. These ions are sent to the analyzer where they are separated according to mass 
(m) - to - charge (z) ratio (m/z). The separated ions are detected and this signal is sent to a 
data system which provides a printout showing molecular weight, and relative amounts of 
the protein(s) in the sample (Hames, 1998).  
 
 
1.5.6 Bacteriocin extraction 
Bacteriocins can be extracellular, cell associated or intracellular peptides. Most published 
data on the bacteriocins isolated from Staphylococcus sp. shows extracellular bacteriocins 
obtained from cell free culture supernate (Crupper & Iandolo, 1996, Crupper, et al., 1997, 
Crupper & Iandolo, 1997, Iqbal, et al., 1999, Hechard, et al., 2005, Minamikawa, et al., 
2005).  
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Some studies of bacteriocins have been hampered by the difficulties in obtaining active 
liquid preparations of the substances. Some studies described bacteriocins that could be 
produced on agar but not when grown in broth. A study from Norway reported that six 
Carnobacterium strains produced bacteriocins on agar but only Carnobacterium 377 
produced the bacteriocin both on agar plates and in broth (Blom, et al., 2001). It is difficult 
to study bacteriocins attached to a solid substrate. For that reason, only the bacteriocin 
produced by Carnobacterium 377 was selected for characterization and purification. In 
another example, a study of a bacteriocins isolated from oral streptococci showed that the 
bacteriocins were labile in liquid media but could be stabilized by increasing the viscosity of 
the media (Kelstrup & Gibbons, 1969). The authors suggested the effective stabilizers such 
as agar, agarose, starch, dextran and glycerol could be used to generate a similar 
environment and possibly similar bacteriocin activity to the matrix of dental plaque 
containing a dextran-like polymer.  
 
Another problem encountered by some investigators is the fact that the bacteriocin 
sometimes remains attached to the producer cells. Release of cell associated bacteriocin 
has been achieved by treatment with saline at acid pH. Bovicin HC5, a bacteriocin from S. 
bovis HC5 and nisin variants produced by S. uberis were extracted by this method 
(Houlihan & Russell, 2006, Wirawan, et al., 2006). Mutacin B-Ny266 produced by S. 
mutans was extracted from cell pellets by a mixture of HCl and ethanol at pH 2.0 (Mota-
Meira, et al., 1997). The suspensions were then heated at 70°C for 40 min and cooled on 
ice and a cell free solution was obtained by centrifugation. The supernate was evaporated 
at 37°C to obtain the bacteriocin-containing solution. The extract from this cell pellet 
showed six times higher specific activity than the culture supernate, which implied the 
higher purity of the bacteriocin.    
1.5.7 Purification of bacteriocins 
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After obtaining the crude bacteriocin in soluble form, recovery of bacteriocin can be 
achieved in many different ways. Purification methods that have been used for bacteriocins 
from staphylococci are varied.  More than one purification step is necessary to reach the 
desired purity in order to identify the protein of interest.  The methods most frequently used 
for isolation, concentration and purification involve salt precipitation followed by a variety of 
chromatography methods such as gel filtration, ion exchange chromatography and 
reversed-phase high performance liquid chromatography (RP-HPLC). 
 
Because most bacteriocins are secreted into the culture medium, purification begins with a 
step to concentrate bacteriocins from culture supernates. Ammonium sulphate precipitation 
(salting out) is frequently used as preliminary step. A high concentration of the salt causes 
proteins to aggregate and precipitate out of solution (Bollag & Edelstein, 1991). After 
protein precipitation, the residue of ammonium sulphate is generally eliminated by dialysis 
(Bollag & Edelstein, 1991). Staphylococcin BacR1, a bacteriocin produced by 
Staphylococcus aureus UT0007 was precipitated from culture supernates by saturation 
with 60% ammonium sulphate (Crupper, et al., 1997). A 8.3-fold purification was achieved 
by this step. The same group of researchers initially purified Bac 1829 from S. aureus 
KSI1829 using saturation with 80% ammonium sulphate, achieving a purification of 1.5 
fold. The advantage of ammonium sulphate precipitation is not only to concentrate the 
protein but also minimize the volume of the sample before proceeding to further purification 
steps. After precipitation with ammonium sulphate, the volume of culture supernate 
containing Warnericin RB4 produced by Staphylococcus warneri RB4 was reduced from 
1000 mL to 100 mL. Ammonium sulphate precipitation does not provide a high degree of 
purification, however.  
 
Further purification techniques differ depending on protein properties such as, charge, 
hydrophobicity and molecular weight (size). Ion exchange chromatography separates 
proteins based on charge. Gel filtration chromatography separates proteins according to 
size. Hydrophobic interaction chromatography or reversed phase HPLC distinguishes 
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proteins by their hydrophobic properties (Harris & Angal, 1990). Each step causes some 
loss of product. Therefore, selection of appropriate purification techniques is extremely 
important.    
 
Affinity chromatography can be very useful for a well-studied bacteriocin such as a 
bacteriocin derived from recombinant producer cells. In a study by Moon et al. (2006), the 
expressed bacteriocin was designated suitable for affinity chromatography. A plasmid 
encoding pediocin PA-1 fused with hexahistidine was introduced to E. coli. The fusion 
protein was expressed and purified by nikel-nitrilotriacetic acid (Ni-NTA) metal affinity 
chromatography, resulting in a high yield of protein of high purity. This method could be 
practical for mass production of bacteriocins (Moon, et al., 2006). A similar method was 
used to purify a recombinant bacteriocin from S. dysgalactiae subsp. equisimilis 
(dysgalacticin), expressed in E. coli (Heng, et al., 2006). 
 
The final step of purification to obtain the highest purity bacteriocin is generally HPLC 
(Muriana & Klaenhammer, 1991, Jimenez-Diaz, et al., 1995, Chumchalova, et al., 2004, 
Ghrairi, et al., 2005). A purified sample may require repeated steps of purification. Crupper 
and coworkers (1997) achieved the final removal of trace elements by two cycles of RP-
HPLC. Fractions containing bacteriocin were obtained by a second cycle of RP-HPLC with 
a shallower gradient of eluent solution.  
1.6 Aims of this study 
Streptococcus uberis has become an important cause of intramammary infection in dairy 
cows. Based on the above background, the first aim of this project was to isolate and 
identify S. uberis from bovine milk in Victoria using a minimum group of conventional tests 
suitable for use in diagnostic veterinary laboratories. 16S rRNA sequencing was used as a 
gold standard for bacterial identification. Since treatment of bovine mastitis requires the use 
of antibiotics, the second aim of this project was to determine the antibiotic susceptibility of 
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the isolates. The third aim was to isolate, purify and characterize a bacteriocin from a 
member of the normal teat flora of cows. 
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Chapter 2 Isolation and identification of Streptococcus 
uberis by conventional methods 
2.1 Introduction 
Streptococcus uberis is a worldwide environmental mastitis pathogen. Epidemiologic 
studies and control of S. uberis have been limited by lack of accurate and convenient 
methods for routine species identification. Accurate and cost effective methods of mastitis 
pathogen identification are important to diagnostic laboratories. Suitable methods for 
identifying this mastitis pathogen would facilitate designing a management strategy to 
reduce cases and improve prognosis for infected cows.  
 
Specific identification of S. uberis is difficult as it has variable reactions on culture media, in 
biochemical tests and by serotyping. The results may vary from one laboratory to another 
depending on the procedures used. Gram-positive cocci causing bovine mastitis are mainly 
Staphylococcus spp. or Streptococcus spp. The catalase test helps differentiate between 
these two genera. In many diagnostic laboratories, Gram-positive cocci, isolated from 
clinical and subclinical mastitis, that are catalase-negative and hydrolyze esculin are 
identified as S. uberis (Anonymous, 1990, Devriese, et al., 1999, Odierno, et al., 2006), 
however, this group of bacteria contains other species such as Aerococccus spp., 
Enterococcus spp., Lactococcus spp., S. bovis, S. dysgalactiae, S. pluranimalium and S. 
gallolyticus (Devriese, et al., 1999, Fortin, et al., 2003).  
 
Generally, differentiation of the genus Streptococcus causing bovine mastitis is undertaken 
by observing the hemolytic reaction on blood-containing media, carbohydrate antigen 
grouping (Lancefield grouping) and phenotypic tests. Esculin is incorporated into the 
primary isolation media (Edwards medium) for isolating streptococci mastitis pathogens by 
most veterinary laboratories. In addition to S. uberis, S. bovis, S. equinus, E. faecalis, E. 
faecium and E. saccharolyticus are esculin hydrolyzing bacteria and S. dysgalactiae and S. 
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equi as esculin-variable species (Anonymous, 1990). Some authors state that the 6.5% 
sodium chloride growth tolerance test must be a part of the S. uberis identification scheme 
to exclude enterococci (Watts, 1988, Anonymous, 1990, Cowan, et al., 1993). Fortin et al. 
(2003) suggested that hippurate hydrolysis and acid production from inulin assisted 
differentiation of S. uberis from catalase negative, esculin-hydrolysing Gram-positive cocci. 
Acid production from mannitol has also been used to differentiate S. uberis from other 
streptococci (Cowan, et al., 1993). Lancefield grouping is a useful assay to differentiate 
mastitis streptococci since S. agalactiae, S. dysgalactiae and enterococci belong to 
Lancefield group B, C and D respectively (Cowan, et al., 1993). However, grouping is not a 
useful discriminatory test for S. uberis since strains fall into at least six serological groups, 
all of which include representatives of a variety of other species.  Streptococcus uberis 
could belong to group A, E, G, P, U or more than one group or be non-groupable (Lammler, 
1991, Khan, et al., 2003). The CAMP test (a test for production enhanced haemolysis, 
designed by Christie, Atkins, Munch and Petersen) was considered to assist in 
identification of S. agalactiae but some cultures of S. uberis  demonstrated CAMP-like 
synergistic hemolytic activity on sheep blood agar (Lammler, 1991, Khan, et al., 2003, 
McDonald, et al., 2005). Thus, the CAMP test was not recommended in identifying S. 
uberis.    Several attempts have been made to develop a simple yet accurate scheme for 
identification of S. uberis (Fortin, et al., 2003, Khan, et al., 2003, Odierno, et al., 2006), 
however, most schemes require a large number of tests or are complicated to use, which 
makes them unsuitable for routine application. A commercial kit which contains several 
biochemical reactions such as API 20 Strep may be useful to confirm the identity of an 
isolate obtained from a cow with mastitis when routine tests give doubtful identification 
(Odierno, et al., 2006). 
 
A survey of methods used by veterinary laboratories in Australia and New Zealand to 
identify mastitis pathogens was undertaken in 2003 by a former PhD student (W. 
McDonald, PhD thesis, RMIT University, 2003). The results showed that of the 17 
diagnostic veterinary laboratories surveyed, including commercial, government and clinical 
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laboratories, each used a range of different biochemical and serological tests to identify 
mastitis pathogens, but did not use genotypic methods. Species-specific PCR assays are 
available for S. uberis. In addition, 16S rRNA gene sequencing is a very accurate, but 
expensive method for classification of streptococci, including S. uberis (Facklam, 2002).  
 
The main objective of this section was to improve the identification procedures for S. uberis 
from milk by developing a scheme with the required level of accuracy while using a 
minimum number of conventional methods suitable for diagnostic veterinary laboratories. 
Catalase-negative, esculin-hydrolyzing Gram-positive cocci isolated from infected bovine 
milk were identified using four additional tests (hippurate hydrolysis, acid production from 
inulin and mannitol and growth in 6.5% NaCl). The API 20 Strep system was used to 
confirm the species identity. The method of 16S rRNA gene sequencing was used as the 
gold standard for evaluating the results of biochemical testing. Since very little information 
is available on the molecular epidemiology of S. parauberis, subspecies identification of 
isolates identified a S. parauberis was performed by PFGE. 
2.2 Materials and methods  
2.2.1 Milk sample collection   
Milk samples from each quarter were collected aseptically following Countdown 
Downunder instructions (Brightling, et al., 1998). Briefly, gloves were worn throughout the 
procedure and were changed after collection from each cow. A paper towel or a cotton ball 
with 70% ethanol was used for wiping teats individually. After cleaning teats, the first squirt 
of milk was discarded, then one to five mL was collected into a sterile container, transported 
on ice and cultured immediately on arrival in the laboratory.   
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Cows with clots in their milk or visible signs of teat inflammation were defined as having 
clinical mastitis. Subclinical mastitis was defined if the somatic cell count (SCC) was 
greater than 250,000 cells/mL when performed by a herd testing service within two weeks 
of milk collection for culture. Cows with milk SCCs less than 250,000 cells/mL were 
defined as having a low cell count. 
 
Chi-square analysis was used to examine the association between disease status and 
qualitative growth of S. uberis. The significance level was set at 0.05. 
2.2.2 Bacterial reference strains 
The bacterial reference strain from the American Type Culture Collection (ATCC) used in 
this study was S. uberis ATCC 700407. The strain was stored at -80°C in Protect Bacterial 
Preservers. The reference strain was cultured from storage at -80°C by aseptically 
transferring the bacterial preserver beads onto horse blood agar (HBA, Appendix C) or brain 
heart infusion agar (BHA, Appendix C), streaking and incubating for 24 hours for further 
testing.  
 
2.2.3 Streptococcus uberis isolation and identification 
Milk samples were mixed by swirling, then 50 µl aliquots were plated onto HBA and 
Edwards medium (Appendix C) and incubated at 37°C for 48 hours. A single colony 
resembling S. uberis was examined macroscopically and microscopically then subcultured 
onto another HBA or BHA to obtain a pure isolate for further identification. Isolate 
designation was set up as follows: cow’s number, dash (-) and isolate number. 
2.2.3.1 Phenotypic identification 
Streptococcus uberis ATCC 700407 was used as a control. 
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Macroscopic examinations 
Colonial morphology on HBA and Edwards agar was observed. Bacterial growth of 1 to 10, 
11 to 50 and more than 50 colonies were defined as +, ++ and +++ respectively. 
Microscopic examinations 
A gram stain of the isolates was examined. The cell morphology and cell arrangement were 
observed under a microscope.   
Physiological and biochemical examinations 
Physiological and biochemical tests performed on bacterial isolates that were Gram 
positive and negative for catalase production were set up for esculin hydrolysis, hippurate 
hydrolysis, inulin fermentation, mannitol fermentation and tolerance to 6.5% sodium 
chloride.  
• Catalase test (Isenberg, 1992) 
The catalase test was performed by transferring a bacterial colony with a sterile tooth pick 
onto a coverslip and placing a drop of 3% H2O2 on top of the cells. Production of gas 
bubbles immediately indicated a positive reaction. Any colony that showed a positive 
reaction was discarded.   
• Esculin hydrolysis test (Isenberg, 1992).   
Esculin broth consisted of 25 g nutrient broth No. 2, 3 g yeast extract, 1 g esculin, 0.5 g 
ferric citrate and made up to 1000 mL with distilled water. The ingredients were mixed to 
dissolve, adjusted to pH 7.3 to 7.5, and 3 mL aliquots were dispensed into 16 × 110 mm 
tubes and sterilized by autoclaving at 110°C for 25 min. After inoculation with the test 
strains, broths were incubated at 37°C for 24 h. A positive result showed black coloration 
due to hydrolysis of esculin to esculitin, which forms a black complex with ferric ions. 
• Hippurate hydrolysis test  (Cowan, et al., 1993)  
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Hippurate broth consisted of 10 g sodium hippurate and 1,000 mL distilled water. The 
ingredients were mixed to dissolve and adjusted pH 7.1, dispensed 2 mL in 16 × 110 mm 
test tubes and sterilized by autoclaving at 121°C for 15 min. A heavy loopful of culture was 
aseptically inoculated into the test tube and incubated for 2 h at 37°C. One mL of ninhydrin 
reagent was added to a test tube, mixed and incubated for 15 min at 37°C. Ninhydrin 
reagent consisted of 3.5 g ninhydrin, 50 mL acetone and 50 mL butanol. The ingredients 
were mixed freshly before use. A blue to purple color indicated hydrolysis of the hippurate 
to benzoate and glycine and the formation of a purple coloured compound after the addition 
of ninhydrin.   
• Inulin or mannitol broth (Isenberg, 1992)  
Inulin or mannitol broths consisted of 10 g bacteriological peptone, 5 g sodium chloride, 1 
mL bromcresol purple (2% solution in ethanol), 10 g inulin or mannitol made up to 1,000 
mL with distilled water. The ingredients were mixed and adjusted to pH 7.2-7.3. The 
medium was dispensed 3 mL in 16 mm × 110 mm test tubes and sterilized by autoclaving at 
110°C for 25 min. The culture was aseptically inoculated into the test tube and incubated for 
24 h at 37°C. Acid production was indicated by a color change from purple to yellow.   
 
• 6.5% sodium chloride broth (Isenberg, 1992)  
The broth consisted of 25 g nutrient broth No.2, 65 g sodium chloride and 1,000 mL 
distilled water. The ingredients were mixed, 3 mL was dispensed in 16 × 110 mm test tubes 
and sterilized by autoclaving at 121°C for 15 min. The culture was aseptically inoculated 
and incubated for 24 hours at 37°C. Any growth indicates tolerance to sodium chloride, 
which is typical of enterococci.     
Commercial kit identification– API 20 Strep   
 46
Isolates that gave equivocal results with the conventional tests were further analyzed using 
the API 20 Strep test, following the manufacturer’s instructions. The dehydrated substrates 
(n = 20) were rehydrated by adding a bacterial suspension. The inoculum was prepared with 
freshly grown bacteria at 37°C overnight on BHA, adjusted with 2 mL sterilized distilled 
water to at least McFarland No.4 turbidity standard. Following recommendations of the 
manufacturer the test strip was inoculated and incubated. After incubation color changes 
were read directly or after addition of reagents. Isolates were identified by referring to the 
identification tables provided by the manufacturer.  S. uberis ATCC 700407 was used as a 
control strain. 
2.2.3.2 Genotypic identification 
16S rRNA gene sequencing was used to estimate the accuracy of the phenotypic 
identification. Another PhD. Student (Takehiro Tomita) performed 16S and 23S species-
specific PCRs on all isolates. Since sequencing is expensive, I set up the 16S rRNA 
sequencing reactions only for isolates that were negative for 16S or 23S species-specific 
PCR. Takehiro Tomita performed the 16S rRNA sequencing when 16S and 23S species-
specific PCR for S. uberis showed positive results.  
 
General techniques for molecular work 
• DNA extraction from cultures by the boiling method 
Fresh cultures from BHA were transferred to a 1.5 mL sterile screw cap tube containing 400 
µl of molecular grade water using sterile swabs. The tubes were incubated in boiling water 
for 10 min, mixed by a vortex mixer for 10 s, and then centrifuged at 13000 x g for 5 min. 
The supernates containing DNA were transferred to sterile eppendorf tubes and stored at -
20°C until required. 
• Master mix preparation 
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To prevent contamination in PCR reactions, master mixes were prepared in a DNA-free area 
(biohazard cabinet sterilized with UV light before use) using DNA-free pipettes (pipettes for 
master mix use only). The master mix contained PCR buffer (including MgCl2), dNTPs, 
primer and Taq polymerase. The master mix was prepared and aliquoted to each tube of 
PCR reaction and stored at -20°C. DNA template was transferred to the tube before starting 
the PCR reaction.    
• Agarose gel electrophoresis 
The agarose gel was prepared by microwaving 1% DNA grade agarose in 1 x Tris acetate 
EDTA (TAE) buffer (50X TAE buffer consisted of 2M Tris, 1 M acetic acid and 0.1 M 
EDTA) and was cooled for 10 min before pouring. The gel was allowed to set for 30 min. A 
mixture of five microliters of PCR product and one microliter of 6 X loading dye was 
loaded into wells. Electrophoresis was conducted at 100 V for 45 min in TAE buffer. The 
gel was stained in ethidium bromide (0.5 µg/mL) for 10 min then destained in running tap 
water for 10 min and the DNA fragments were visualized using a Gel Doc Imaging system 
(Bio-Rad).   
16S rRNA gene sequencing 
The 16S rRNA genes were amplified by PCR in 200 µl PCR tubes. A 50 µl PCR reaction 
mix contained five microliters of 10 X PCR reaction buffer, 0.25 µl of Taq DNA 
polymerase 5 U/µl, 0.1 µl of 100 mM dNTPs, 50 pmol of primer SEQ27f (5’-AGA GTT 
TGA TCA TGG CTC AG-3’), 50 pmol of SEQ1492r (5’-GGC TAC CTT GTT ACG ACT 
T-3’) (Pullinger et al., 2006), five microliters of DNA template and molecular grade water 
to 50 µl. The PCR cycle consisted of 94°C for five min then 35 cycles of 94°C for 30 s, 
56°C for one minute and 72°C for 1.5 min followed by a final extension at 72°C for six 
minutes and was conducted in a PCR Thermal Cycler (Corbett Research GP001, Sydney, 
Australia). To confirm the size of the PCR product, five microliters was examined by 
agarose gel electrophoresis as previously described in section of agarose gel electrophoresis.  
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Two volumes of 20% polyethylene glycol (PEG) in 2.5 M NaCl were added to one volume 
of each PCR product and transferred to a new 1.5 mL eppendrof tube. The tubes were 
mixed and incubated at 37°C for 15 min. After centrifugation at 13000 x g for 10 min, the 
supernate was carefully removed. The pellet was washed with 400 µl of 80% ethanol and 
centrifuged at 13000 x g for 5 min. The supernate was then removed and the pellet was 
dried in a heat box at 73°C for 5 min. The dried pellet was resuspended to the original 
volume with molecular grade water.  
 
The PCR products were sequenced by BigDye™ Terminator system in 200 µl PCR tubes. 
The BigDye reaction consisted of 2 µl of 0.8 pmol/µl primer (using forward or reverse 
primer in single tubes), 1 µl of BigDye, 1 µl of 10 X PCR buffer and 1 µl of DNA template 
(PCR product described above). The PCR cycle consisted of 94°C for 5 min, 35 cycles of 
94°C for 30 s, 56°C for 60 s and 72°C for 90 s and followed by final extension at 72°C for 6 
min.   
 
After the BigDye reaction, fifteen microliters of molecular grade water was added to the 
reaction tubes and transferred to 1.5 mL eppendorf tubes containing 80 µl of 75% 
isopropanol to precipitate the DNA. The tubes were mixed and incubated at room 
temperature for 15 min then centrifuged at 13000 x g for 20 min. Precipitated DNA was 
washed three times in 250 mL 75% (v/v) isopropanol using centrifugation at 13000 x g for 
10 min room temperature.  The samples were dried in a heat box at 73°C for 5 min and 
forwarded to the Microbiological Diagnostic Unit, University of Melbourne for DNA 
sequence determination using an ABI 3100 automated sequencer and the resulting 
chromatograms were analyzed using the ChromasPro software package (Technelysium 
Pty Ltd, Tewantin QLD, Aus). Sequence data for comparison was obtained from NCBI. 
Sequence alignment was performed using ClustalW (www.ncbi.nlm.nih.gov).   
2.2.4 Pulse field gel electrophoresis (PFGE) of Streptococcus parauberis   
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2.2.4.1 Preparation of genomic DNA in agarose plugs 
Genomic DNA was prepared in agarose plugs according to the methods of Smith and 
Cantor (1987), with some modifications. Cells from each S. parauberis isolate were grown 
on BHA at 37°C for approximately 18 hours. An isolated colony was inoculated into 10 mL 
THB and incubated at 37°C with gentle shaking to reach an optical density (A600) between 
0.4 and 0.45. The cells were collected by centrifugation at 3,000 x g for 15 min and 
resuspened in 10 mL of Pett IV buffer (10 mM Tris-HCl pH 7.6 and 1 M NaCl). Following a 
second wash in Pett IV buffer, cells were resuspended in 500 µl of the same buffer. Equal 
volumes of cell suspension and molten 2.4% low-melting temperature agarose (Progen) 
were mixed and dispensed into 100 µl plug moulds and allowed to set at 4°C for 20 min. 
Once solidified, the agarose plugs were incubated in EC lysis buffer (6mM Tris HCl pH7.6, 
1M NaCl, 100 mM EDTA pH 7.6, 0.2% sodium deoxycholate, 0.5% Sarkosyl and 1 mg/mL 
lysozyme added prior to use) at 37°C overnight. The EC lysis buffer allowed DNA to be 
released from the cells. The DNA was then purified by incubating agarose plugs with EPS 
buffer (0.5 M EDTA pH 8.6, 1% Sakosyl and 1mg/mL of proteinase K added prior to use) at 
50°C for 24 h. The EPS buffer was replaced with fresh ESP buffer, and then agarose plugs 
were further incubated at 50°C for 24 h. The proteinase K activity was then inactivated by 
incubating the agarose plugs at 37°C for 2 h with TE buffer (10 mM Tris-HCl pH 7.6 and 1 
mM EDTA pH 8.0) containing 0.0175 mg/mL PMSF in isopropanol.    
2.2.4.2 Restriction of endonuclease digestion of genomic DNA 
Prior to digestion, the agarose plugs were equilibrated with TE buffer for 2 h, followed by 
four additional 20 min washes in the same buffer to remove proteins and proteinase K. The 
agarose plugs were cut to a size of 1 to 2 mm in thickness with a clean blade. The plug 
slices were washed twice by incubating in restriction buffer (1 X Tango buffer, Fermentas) 
for 30 min. Plug slices were next transferred to the restriction buffer containing 50 units of 
the restriction endonuclease SmaI (Fermentas) in 200 µl of restriction buffer and incubated 
at 30°C overnight. The SmaI was inactivated by incubating with 1 mL of TE buffer at 37°C 
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for 1 h. The slices were placed at 4°C for 15 min prior to loading into wells of a 1% agarose 
gel.   
2.2.4.3 Pulsed-field gel electrophoresis 
Separation of DNA fragments was achieved by using a CHEF-DR II (BioRad). Digested 
samples were electrophoresed through 1.5% agarose gel in 0.5 X TBE buffer (1 X TBE 
consisted of 89 mM Tris, 89 mM boric acid, 2 mM EDTA, pH 8.3). Electrophoresis was 
carried out at 6 V/cm at 14 °C for 20 h with the pulse time increasingly linearly from 1 to 20 
s. The gel was stained with ethidium bromide (0.5 µg/mL) for 20 min and destained in 
running water for 20 min. The DNA restriction patterns were viewed on a Gel Doc (BioRad). 
A CHEF DNA size standard (Lambda ladder, molecular weight range 48.5 to 970 kbp, 
BioRad) was used as a molecular size marker.  
 
Strains were defined using criteria proposed by Tenover et al. (1995). Isolates were 
designated different strains if the PFGE patterns differed by more than three bands, 
possibly related if patterns differed by ≤ 3 bands and closely related if patterns differed by 
one band. Isolates that had similar PFGE patterns were considered to be genetically 
related isolates and to be derived from a common parent.  
2.3 Results  
Three hundred and twelve bovine milk samples from 114 cows were collected from two 
farms in western and eastern Victoria (Timboon and Newry), which were reported to have 
S. uberis problems.  
 
Reference strain, S. uberis ATCC 700407, was confirmed to the species level by the API 
20 Strep system. In addition, the strain showed hydrolysis of esculin and hippurate, acid 
production from inulin and mannitol and no growth in 6.5% NaCl.     
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Colonies obtained from milk samples cultured on Edwards medium (dark colonies) or HBA 
were selected and further tested if they were alpha or non-hemolytic, circular, translucent, 
white to yellowish and approximately one mm in diameter. One hundred and fifteen isolates 
that were Gram positive cocci arranged in chains, that did not produce catalase and 
hydrolyzed esculin were presumptively identified as S. uberis. Of these, 28 were from 
quarters with clinical mastitis, 48 from subclinical mastitis and 39 from cows with low cell 
counts (Appendix B, Table 1). An additional four tests (hippurate hydrolysis, acid 
production in inulin and mannitol and growth in 6.5% NaCl) performed on the isolates (n = 
115), provided seven different patterns (Table 2.1 or more detail in Appendix B, Table 1). 
Most isolates (n = 70, 61%) belonged to pattern 1 (hippurate hydrolysis positive, inulin and 
mannitol fermentation positive and no growth in 6.5% NaCl). Selected isolates belonging to 
pattern 1 were confirmed as S. uberis by the API 20 Strep test. All isolates belonging to 
pattern 1 were identified by 16S rRNA sequencing as S. uberis (64, 91%) or S. parauberis 
(6, 9%). Isolates showing pattern 2 (differing from pattern 1 only in the inability to ferment 
inulin) were identified by API 20 Strep test as S. uberis (n = 4) and Aerococcus viridans (n 
= 8). The 16S rRNA sequencing confirmed that the four isolates were indeed S. uberis, but 
of the other eight isolates, two were S. parauberis and the remaining six were A. viridans. 
Pattern 3 consisted of 13 isolates which were identified by API 20 Strep as A. viridans (11 
isolates) and S. bovis (2 isolates). Two isolates identified as A. viridans by phenotypic 
methods were identified as S. parauberis by the molecular methods. Isolates belonging to 
pattern 4 showed growth tolerance in 6.5% NaCl and the one isolate was identified as 
Enterococcus spp. by both the API 20 Strep and 16S rRNA sequencing. Isolates with 
patterns 5, 6 and 7 (esculin positive but hippurate negative) were selected and identified as 
S. bovis by API 20 Strep. Some of these isolates were randomly selected and sequenced, 
and identified as S. bovis.  
 
Chi-square analysis of the association between disease status (clinical, subclinical compared 
with cows producing milk with a low somatic cell countcell count) and the qualitative 
growth of S. uberis (+++, ++ and +) was statistically significant (P = 0.0003) (Table 2.2).   
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Table 2.1 Biochemical test patterns of esculin-degrading streptococci isolated from bovine milk samples 
 
Pattern Biochemical tests Species (16S rRNA 
sequencing) 
Total 
 Hippurate Inulin Mannitol 6.5%NaCl S. 
uberis 
S. 
parauberis 
Other
s 
 
1 + + + - 64 6 0 70 
2 + - + - 4 2 6 12 
3 + - - - 0 2 11 13 
4 + - - + 0 0 1 1 
5 - + - - 0 0 14 14 
6 - - + - 0 0 1 1 
7 - - - - 0 0 4 4 
Total     68 10 37 115 
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Table 2.2 Association between disease status and qualitative growth of Streptococcus uberis 
No. (%) of isolates and disease status Qualitative growth 
of S. uberisa Clinical Subclinical Low cell count 
Total no. of isolates 
+++ 4 (15) 21 (68) 2 (17) 27 
++ 10 (39) 6 (19) 3 (25) 19 
+ 12 (46) 4 (13) 6 (58) 22 
Total no. of isolates 26 31 11 68 
 
aQualitative growth of S. uberis is defined as follow: +, 1-10 colonies; ++, 11-50 colonies; 
+++, more than 50 colonies 
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Analysis with the chi-square test showed statistical significance (P = 0.0003) in the 
association between disease status and the qualitative growth of S. uberis 
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The restriction patterns of chromosomal DNA of ten S. parauberis isolates digested with 
SmaI showed from 8 to 16 fragments which allowed the clear differentiation of the isolates 
(Figure 2.1). Using the criteria suggested by Tenover et al. (1995) for interpretation of 
PFGE patterns, no identical strains were found. All seven isolates from the Timboon farm 
(lane 1-7) showed different patterns from each other. Isolates 3218-1, 3218-9 and 3218-10 
(lanes 8, 9 and 10) were from the same cow on the farm at Newry. Isolates 3218-9 and 
3218-10, from the same quarter, were closely related but not identical (arrows indicate 
different bands); isolate 3218-1 was a different strain.   
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Figure 2.1 PFGE of 10 isolates of S. parauberis from milk samples: 1, 698-4; 2, 819-2; 3, 923-4; 4, 2407-5; 
5, 2655-10; 6, 2893-7; 7, H3133-5; 8, 3218-1; 9, 3218-9; 10, 3218-10 and M, broad range PFGE marker 
(1-20 kb ). Lane 1-7: isolates from Timboon farm. Lane 8 – 10: isolates from the same cow at Newry 
farm with lanes 9 and 10 from the same quarter. Arrows in lane 9 and 10 indicate the different bands. 
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2.4 Discussion  
The presence of potential pathogens in milk indicates a problem with udder health and milk 
quality. Accuracy of isolation and identification could provide information that would 
improve treatment procedures, health status, milk quality and farm management.   
 
Esculin degrading streptococci isolated from clinical and subclinical mastitis cases in dairy 
cows are commonly categorized as S. uberis in routine diagnostic laboratories.  Genotypic 
tests were not used in veterinary diagnostic laboratories surveyed in Australia and New 
Zealand (W. McDonald, PhD Thesis, RMIT, 2003). The esculin positive streptococci (n = 
115) would be identified as S. uberis using the routine classification, but only 59% (68 of 
115) of isolates were correctly identified when compared to the 16S rRNA sequencing data.  
In this study, esculin degrading streptococci (n = 115) presented seven patterns when 
further identified with hippurate hydrolysis, inulin and mannitol fermentation and growth 
tolerance in 6.5% NaCl. Most S. uberis isolates in this study belonged to pattern 1 (60.9%, 
70 of 115) and the biochemical tests resulted in accuracy of identification of 91.4% (64 of 
70). One species in this group that was incorrectly identified was S. parauberis (8.6%, 6 
isolates from 70) therefore identification of S. parauberis was included in this study. 
Streptococcus parauberis required molecular procedures for accurate identification. Pattern 
1 was able to differentiate S. uberis from other streptococci and enterococci. Of the milk 
samples from which incorrect identification was obtained, S. parauberis could be found in 
cases of clinical mastitis, subclinical mastitis and low cell count milk (Appendix B, Table 1). 
The amount of S. parauberis growth varied from slight growth (+) to heavy growth (+++). 
Some milk samples contained both S. parauberis and S. aureus or S. uberis.  As S.  
parauberis is not frequently isolated from milk samples, the proposed tests (hippurate 
hydrolysis, inulin and mannitol fermentation and groth in 6.5% NaCl) are acceptable for S. 
uberis identification.   
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Isolates showing pattern 2 (n = 8, inulin negative) included S. uberis, S. parauberis and A. 
viridans. API 20 Strep assisted in the identification of S. uberis (n = 4, 100% correct). 
These results agree with those of Jayarao et al. (1991) who reported that 4.8% of S. uberis 
were inulin negative. Another two isolates, which were confirmed as S. parauberis by 16S 
rRNA sequencing, were misidentified as A. viridans.  
 
Isolates belonging to patterns 3 to 7 (n = 33) can be eliminated since S. uberis was not 
confirmed by 16S rRNA sequencing in these groups (28.7%, 33 of 115). Of isolates 
belonging to pattern 3, Aerococcus viridans predominated and no S. uberis was included, 
however two S. parauberis isolates were misidentified as A. viridans.  Isolates which were 
incorrectly identified S. parauberis (patterns 2 and 3) were predominantly from cows with 
low cell counts. Misidentifying these isolates could be acceptable since A. viridans and S. 
parauberis are not considered to be potential mastitis pathogens.  
 
In this study, the single isolate of Enterococcus faecalis (pattern 4) was correctly identified 
by the salt tolerance test which agrees with the results of Watts (1988) and Cowan et al. 
(1993). In this study, all 68 isolates of S. uberis were salt intolerant, in contrast to the 
finding of Fortin et al. (2003) that showed 32% of S. uberis to be salt tolerant. 
 
Hippurate negative isolates were not followed up in detail (patterns 5, 6 and 7). Negative 
isolates that were further identified were mainly S. bovis, although, small numbers of S. 
uberis have been reported that are hippurate negative (Lammler, 1991, Odierno, et al., 
2006). Serological grouping might assist in differentiating S. uberis and S. bovis because S. 
bovis mainly belongs to serological group D (Cowan, et al., 1993). Interestingly, S. bovis 
was isolated from the milk, in moderate (++) or high (+++) numbers, of cows with 
subclinical mastitis. Therefore, other potential mastitis pathogens should be searched for in 
milk samples with high somatic cell count.  
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Mannitol negative S. uberis have been found to be rare (2%) (Odierno, et al., 2006). There 
were no mannitol negative isolates in this study. 
 
Full identification can be made with commercial biochemical kits as suitable alternatives for 
identification of streptococci by conventional methods. However, the cost of the kits may 
limit their use by veterinary laboratories. The results from this study suggest that using the 
API 20 Strep test to identify S. uberis obtained from mastitis cases where the results of 
conventional tests are inconclusive, would be useful (i.e. when the results obtained follow 
pattern 2). However, difficulties remain with the use of API 20 Strep for the identification of 
streptococcal mastitis pathogens. In this study, there were misidentifications of S. 
parauberis as S. uberis (6 isolates, pattern 1) and A. viridans (4 isolates, patterns 2 and 3). 
The current database provided with the commercial kit system is incomplete, as it does not 
include some of the less well known organisms of veterinary importance; for example, S. 
parauberis and S. iniae. Testing for of the enzyme β-D-glucuronidase has been suggested as 
phenotypic test that is able to differentiate S. uberis and S. parauberis (Khan, et al., 2003); 
however, some isolates of S. uberis have been shown to be β-D-glucuronidase negative 
(Schaufuss, et al., 1986). Therefore genotypic examinations such as DNA/DNA 
hybridization, restriction fragment length polymorphism analysis of 16S rDNA, species-
specific PCR or 16S rRNA sequencing are required to differentiate between S. uberis and S. 
parauberis and other streptococci (Garvie & Bramley, 1979, Jayaro, et al., 1991, Hassan, et 
al., 2001, Khan, et al., 2003, Alber, et al., 2004, McDonald, et al., 2005). Of these,  PCR is 
the most suitable testing platform for diagnostic laboratories.  
 
In summary, the phenotypic identification set proposed tn the current study is convenient for 
use in veterinary diagnostic laboratories and would increase the accuracy of routine S. 
uberis identification compared with using the results of esculin hydrolysis alone or the 
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combined results of esculin and hippurate hydrolysis. The significance or pathogenicity of 
S. parauberis is not known at present.  Some isolates were found in infected udders with 
cell counts greater than 250,000 cells/mL in cases where no other pathogens were isolated. 
 
Streptococcus parauberis isolates from two dairy herds showed a diverse range of PFGE 
patterns. Seven isolates of S. parauberis from the Timboon farm showed different patterns, 
indicating that the organism was not likely to have been transmitted from cow to cow but 
probably was acquired from the environment or from the endogenous faecal flora.  Three 
isolates of S. parauberis were from the same cow on another farm (Newry). Isolate 3218-1 
showed dissimilar pattern from isolates 3218-9 and 3218-10 which were from the same 
quarter of this same cow and were considered to be closely related strains. It is likely these 
minor differences in banding patterns were caused by a single genetic event such as a point 
mutation or an insertion or deletion of DNA (Tenover, et al., 1995). Similar variations were 
observed in other species, on repeated subculture or from the same patient over a period of 
time (Tenover, et al., 1995).  
 
The occurrence of S. parauberis as a mastitis pathogen appears to be rare, however it has 
been isolated all over the world. For example, it was reported from British dairy herds 
(Garvie & Bramley, 1979), the USA (Jayaro, et al., 1991), Europe (Hassan, et al., 2001, 
Khan, et al., 2003) and Australia (Baseggio, et al., 1997, Phuektes, et al., 2001, McDonald, 
et al., 2005). Similar to reports of S. uberis (Baseggio, et al., 1997, Phuektes, et al., 2001, 
Khan, et al., 2003), in this study S. parauberis showed great genetic diversity. At this stage, 
studies of the epidemiology of S. parauberis using PFGE fingerprinting have been limited 
and no reports have been published so far. This has resulted in lack of information 
concerning bacterial reservoirs responsible for new infections and limits our understanding 
of transmission patterns. A larger number of S. parauberis isolates from intramammary and 
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extramammary sources is required for examination in order to understand the epidemiology 
and pathogenic potential of this species. 
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Chapter 3 Determination of Streptococcus uberis 
antibacterial susceptibility patterns   
3.1 Introduction 
Antibiotic therapy is an important aspect of herd management practice to control mastitis 
infections. Understanding the prevalence of resistance and antibiotic susceptibility patterns 
of the microorganisms isolated from milk of cows with the infection can improve the 
treatment of mastitis. As a matter of practical management on many dairy farms, antibiotic 
intramammary infection therapy is initiated prior to microbiological culturing (Guterbock, et 
al., 1993, Milner, et al., 1997). The treatment strategies for the environmental streptococci 
are often based on the assumption that the antibiotic susceptibility of this group is 
homogenous. However, a previous study (Brown and Scasserra, 1990) has reported higher 
antibiotic resistance levels in strains of S. uberis than in strains of S. dysgalactiae and S. 
agalactiae. Thus, information on the antibiotic susceptibility of the various organisms 
categorized as environmental streptococci would guide veterinarians and dairy farmers 
towards the most prudent selection of an antibiotic for treatment of mastitis. In addition, 
knowledge of antibiotic susceptibility patterns helps in developing therapy protocols for 
particular dairy farms and there is need for effective monitoring.  
 
Several reports of antibiotic susceptibility of S. uberis isolated from bovine mastitis have 
been published (Brown & Scasserra, 1990, Salmon, et al., 1998, Rossitto, et al., 2002). 
However, there is no recent data available in the literature on the susceptibility of S. uberis 
to antibacterial agents isolated in Australia.  
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The mechanisms of erythromycin resistance are target site modification, enzymatic 
inactivation and active efflux (Leven, 2005). In streptococci, target site modification is a 
common resistance mechanism. The mechanism involves production of a methylase which 
is encoded by erythromycin resistance methylase genes (ermA or ermB) (Seppala, et al., 
2003). Methylases cause conformational change in the prokaryotic ribosome leading to 
reduced binding of the macrolides, lincosomides and streptogramin B (MLSB) group of 
antibiotics. Initial results of erythromycin susceptibility testing showed high Minimal 
Inhibitory Concentration (MIC) values and identified some isolates likely to be resistant to 
this group of antibiotics. 
 
The objective of this study was therefore to determine the antibiotic susceptibility patterns 
of S. uberis isolates from the milk of cows in Victoria, to penicillin, ampicillin, oxacillin, 
cephalothin, erythromycin, tetracycline, gentamicin, vancomycin and novobiocin. Antibiotic 
agents were selected according to those used for routine testing by veterinary laboratories 
(NCCLS, 2002). Although, vancomycin is not approved for mastitis treatment, it was 
included in this study as representative of the glycopeptide antibiotic family. In addition, 
detection of ermA by PCR was performed.  
3.2 Material and methods  
The determination of antibacterial susceptibility is usually made by exposing 
microorganisms to different concentrations of antibacterial agents and evaluating whether 
the microorganism is inhibited or killed. The tests were performed according to the recent 
recommendations of the National Committee for Clinical Laboratory Standards (NCCLS, 
now Clinical Laboratory Standards Institute, CLSI) M31-A2 (NCCLS, 2002) for determining 
antibiotic susceptibility of bacteria isolated from animals together with interpretive criteria. 
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Mimimum inhibitory concentrations (MIC) and where indicated minimal bactericidal 
concentrations (MBC) were performed.   
3.2.1 Bacterial strains  
Streptococcus uberis isolates used in this study were the same as these identified from 
Chapter 2 and are listed in Appendix B, Table 2. The bacterial reference strain used in this 
study as a control was Staphylococcus aureus ATCC 29213. An erythromycin resistance 
strain, S. aureus 344/2-7, was obtained from the Microbiology Laboratory Culture 
Collection, RMIT University. The bacteria were stored at -80°C in Protect Bacterial 
Preservers. They were cultured from the storage at -80°C by aseptically plating the 
bacterial preserver beads into HBA or BHA (Appendix C), streaking and incubating for 24 
hours for further testing.   
3.2.2 Calibration of turbidity 
McFarland turbidity standards were used as a reference to adjust the turbidity of bacterial 
suspensions so that the numbers of bacteria were estimated within a given range. A 
McFarland 0.5 standard suspension was made up by mixing 0.5 mL of 0.048 M BaCl2 and 
99.5 mL of 1% H2SO4. The absorbance of the standard at 625 nm was confirmed to be 
0.08 to 0.10 (NCCLS, 2002). The standard was transferred to a screw cap tube of the 
same size as those used in preparing the culture inoculum and stored in a dark place at 
room temperature. Cultures adjusted to this standard turbidity are equivalent to a 
concentration of approximately 108 colony forming unit (CFU) per milliliter (mL).   
 
3.2.3 Antibiotic compounds   
Stock solutions containing 1280 µg/mL of antibiotic agent were prepared according to 
NCCLS guideline (2002). Stock solutions were prepared using the formula (1000/P) × V × 
C = W, where P is potency of the antibiotic, V is volume in mL, C is final concentration and 
W is weight of the antibiotic to be dissolved in V. Solvents and diluents for preparation of 
stock solutions of antibiotic agents were suggested by NCCLS (2002). Ampicillin was 
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dissolved in 0.1 M phosphate buffer, pH 8.0 then 0.1 M phosphate buffer, pH 6.0 was used 
as a diluent. Cephalothin was dissolved in 0.1M phosphate buffer, pH 6.0 then water was 
used as a diluent. Erythromycin was dissolved in 95% ethanol then water was used as a 
diluent. Gentamicin, oxacillin, penicillin, tetracycline, vancomycin and novobiocin were 
dissolved and diluted in sterile distilled water. The stock solutions were stored at -20°C for 
a maximum of 1 month.   
3.2.4 Antibiotic susceptibility tests 
3.2.4.1 Minimum inhibitory concentration (MIC); broth dilution 
The MIC is the lowest concentration of antibacterial agent that completely inhibits growth 
of the organism as detected by the unaided eye.  
 
Streptococcus uberis isolates were cultured on horse blood agar (HBA, Appendix C) or 
brain heart infusion agar (BHA, Appendix C) at 37° C overnight. Four to five colonies of 
each isolate were inoculated into Mueller-Hinton broth (MHB, Appendix C) (5 mL) and 
incubated at 37°C with agitation until the cultures were visibly turbid. The bacterial 
suspension was adjusted to that of a 0.5 McFarland standard. The suspension was then 
diluted 1:100 with MHB to obtain approximately 106 CFU/mL.   
 
Antibacterial solutions of 50 µl were serially diluted two-fold in 96-well polystyrene round-
bottom microtiter plates by adding the inocula to 50 µl per well of MHB. A standardized 
bacterial suspension (described above) of 50 µl was then added to each well. This volume 
corresponded to approximately 2.5-5.0 × 104 CFU per well. Controls (wells inoculated with 
S. uberis culture without antibiotic added) and blanks (wells containing uninoculated broth 
medium) were run for each isolate. The bacterial reference strain (Staphylococcus aureus 
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ATCC 29213) was included in each batch. The microtiter plates were incubated at 37°C for 
16 to 20 h after which time bacterial growth was observed. Results were interpreted 
according to breakpoints for veterinary streptococci (NCCLS, 2002) (Table 3.1)  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1 Minimal inhibitory concentration breakpoints for veterinary streptococci (NCCLS, 2002) 
Antibiotics Susceptible (µg/mL) Intermediate (µg/mL) Resistance (µg/mL) 
Ampicillin ≤ 0.25 0.5-4 ≥ 8 
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Penicillin ≤ 0.12 0.25-2 ≥ 4 
Oxacillin1 ≤ 0.25 - ≥ 4 
Erythromycin ≤ 0.25 0.5 ≥ 1 
Tetracycline ≤ 2 4 ≥ 8 
Penicillin-novobiocin2 ≤ 1/2 2/4 ≥ 4/8 
Cephalothin ≤ 8 16 ≥ 32 
Vancomycin ≤ 1 - - 
Gentamicin ≤ 4 8 ≥ 16 
 
1 interpretative for staphylococci 
2 β-lactam and other class combinations, interpretative for S. uberis causing bovine mastitis   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.4.2 Disk diffusion test 
Fresh cultures of S. uberis isolates were adjusted to obtain turbidity equivalent to 0.5 
McFarland standard as described above. The bacterial suspension was inoculated onto 
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Mueller-Hinton agar (MHA, Appendix C) supplemented with 5% defibrinated sheep blood 
(Appendix C) using a sterile cotton swab. The excess moisture was allowed to be absorbed 
for five min before applying the antibacterial disks. The disks were placed on the agar 
plates (no more than seven disks per plate). The plates were incubated at 37°C for 16 to 18 
h and the diameter of inhibition zones was recorded.   
3.2.4.3 Minimum bactericidal concentration (MBC) 
The MBC is the lowest concentration of antibiotic that reduces the viable count by 99.9%. 
After observing the results of MIC, 50 µl of the content of wells at and below the MIC value 
were cultured on BHA, incubated at 37°C for approximately 16 h, and the number of 
colonies were counted.  
3.2.5 Erythromycin resistance gene PCR    
Detection of the erythromycin-resistance gene (erm A) by PCR was as follows. The primers 
were as described by Sutcliffe et al. (1996) with modification of PCR reaction conditions. 
The product size was 645 bp. for Staphylococcus aureus 344/2-7 which was used as a 
positive control. A 50 µl PCR reaction mix contained 40.19 µl of molecular grade water, 
6.66 µl of 10X PCR buffer, 0.4 µl of dNTPs, 0.625 µl of 20 µM primer (ermA 5’ – CTA AAA 
AGC ATG ATA AAA GAA - 3’ and 5’-CTT CGA TAG TTT ATT TAA TAT TAG - 3’), 0.5 µl of 
5 U/µl Taq polymerase and 1 µl of DNA template. The PCR cycle consisted of 94°C for 1 
min, 30 cycles of 94°C for 30 s, 46°C for 30 s and 72°C for 30 s followed by final extension 
at 72°C for 5 min.  The PCR reaction was performed using a PCR Thermal Cycler (Corbett 
Research Model GP001). 
 
3.2.6 Transmission electron microscopy  
Transmission electron microscopy was performed as described in section 5.2.2.2. 
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3.3 Results 
A total of 68 S. uberis isolates (Appendix B, Table 2) from cow milk samples were 
examined for antibiotic susceptibility. The distribution of MIC values observed for the 
isolates and the concentrations of antibiotics required to inhibit growth of 50 (MIC50) and 
90% (MIC90) of the isolates are shown in Table 3.2. No isolate was resistant to all nine 
antibiotics. All isolates of S. uberis tested (100%) were susceptible to penicillin, 
tetracycline, cephalothin, oxacillin and vancomycin. Fifty-eight isolates (85.3%) were 
susceptible to erythromycin, 49 (72%) to novobiocin, 46 (67.6%) to ampicillin and 36 (53%) 
to gentamicin.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2 Distribution of Minimal Inhibitory Concentrations (MIC) of 68 isolates of Streptococcus uberis  
 
Number of isolates at each indicated MIC (µg/mL) Antibiotic 
≤ 0.03 0.06 0.12 0.25 0.5 1.0 2.0 4.0 8.0 16.0 
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Ampicillin - 3 22 21 14 4 4 - - - 
Penicillin 53 10 5 - - - - - - - 
Oxacillin 2 22 20 24 - - - - - - 
Erythromycin - 1 21 36 10 - - - - - 
Tetracycline - - 12 31 19 6 - - - - 
Novobiocin - - - - - 20 29 19 - - 
Cephalothin - 7 44 12 5 - - - - - 
Vancomycin - - - 8 59 1 - - - - 
Gentamicin - - - - - - 15 21 32 - 
 
MIC50 values are given in bold 
MIC90 values are underlined 
 : susceptible 
 : intermediate 
 : resistance 
 
 
 
 
 
 
 
 
 
The MIC of erythromycin, gentamicin and novobiocin was difficult to read due to the 
presence of tiny aggregates of flocculent material (pin point size) in the bottom of the 
microtiter plates. This phenomenon was observed for all isolates that were examined. In 
order to determine whether this material represented live or dead cells, 50 µl of the content 
of wells at the MIC breakpoint level was cultured, but no growth was observed. As a further 
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confirmation, the response to erythromycin was examined by the disk diffusion method. 
Erythromycin was chosen because initial results appeared to show a high MIC value due to 
the presence of flocculent material. The results showed no resistance to erythromycin in 
any isolate (zone diameter more than 15 mm, NCCLS, 2002). In addition, all S. uberis 
presented negative results in the ermA PCR. A representative gel showing results of the 
ermA PCR is shown in Figure 3.1. Examination of the flocculent material by transmission 
electron microscopy (TEM) showed the production of massive amounts of fibrous material 
and  few cells (Figure 3.2).   
 
 
 
 
 
 
 
 
 
 
 
 
645 bp 
      1      2       3      4      5       6      7      8      9     10     11
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Figure 3.1 PCR of ermA gene erythromycin-resistant isolate.  Lane 1-8; Streptococcus 
uberis isolates 796-2, 2169-2, 2481-1, 2530-2, 2530-4, 2530-5, 2565-2 and 2730-5.  Lane 
9; Staphylococcus aureus 344/2-7 (positive control). Lane 10; Molecular grade water 
(negative control). Lane 11; DNA marker.
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Figure 3.2 Streptococcus uberis 796-2 treated with erythromycin. a; S. uberis with no antibiotic (control 
cell), magnification 8000X. b; flocculent material (arrow) and S. uberis cells after treatment with 
erythromycin, magnification 4000X, c; flocculent material (arrow) obtained after treatment of S. uberis 
treated with erythromycin, magnification 4000X.
a b c 
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3.4 Discussion  
Several reports have published the results of antibiotic susceptibility testing of streptococci 
isolated from bovine mastitis (Jousimies-Somer, et al., 1996, Salmon, et al., 1998, Erskine, 
et al., 2002, Guerin-Faublee, et al., 2002, Rossitto, et al., 2002). In this study S. uberis 
isolates were examined from Victoria for resistance to antibiotics recommended for routine 
testing by veterinary microbiology laboratories (NCCLS, 2002).  
 
Comparison of antibiotic susceptibility results reported in the literature must be made with 
caution since different techniques have been used including disk diffusion (Owens, et al., 
1990, Denamiel, et al., 2005), agar dilution (Owens, et al., 1990, Guerin-Faublee, et al., 
2002) and broth dilution (Salmon, et al., 1998, Rossitto, et al., 2002). Agar or broth dilution 
methods provide a quantitative result (MIC), while disk diffusion presents a qualitative 
result (usually susceptibile, intermediate or resistant). Also the interpretative guidelines 
used to categorized isolates as susceptible or resistant are not always the same, and some 
studies used criteria for human isolates rather than the criterion for veterinary isolates 
(Owens, et al., 1990, Guerin-Faublee, et al., 2002). The criteria for human isolates can be 
used only as a comparative guide in the veterinary field. Additionally, some reports did not 
offer data by individual bacterial species, but for example grouped all streptococci together 
(Jousimies-Somer, et al., 1996).  
 
Comparison of the levels of resistance to antibiotic agents (MIC50 and MIC90) for S. uberis 
isolated from America, Denmark, New Zealand and Australia is shown in Table 3.3. Using 
NCCLS criteria (2002) for determining antibiotic susceptibility of bacteria isolated from 
animals, the results showed that more than 90% of S. uberis examined in the USA and in the 
present study 100% were susceptible to cephalothin, but variable results were obtained for 
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most other antibiotics. Resistance to penicillin and oxacillin is not common in Australia and 
New Zealand but strains with reduced susceptibility appear to be emerging in the USA and 
Denmark. Streptococcus uberis appear to be less susceptible to ampicillin than to other β-
lactams in the USA and in this present study. This is of concern, since β-lactams are widely 
used for dry cow treatment. Resistance to erythromycin and tetracycline was not found in 
the present study or in a study from New Zealand, but was common in the USA and 
Denmark.  Susceptibility to novobiocin in Denmark appeared to be higher than in this study 
and New Zealand. Vancomycin has not been approved for use in cattle (Jousimies-Somer, et 
al., 1996), however, there was no resistance of S. uberis to vancomycin in this study, which 
agrees with the results from the USA (Owens, et al., 1990). No resistant isolates to 
gentamicin were found in this study but 47% resistance from the USA was reported (Owens, 
et al., 1990). The different use of antibiotics in different geographical regions may cause 
different patterns of resistance. In general, resistance to erythromycin and tetracycline 
appeared to be a problem in the USA. Antibiotic resistance of S. uberis was not found to be 
a problem in this study, and MIC90 values were relatively low when compared with those of 
other continents. This may be because of strict regulation of antibiotic use in food-
producing animals in Australia (Joint Expert Advisory Committee on Antibiotic Resistance, 
1999).  However, resistance to erythromycin has been demonstrated in Denmark which has 
similar regulations (Aarestrup, 1999). It is important to monitor and to continue to regulate 
the use of antibiotics for food producing animals, in order to decrease the risk of resistant 
strains emerging and to detect those strains if resistance does emerge.  
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Table 3.3 Activity of antibiotic agent for Streptococcus uberis 
Antibiotic MIC50 (µg/mL) MIC90 (µg/mL) Country References 
Ampicillin 0.25 0.5 USA (Rossitto, et al., 2002) 
 0.25 1.0 Australia This study 
Penicillin ≤ 1.0 ≤ 1.0 USA (Brown & Scasserra, 
1990) 
 ≤ 0.06 ≤ 0.06 New 
Zealand 
(Salmon, et al., 1998) 
 ≤ 0.06 2.0 Denmark (Salmon, et al., 1998) 
 0.25 0.25 USA (Rossitto, et al., 2002) 
 ≤0.03 0.06 Australia This study 
Oxacillin 1.0 1.0 USA (Rossitto, et al., 2002) 
 0.12 0.25 Australia This study 
Erythromycin 2.0 ≥ 256 USA (Brown & Scasserra, 
1990) 
 ≤ 0.06 0.13 New 
Zealand 
(Salmon, et al., 1998) 
 0.13 4.0 Denmark (Salmon, et al., 1998) 
 0.12 8.0 USA (Rossitto, et al., 2002) 
 0.25 0.5 Australia This study 
Tetracycline 0.5 32 USA (Brown & Scasserra, 
1990) 
 16 16 USA (Rossitto, et al., 2002) 
 0.25 0.5 Australia This study 
Novobiocin 0.5 2.0 New 
Zealand 
(Salmon, et al., 1998) 
 0.25 1.0 Denmark (Salmon, et al., 1998) 
 2.0 4.0 Australia This study 
Cephalothin 1.0 1.0 USA (Rossitto, et al., 2002) 
 0.12 0.25 Australia This study 
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Vancomycin 0.25 0.5 Australia This study 
Gentamicin 4.0 8.0 Australia This study 
      
 : susceptible  :intermediate  : resistance 
 
In this study, erythromycin, gentamicin (which inhibits bacterial protein synthesis) and 
novobiocin (which interferes with DNA supercoiling) caused formation of loose aggregates 
which confused the reading of the MIC values. Examination of the flocculent material by 
TEM confirmed that it was extracellular, similar to a finding of Sieradzki et al. (1998). The 
production of large amounts of extracellular material has been found in methicillin-resistant 
coagulase-negative staphylococci treated with vancomycin (which inhibits cell wall 
synthesis) (Sieradzki, et al., 1998). These authors found that the material resembled cells 
with extracellular material, which had staining properties similar to that of cell wall 
material. Culture of the material showed the presence of a subpopulation with decreased 
susceptibility to the antibiotic. In the current study, subculture of the flocculent material 
showed that no live bacteria were present. The mechanism of production of flocculent 
material by S. uberis in the presence of antibiotics remains unknown. 
 
In conclusion, all β-lactam and other antibiotics had low MICs for S. uberis isolated from 
milk of Victorian dairy cattle in spite of the fact that most cows were treated with 
intramammary orbenin (penicillin) at drying off. The results of this study support the 
conclusion of Pyorala (2002) that penicillin still remains the drug of choice for S. uberis. In 
order to treat mastitis successfully, susceptibility patterns should be regularly determined 
and the information disseminated widely to veterinarians and farmers. The data provided 
by this study will be valuable for informing the selection of appropriate treatment of S. 
uberis bovine mastitis.  In addition, the data can be used as a base line for monitoring the 
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patterns of resistance in order to detect increasing resistance to antibiotic agents for 
mastitis treatment. 
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Chapter 4 Bacteriocins isolation and production  
4.1 Introduction  
Mastitis pathogens, particularly environmental bacteria, are still a serious problem on dairy 
farms (Leigh, 1999). Antibiotics are used to treat clinical mastitis and to control subclinical 
mastitis during the dry period. After antibiotic treatment of clinical mastitis, it is important to 
withhold milk for some days to ensure no antibiotic residues are in the milk sold to 
customers. This causes problems economically due to loss of milk production. Moreover, 
there has been increased concern regarding the widespread over prescrition of antibiotics 
(Dairy Australia, 2007) with resultant increased development of antibiotic-resistant bacteria 
(Erskine, et al., 2002). Thus, the investigation of an alternative strategy to control the 
disease is essential.    
 
Studies of bacterial isolates from mammary glands of dairy cows have suggested that 
members of the normal teat flora of cows or minor mastitis pathogens influence the ability 
of major pathogens to establish infection. For example, the presence of Corynebacterium 
(Green, et al., 2005), CoNS and Staphylococcus chromogenes  (Todhunter, et al., 1993, 
Vliegher, et al., 2004) resulted in reduction of mastitis pathogens. Therefore, a possible use 
of normal flora bacteria from cows or inhibitory substances isolated from these bacteria 
was suggested for the mastitis biological control.  
 
A few studies showed success in vitro and in vivo in the use of bacteriocins for mastitis 
control (Sears, et al., 1992, Ryan, et al., 1999, Twomey, et al., 2000, Wu, et al., 2007). 
These authors reported the inhibition of different bacteriocins against S. dysgalactiae, S. 
aureus and E. coli. Bacteriocins can be used in combination with teat seals or as a teat 
disinfectant. Since bacteriocins are antibiotic peptides, non-toxic and inactivated by 
digestive enzymes in the gut of humans (Jack, et al., 1995, Chen & Hoover, 2003), it 
should be possible to show that these agents present no hazard to milk and are able to be 
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used during lactation. Bacteriocins or inhibitory substances from CoNS may play an 
important role in S. uberis control. The aims of this chapter were to examine a collection of 
CoNS and related bacteria isolated from cow’s milk for bacteriocin production.  
4.2 Materials and methods    
4.2.1 Bacterial isolates and control strains  
4.2.1.1 Coagulase negative staphylococci (CoNS) as test strains      
Milk samples (described in Chapter 2) were processed and CoNS were isolated and 
identified by the following method. An aliquot of 50 µl of milk was plated onto horse blood 
agar (HBA, Appendix C) and the culture was incubated at 37°C for 48 hours. Coagulase 
negative staphylococci were purified by repeated streaking. Strains were characterized as 
described in 4.2.3. Seventy eight bovine CoNS isolates from a previous study (Abadin, 
M.Sc. Thesis, RMIT, 1994) were also included in this study. The isolates were maintained 
at -70°C in Protect Bacterial Preservers. They were cultured on brain heart infusion agar 
(BHA, Appendix C) at 37°C for approximately 18 h before use. A bacterial reference strain, 
Pedicoccus acidilactica FSAW 2702, kindly provided by Food Science Australia from the 
culture collection maintained was used as a positive control strain for bacteriocin 
production. The strain was stored at -70°C in Protect Bacterial Preservers and retrieved from 
storage by aseptically culturing from the bacterial beads onto De Man Rogosa Sharpe agar 
medium (MRS, Appendix C). Listeria innocua (a strain from the Microbiology Laboratory, 
RMIT University) was used as an indicator strain against Pedicoccus acidilactica FSAW 
2702. The strain was also stored at -70°C in Protect Bacterial Preservers and retrieved from 
storage by aseptically culturing from the bacterial beads onto BHA.     
 
4.2.1.2 Streptococcus uberis as indicator strains    
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The same S. uberis isolates described in previous chapter (n = 68) (Appendix B, Table 2) 
were used as indicator organisms for the bacteriocin assay. The isolates were maintained at -
70°C in Protect Bacterial Preservers. They were propagated at 37°C on either HBA or BHA 
at 37°C overnight before use. 
4.2.2 Identification procedures for coagulase negative staphylococci  
Conventional methods for CoNS identification included Gram staining, catalase test, 
coagulase test and deoxyribonuclease (DNase) test. After screening for bacteriocin activity, 
one isolate that showed inhibitory activity against S. uberis was further identified using 16S 
rRNA sequencing (2.2.3.1). 
4.2.2.1 Coagulase test (Isenberg, 1992) 
 Staphylococcus aureus has the ability to clot plasma by production of the enzyme 
coagulase. It is an important criterion to distinguish Staphylococcus aureus (coagulase 
positive) from other Staphylococcus species (CoNS).   
 
Lyophilized rabbit plasma (Bio Merieux) was diluted with sterile distilled water according 
to the manufacturer’s instruction. Working stocks of rabbit plasma was prepared by adding 
three volumes of sterile peptone water to the diluted rabbit plasma. An aliquot of 400 µl of 
working rabbit plasma was pipetted into 13 x 100 mm sterile test tubes, then one loopful of 
bacterial culture was added. After incubation at 37°C, cultures were examined for clots at 4 
h and again at 24 h. S. aureus ATCC 29213 was used as a positive control.  
4.2.2.2 Deoxyribonuclease (DNase) test 
This test detects microbial DNase based on its ability to hydrolyze polymerized DNA in the 
agar to a mixture of mono and oligonucleotides. The bacteria were spot inoculated on the 
surface of DNase agar and incubated at 37°C for 24 h, after which the plates were flooded 
with 1 M HCl. DNase producing colonies were surrounded by a clear area that contained 
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nucleotide fractions which were not precipitated by acid (Isenberg, 1992). The control 
strain, S. chromogenes NTCC 10530, showed non-hemolytic, opaque, yellow pigmented 
colonies and an intermediate zone in the DNase test (Devriese, et al., 2002).   
4.2.2.3 16S rRNA sequencing 
The sequencing method was described in 2.2.3.2 
4.2.3 Detection and isolation of bacteriocin-producing strains    
Three different methods for assaying bacteriocin were used in the present study. The agar 
inversion method and the spot on lawn assay were used for testing inhibitory activity 
directly from cultures, whereas the agar diffusion assay was used for testing inhibitory 
activity from liquid containing bacteriocin.    
4.2.3.1 Agar inversion method (Vliegher, et al., 2004) 
The agar inversion method was used as a screening test for bacteriocin production. This 
method is not only a practical and simple method of screening for bacteriocin-producing 
bacteria but it is able to distinguish inhibition by bacteriocin from inhibition by bacteriophage 
(Vliegher, et al., 2004). The plates were prepared by measuring 25 mL of HBA to ensure 
the same thickness of the agar for all plates. Freshly grown CoNS isolates were inoculated 
approximately five mm in width across the centre of an agar plate and incubated at 37°C 
overnight. The agar was then turned upside down into the cover of the Petri dish and 
cultures of indicator strains were inoculated perpendicular to the test organisms. Cross 
streaks of CoNS against themselves were also inoculated as a self control to exclude 
inhibition caused by nutrient depletion. After incubation at 37°C for a further 24 h, patterns 
of S. uberis inhibition were observed as total, partial or no inhibition. Total inhibition 
referred to no growth of S. uberis whereas partial inhibition indicated a reduction in size of 
colonies of S. uberis. The inhibition zone sizes were measured. 
4.2.3.2 Spot on lawn method (Oscariz, et al., 1999) 
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The spot on lawn method is a simple method to detect bacteriocin activity from test strain 
cultures. For screening of bacteriocin producers, five to ten colonies were spot-inoculated 
onto BHA using sterile toothpicks, such that the spots were equidistant from each other and 
approximately 2 cm from the edge of the plate.  The cultures were incubated at 37°C 
overnight. S. uberis at a concentration of 106 CFU/mL (1:100 dilution of a suspension with 
turbidity equivalent to 0.5 McFarland standard) in BHI soft agar was poured over the 
sample of the inoculated plates and the plates were further incubated at 37°C overnight. 
The diameter of inhibition zones produced by CoNS against S. uberis was then measured. 
Strains that produced inhibition zones were further investigated (section 4.2.4) before being 
designated as bacteriocin producers. Pedicoccus acidilactica FSAW 2702 was used as 
positive control producer strain against the indicator strain, Listeria innocua.  
4.2.3.3 Agar diffusion assay 
The agar diffusion assay was used for detection of antibacterial activity from liquid solution. 
Twenty five mL of molten BHA was cooled to 45°C and seeded with fresh indicator cells to 
a final inoculum at 106 CFU/mL by adding 250 µl of a suspension with turbidity equivalent 
to a 0.5 McFarland standard. The plate was allowed to solidify and put into a laminar flow 
cabinet with the lid open for 30 min to ensure the plate was completely dry. Wells 6 mm in 
diameter were cut in the seeded agar plate with a sterile Pasteur pipette. Crude bacteriocin 
from culture supernates and bacteriocin ammonium sulphate precipitate, which had been 
filter-sterilized by passing through a filter membrane (pore size of 0.45 µm) or 
chromatographic fractions were used for assessing inhibitory activity. Aliquots of 100 µl of 
samples were added into the wells. The plates were incubated at 37°C overnight then 
diameters of inhibition zones were measured.  
 
For assay of bacteriocins, 100 µl of two-fold dilutions of the samples were transferred to the 
wells. The plates were incubated at 37°C overnight then the diameters of the inhibition 
zones were measured. Activity was defined as the reciprocal of the last serial dilution giving 
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a zone of inhibition and expressed as arbitrary units (AU) per milliliter (Crupper & Iandolo, 
1997). 
4.2.4 Confirmation that observed activity is due to a bacteriocin 
Bacteriocins are proteins excreted by bacteria that inhibit the growth of other closely related 
bacteria (Tagg, et al., 1976).  In order to prove that the observed antibiotic activity is due to 
a bacteriocin, it was necessary to confirm the protein nature of the antibiotic activity and to 
exclude inhibition caused by bacteriophage (refer to 4.2.3.1) or metabolic by-products such 
as organic acids and hydrogen peroxide. 
4.2.4.1 Effect of proteases (proteinase K, trypsin and chymotrypsin), lipase and catalase on 
bacteriocin  (Villani, et al., 2001)  
The bacteriocin producer strain was spotted onto BHA using a sterile toothpick and 
incubated at 37°C overnight. A series of holes, two mm in diameter, were aseptically cut 
three mm from the edge of the culture. A 10 µl aliquot of 10 mg/mL of each enzyme 
(proteinase K, trypsin, chymotrypsin, lipase and catalase) was pipetted into each hole, after 
which the plates were allowed to stand at room temperature for 30 min to allow the 
enzymes to diffuse into the agar. BHI soft agar containing 106 CFU/mL of S. uberis 796-2 
as an indicator strain was poured onto the surface of the plates. The control consisted of 
untreated cell-free supernate of potential bacteriocin producer strains, and enzyme solution 
alone incubated under the same conditions. After incubation at 37°C for approximately 16 
h, the shape of inhibition zones was observed.  
 
An even annular radius indicated the substance/s produced by the test strain was resistant 
to the test enzyme. An irregular shaped annular radius (reduction of the diameter close to 
the enzyme spot) indicated that the substance/s produced by the test strains was sensitive 
to the enzyme.  
4.2.4.2 Neutralization of acid production   
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Inhibitory activity due to acid production was excluded by adding CaCO3 to the media 
(Heng, et al., 2006).  The bacteriocin producer strain was assayed for inhibitory activity by 
spot on lawn method on BHA containing 0.1% (w/v) CaCO3.   
4.2.5 Studies of bacteriocin production  
Most bacteriocins are secreted by the producer cells and can be detected in culture 
supernates, but some bacteriocins cannot be detected in liquid media. Optimization of 
culture media or culture conditions was studied in an attempt to find the optimum conditions 
for bacteriocin production. Each of the following conditions was examined for bacteriocin 
production and repeated at least twice. 
4.2.5.1 Media selection 
Ten S. uberis isolates (684-1, 686-5, 796-2, 853-4, 883-7, 2042-5, 2655-5, 2690-2, 3147-1 
and H2581-3) were selected at random to be examined for susceptibility to the bacteriocin 
produced by isolate 2042-4. The isolate 2042-4 was spot inoculated onto BHA, milk agar 
(MA), nutrient agar (NA), and trypticase soy agar (TSA) (Appendix C) and the degree of 
inhibition was determined by the spot on lawn method. The size of inhibition zones 
obtained on each of the media was compared.   
 
4.2.5.2 Extracellular bacteriocin     
Effect of culture conditions and broth compositions on production of the bacteriocin  
A fresh culture of the bacteriocin producer (108 CFU/mL, 200 µl) was transferred to 20 mL 
of the following media and incubated under the following conditions. After incubation, the 
inhibitory activity was determined by the agar diffusion method against S. uberis.  
• The bacteriocin producer was cultured in brain heart infusion broth (BHB, Appendix 
C) at room temperature, 30°C and 37°C with and without agitation. The initial pH of 
the media ranged from 2 to 11. The culture supernate was collected after incubation 
for 0, 3, 6, 9, 12, 18, 24 and 48 h and was tested for inhibitory activity.  
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• To obtain anaerobic conditions, BHB was placed in boiling water for 10 min to 
eliminate oxygen from the broth. The culture tube was cooled immediately in tap 
water. The producer strain was inoculated into the broth and sterile liquid paraffin 
was gently overlaid onto the surface of the broth to maintain anaerobic conditions. 
The culture was incubated at 37°C overnight and examined for inhibitory activity.    
• The effect of sub-lethal concentrations of nine antibiotics (ampicillin, cephalothin, 
erythromycin, gentamicin, oxacillin, penicillin, tetracycline, vancomycin and 
novobiocin) on production of inhibitory substance by the bacteriocin producer strain 
was examined. The minimal inhibitory concentration (MIC) of the bacteriocin 
producer strain was determined (refer to method in chapter 3). BHB was 
supplemented with each antibiotic at final concentration of 1/2, 1/4 and 1/8 of the 
MIC value. The isolate was grown at 37°C overnight then the culture supernate was 
tested for inhibitory activity. Media with antibiotics alone were used as negative 
controls. 
• BHB was supplemented with increasing concentrations of glucose, lactose, skim 
milk, full cream milk, yeast extract and casein to a final concentration of  0, 0.1, 0.2, 
0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.5, 2.0, 2.5 and 3.0 % (w/v). After inoculation, 
the culture was incubated at 37°C overnight then the culture supernate was tested for 
inhibitory activity. Non inoculated media was use as a negative control. 
• Inhibitory activity was assayed in BHB supplemented with different concentrations 
of Tween 20 and Tween 80 at a final concentration of 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 
0.7, 0.8, 0.9, 1.0, 2.0, 3.0, 4.0 and 5.0 % (v/v). After inoculation, the culture was 
incubated at 37°C overnight then culture supernate was tested for inhibitory activity.  
Non inoculated media was use as a negative control. 
Bacteriocin production from semisolid culture 
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Since inhibitory activity was not reliably detected in broth culture, extraction of inhibitory 
substance from semi-solid agar was attempted (Mayr-Harting, et al., 1972, Balakrishnan, et 
al., 2000). An inoculum of approximately 108 cfu/mL (a suspension with the turbidity 
equivalent to 0.5 McFarland standard) of the bacteriocin producer strain was prepared in 
BHB. The strain was inoculated with a sterile swab onto BHI soft agar plates and incubated 
at 37°C overnight. The plate was frozen at -20°C overnight, then thawed at 37°C for 1 h. 
This procedure was used to extract any bacteriocin that was embedded in the agar. The 
slurry was transferred to a centrifuge tube. After centrifugation at 10,000 × g at 4°C for 30 
min, the supernatant fluid was collected and sterilized by passage through a 0.45 µm 
membrane filter. This liquid was referred to as crude bacteriocin. The inhibitory activity of 
the crude bacteriocin was then examined by the agar diffusion assay.  
4.2.5.3 Attempt to extract intracellular bacteriocin 
Physical extraction 
Sonication is physical cell disruption procedure using high frequency sound waves to shear 
cells. The bacteriocin producer cells from cultures in 500 mL BHB, after incubation at 37°C 
for 24 h, were harvested by centrifugation at 10,000 × g for 15 min then washed three times 
with PBS (pH 7.0). The cells were suspended in 2 mL distilled water and sonicated for 3 
min (6 times, 30 s each) in an ice bath or until the cloudy cell suspension became 
translucent. The sonicator probe was set below the surface of the solution at all times. The 
suspension was centrifuged at 10,000 × g, 4°C for 15 min to eliminate bacterial cells and 
cell debris. The supernate was collected and tested for the bacteriocin activity by the agar 
diffusion assay. 
Chemical extraction 
Attempts to extract bacteriocin from the producer cells were made using a mixture of HCl 
and ethanol (Mota-Meira, et al., 1997, Wescombe, et al., 2006). Cultures in 1,000 mL BHB 
were incubated at 37°C overnight. The cells were then harvested by centrifugation at 
10,000 × g for 15 min. A mixture consisting of 20 mL HCl (20 mM) and 80 mL ethanol 
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(70%) at pH 2.0 was added to the cell pellets and left at 4°C overnight. The cell suspension 
was heated at 70°C for 40 min, cooled on ice for 30 min and centrifuged at 10,000 × g for 
15 min to eliminate cell debris. The supernate was removed by evaporation using a rotary 
evaporator at 50°C for 1 h and the concentrate was filtered (0.45 µm) and used for 
bacteriocin assay.  
 
Another method was reported by Yang et al. (1992). Cells from the culture in 1000 mL BHB 
incubated at 37°C for 16 h were harvested by centrifugation at 10,000 × g for 15 min, 
washed with a solution of 5 mM sodium phosphate at pH 6.5, resuspended in sterile Milli Q 
water and adjusted to pH 2.0 with 1 M HCl. The mixture was stirred at 4°C for 2 h. The cell 
suspension was centrifuged at 10,000 × g for 30 min and the supernate was filter -sterilized 
(0.45 µm).  A solution without added cells was treated under the same condition and used 
as a control.  
 
The culture supernate or extract of each treatment was filtered (0.45 µm) membrane and 
tested for inhibitory activity by the agar diffusion method against S. uberis (796-2).   
4.3 Results 
4.3.1 Isolation of coagulase negative Staphylococcus and the bacteriocin-producing strain 
Colonies obtained from milk samples cultured on HBA were selected for further testing if 
they were round, smooth, opaque and either white, grey to yellow with an approximate 
diameter of one to four mm. Isolates that were Gram-positive, spherical, arranged in 
irregular clusters and produced catalase but not coagulase were tentatively identified as 
CoNS. None of the isolates were identified as S. chromogenes as no isolate showed 
intermediate zones of clearing on DNase agar. Seventy-seven of CoNS isolates were 
obtained from milk samples and a further 78 isolates were obtained from a previous study 
(Abadin, 1994) (Appendix B). Screening for inhibitory activity of all CoNS isolates (n = 155) 
by agar inversion and spot on lawn method identified only one isolate (number 2042-4) with 
 89
inhibitory activity against all the S. uberis tested. Isolate 2042-4 was not sensitive to its own 
bacteriocin, as shown by the agar inversion method (Figure 4.1a). The observed inhibitory 
activity was not due to bacteriophages. S. uberis 796-2 was the most sensitive indicator 
strain. It showed an inhibitory radius of 5 mm (Figure 4.1b) while other S. uberis isolates 
showed an inhibitory radius ranging from 1 to 4 mm.  
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Figure 4.1 Inhibitory effect of the strain 2042-4. a: agar inversion method against S. uberis 796-2, 686-5, 
684-1 (1, 2, 3), S. aureus ATCC 29213 (4) and self control the strain 2042-4 (5), b: inhibitory activity 
against S. uberis 796-2 by spot on lawn method, c: inhibitory activity against S. uberis 796-2 in the 
presence of proteinase K (arrow), d: inhibitory activity against S. uberis 796-2 in presence of catalase 
(arrow). Scale bar = 2 mm 
 
 
 
 
 
 
 
 
 
Isolate number 2042-4 was a Gram-positive clustering coccus producing catalase but not 
coagulase. Figure 4.2 shows the 16S rRNA sequence of the strain 2042-4 from nucleotide 
number 1 to 366. A blast sequence search in the NCBI database revealed a close 
relationship of the strain 2042-4 with Macrococcus caseolyticus.  Figure 4.2 shows the 
multiple alignments of 16S rRNA gene partial sequences of the isolate 2042-4 and four 
strains of Macrococcus caseolyticus (accession numbers AY126154, DQ518592, 
EF204307 and EU048336). isolate 2042-4 showed 97 - 98% similarity to M. caseolyticus 
and was therefore designated as M. caseolyticus 2042-4.     
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2042-4          -------------------------------TGGCGGCGTGCCTAATACATGCAAGTCGA 29 
AY126154-s      TAGAGTTTTGATCCTGGCTCAGGATGAACGCTGGCGGCGTGCCTAATACATGCAAGTCGA 60 
DQ518592        ----------------------GATGAACGCTGGCGGCGTGCCTAATACATGCAAGTCGA 38 
EF204307        -------------------------------------------------------GTCGA 5 
EU048336        -----------------------ATGAACGCTGGCGGCGTGCCTAATACATGCAAGTCGA 37 
                                                                       ***** 
 
2042-4          GCGAATTGACAGAGATGCTTGCATCTCTCGATTTTAGCGGCGGACGGGTGAGTAACACGT 89 
AY126154-s      GCGAATTGACAGAGGTGCTTGCACCTCTCGATTTTAGCGGCGGACGGGTGAGTAACACGT 120 
DQ518592        GCGAACTGACNGAGGTGCTTGCACCTCTCGAAGTTAGCGGCGGACGGGTGAGTAACACGT 98 
EF204307        GCGAATTGACAGAGGTGCTTGCACCTCTCGATTTTAGCGGCGGACGGGTGAGTAACACGT 65 
EU048336        GCGAACGGACGAGAGTGCTTGCACTCTCTGATGTTAGCGGCGGACGGGTGAGTAACACGT 97 
                *****  ***     ********      **  *************************** 
 
2042-4          GGGTAACCTACCTATAAGACTGGGATAACTTCGGGAAACCGGAGCTAATACCGGATAATA 149 
AY126154-s      GGGTAACCTACCTATAAGACTGGGATAACTTCGGGAAACCGGAGCTAATACCGGATAATA 180 
DQ518592        GGGTAACCTACCTATAAGACTGGGATAACTTCGGGAAACCGGAGCTAATACCGGATAATA 158 
EF204307        GGGTAACCTACCTATAAGACTGGGATAACTTCGGGAAACCGGAGCTAATACCGGATAATA 125 
EU048336        GGGTAACCTACCTATAAGACTGGGATAACTTCGGGAAACCGGAGCTAATACCGGATAATA 157 
                ************************************************************ 
 
2042-4          TTTAGCTTCGCATGAAGCAATAGTGAAAGACGGTTTTGCTGTCACTTATAGATGGACCTG 209 
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AY126154-s      TTTAGCTTCGCATGAAGCAATAGTGAAAGACGGTTCTGCTGTCACTTATAGATGGACCTG 240 
DQ518592        TTTAGCTTCGCATGAAGCAATAGTGAAAGACGGTTCTGCTGTCACTTATAGATGGACCTG 218 
EF204307        TTTAGCTTCGCATGAAGCAATAGTGAAAGACGGTTCTGCTGTCACTTATAGATGGACCTG 185 
EU048336        TTTAGCTTCGCATGAAGCAATAGTGAAAGACGGTTCTGCTGTCACTTATAGATGGACCCG 217 
                *********************************** ********************** * 
 
2042-4          CGGTGTATTAGCTAGTTGGTGAGGTAATGGCTCACCAAGGCAACGATACATAGCCGACCT 269 
AY126154-s      CGGTGTATTAGCTAGTTGGTGAGGTAACGGCTCACCAAGGCAACGATACATAGCCGACCT 300 
DQ518592        CGGTGTATTAGCTAGTTGGTGAGGTAACGGCTCACCAAGGCAACGATACATAGCCGACCT 278 
EF204307        CGGTGTATTAGCTAGTTGGTGAGGTAACGGCTCACCAAGGCAACGATACATAGCCGACCT 245 
EU048336        CGGTGTATTAGCTAGTTGGTGAGGTAACGGCTCACCAAGGCAACGATACATAGCCGACCT 277 
                *************************** ******************************** 
 
 
 
 
 
 
2042-4          GAGAGGGTGATCGGCCACACTGGGACTGAGACCAGGCCCAAACTCCTACGGGAGGCAGCA 329 
AY126154-s      GAGAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCA 360 
DQ518592        GAGAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCA 338 
EF204307        GAGAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCA 305 
EU048336        GAGAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCA 337 
                ********************************  ****** ******************* 
 
2042-4          GTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGA----------------------- 366 
AY126154-s      GTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGTGAAGAAG 420 
DQ518592        GTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGTGAAGAAG 398 
EF204307        GTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGTGAAGAAG 365 
EU048336        GTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGTGAAGAAG 397 
                *************************************                                                    
 
Figure 4.2 Multiple alignments of 16S rRNA gene partial sequencing of the strain 2042-4 and 
Macrococcus caseolyticus accession numbers AY126154, DQ518592, EF204307,and EU048336. An 
asterisk is used to indicate a match column.
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4.3.2 Characterization of antibiotic substance 
The inhibitory activity of M. caseolyticus 2042-4 against S. uberis 796-2 was lost after 
treatment with three proteolytic enzymes (Table 4.1): proteinase K, trypsin and 
chymotrypsin. An example of reduction in inhibitory activity by proteinase K is shown in 
Figure 4.1 c. Treatment with catalase and lipase (result not shown) did not result in loss of 
activity (Table 4.1, Figure 4.1 d). The inhibitory activity on BHA containing CaCO3 (Table 
4.1) showed the same activity as in BHA alone (Figure 4.1b). Together these results 
suggested that the antibacterial activity demonstrated by M. caseolyticus 2042-4 was due 
to production of a bacteriocin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1 Factors affecting antibiotic activity of Macrococcus caseolyticus 2042-4 
Treatment Activity 
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Protinase K - 
Trypsin - 
Chymotrypsin  - 
Catalase  + 
Lipase + 
CaCO3 + 
-: lost of inhibitory activity, +: present of inhibitory activity 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.3 Bacteriocin production    
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4.3.3.1 Media selection 
The growth of the bacteriocin producer strain, Macrococcus caseolyticus 2042-4, varied on 
different agar media, ranging from very heavy on BHA, good on NA, to poor on TSA. There 
was no growth on MA. The inhibition zones against all isolates of S. uberis that were tested 
were clearer and larger on BHA than on NA (Table 4.2). There were no zones of inhibition 
on TSA. For these reasons, BHA was selected for further studies on production of the 
bacteriocin.   
 
The inhibition zones around M. caseolyticus 2042-4 against S. uberis were less than 4.0 
mm in most cases, except in the case of S. uberis 796-2 which was the most sensitive 
strain. S. uberis 796-2 was therefore selected as an indicator strain for further studies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.2 Effect of media on bacteriocin activity  
Media Inhibition zone (mm) around S. uberis strain: 
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684-1 686-5 796-2 853-4 883-7 2042-
5 
2655-
5 
2690-
2 
3147-
1 
H2581-
3 
BHA 3.9 4.1 4.5 4.0 3.8 3.7 4.0 3.9 3.8 3.7 
NA 2.1 2.0 2.2 2.0 2.1 1.9 2.2 1.8 1.9 1.9 
TSA 0 0 0 0 0 0 0 0 0 0 
MA N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A 
N/A: not accessible   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.3.2 Effect of physical conditions on bacteriocin production  
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In this section, different culture conditions were evaluated in order to obtain maximum yield 
of the bacteriocin produced by M. caseolyticus 2042-4. M. caseolyticus 2042-4 grew well in 
BHB with agitation and non-agitation at room temperature, 30°C, 37°C and between pH of 
6 and 9 (Table 4.3). No growth of the bacteriocin producer was observed anaerobically. No 
inhibitory activity was detected by the agar diffusion method in cell free supernate after 
growth of the producer strain in BHB with or without agitation at different temperatures of 
incubation (RT, 30°C and 37°C), different initial pH values or  from 0 to 48 h. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.3 Growth of Macrococcus caseolyticus 2042-4 in BHB, 24 h 
Agitation Temperature (°C) pH 
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2 3 4 5 6 7 8 9 10 11 
Room 
temperature 
- - - - + +++ +++ ++ - - 
30 - - - - ++ +++
+ 
+++ +++ - - 
Agitation 
37 - - - - ++ +++
+ 
+++ +++ - - 
Room 
temperature 
- - - - + +++ +++ ++ - - 
30 - - - - ++ +++ +++ +++ - - 
Non-agitation 
37 - - - - ++ +++
+ 
+++ +++ - - 
 
-: no growth, +: poor growth, ++: moderate growth, +++: good growth, ++++: excellent  
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The MICs of ampicillin, cephalothin, erythromycin, gentamicin, novobiocin, oxacillin, 
penicillin, tetracycline and vancomycin for the producer strain (M. caseolyticus 2042-4) are 
shown in Table 4.4. After culturing of the bacteriocin producer strain, in broth containing 
sub-lethal concentrations (1/2, 1/4 and 1/8 of MIC) of these nine antibiotic agents, no 
inhibitory activity was observed by the agar diffusion assay after growth in antibiotics at any 
concentrations. The negative control of the broth containing sub-lethal concentration of 
antibiotics alone against the indicator strains did not show activity, even though the sub-
lethal concentrations in the broth were higher than the MICs of the indicator strain 
(Appendix B, Table 2).  These results could be explained by the fact that the concentration 
of indicator strain used in the agar diffusion method (106 CFU/mL) was higher than in the 
MIC procedure (104 CFU/mL) (NCCLS, 2002) therefore no inhibition was observed.   
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Table 4.4 Minimal inhibitory concentration of a range of antibiotic agents for Macrococcus caseolyticus 
2042-4   
Antibiotic agent MIC (µg/mL) 
Ampicillin 16 
Cephalothin 16 
Erythromycin 2 
Gentamicin 128 
Novobiocin 16 
Oxacillin 32 
Penicillin 4 
Tetracycline 32 
Vancomycin 8 
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No inhibitory activity was detected in the culture supernate of M. caseolyticus  2042-4 
grown in BHB supplemented with glucose, lactose, skim milk, full cream milk, casein or 
yeast extract in the range of 0 to 3% at 37 °C or in BHB containing Tween 20 or Tween 80 
at concentrations of 0 to 5%.  
 
Extraction of intracellular bacteriocin was also performed by sonication and chemical 
extractions but no inhibitory activity was discovered. Inhibitory activity of 10 AU/mL was 
finally observed by culturing the producer strain on semi-solid agar (0.7% of agar in BHI) 
followed by freezing and thawing as shown in Figure 4.3. 
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Figure 4.3 Inhibitory effect of crude bacteriocin extracted from semi-solid agar by agar diffusion 
method, Scale bar = 6 mm
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4.4 Discussion  
Of the 155 isolates from milk, which were initially identified as CoNS, one had antagonistic 
activity against all S. uberis that were examined in this study. The antagonistic activity was 
shown to be due to the production of a bacteriocin rather than other types of inhibitory 
substances such as bacteriophages, hydrogen peroxide or acid production (Jack, et al., 
1995). Bacteriophages were ruled out because activity was detected by the agar inversion 
method, which requires the inhibitory agent to pass through the agar, which is not possible 
for a bacteriophage. Hydrogen peroxide was also excluded as a cause of the antibacterial 
activity since the inhibition was demonstrated in the presence of catalase. Activity was also 
retained on BHA containing CaCO3, indicating that the inhibition was not caused by acid 
production, as CaCO3 neutralizes acidity of organic acids (Nicolas, et al., 2004). Nutrient 
depletion was also eliminated as a cause of the observed inhibition, since no activity was 
observed in the agar inversion method if the producer strain was used as both producer 
and indicator. Depletion of inhibitory activity was observed on treatment with proteolytic 
enzymes but not with lipase. These results suggested that the inhibitory activity of the 
isolate 2042-4 is due to the production of bacteriocin and that no lipid moieties are 
contained in the molecule.  
 
The bacteriocin producer was initially thought to be a CoNS, but was identified by 16S 
rRNA sequencing as Macrococcus caseolyticus 2042-4 with 98% similarity to M. 
caseolyticus in the NCBI database. In 1998, Macrococcus was separated from most 
species of staphylococci and designated as a novel genus (Kloos, et al., 1998). The genus 
Macrococcus contains four species: M. bovicus, M. caseolyticus, M. carouselicus and M. 
equipercicu. Members of this genus are coagulase negative and catalase positive and can 
be distinguished from CoNS by molecular identification techniques including 16S rRNA 
sequencing. To date, there have been no reports of Macrococcus as pathogens, in contrast 
to CoNS which are classified as minor mastitis pathogens (Radotits, et al., 1994). M. 
caseolyticus can be isolated from the skin of cattle, goats, horses, whales and dolphins 
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(Kloos, et al., 1998), dairy products (Randazzo, et al., 2002), fermented sausages (Blaiotta, 
et al., 2003) and meat products (Olsson, et al., 2003). Over the last few decades, a variety 
of bacteriocins from CoNS have been characterized but no bacteriocins from M. 
caseolyticus or Staphylococcus caseolyticus with activity against S. uberis have been 
described so far in the literature. Thus, this antibacterial substance is of interest for further 
characterization and identification.    
 
In contrast to most published data, which describes the harvest of bacteriocins released 
from the producer cells into liquid culture, no bacteriocin activity was detected in liquid 
cultures of M. caseolyticus even though the bacteriocin activity was produced on solid 
media and apparently diffused from the site of inoculation of the indicator strain to create a 
zone of inhibition. Optimal growth conditions usually result in optimal bacteriocin production 
(Parente & Ricciardi, 1999). Attempts were made to recover bacteriocin from liquid cultures 
by optimizing culture conditions such as temperature, pH, incubation time and agitation but 
these were unsuccessful. Also, the producer cells did not grow under anaerobic conditions 
and thus inhibitory activity was not detected. Moreover, in contrast to other studies 
(Ogunbanwo, et al., 2003, Avonts, et al., 2004, Nicolas, et al., 2004), optimization of the 
media composition with addition of carbon sources, milk or yeast extract did not assist in 
enhancing bacteriocin production from M. caseolyticus 2042-4. Additionally, sub-lethal 
concentrations of nine antibiotics failed to induce bacteriocin synthesis from M. 
caseolyticus 2042-4 in broth cultures. These results are in contrast to those of Jerman et al. 
(2005), which showed that sub-lethal concentrations of ciprofloxacin induced bacteriocin 
synthesis in E. coli.  They suggested that ciprofloxacin interferes with DNA replication and 
cell wall synthesis, which may induce production of bacteriocins by inducing the SOS 
response. In this study, Tween 20 and Tween 80 did not stimulate bacteriocin production 
which is in contrast to the study of Garver and Muriana (1994) that showed an increase in 
curvaticin FS47 (a bacteriocin from Lactobacillus curvatus FS47) production by adding 
Tween 20 or Tween 80 to the medium at concentrations from 0.75 to 1%. Other studies 
showed that Tween did not enhance bacteriocin production but could possibly bind to 
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producer cells. For example, adding Tween 80 to the culture media reduced adsorption of 
lacticin RM to producer cells, Lactobacillus lactis (Keren, et al., 2004). However Li, et al. 
(2002), reported that addition of Tween 20 caused increased sensitivity of L. 
monocytogenes to nisin by increasing the binding of nisin to the indicator cells.  
 
In this study, no bacteriocin activity was detected after physical and chemical extraction of 
producer cell pellets, suggesting that the bacteriocins did not adhere to the surface of the 
producer cells. This is contrast to some investigators who successfully extracted 
bacteriocins from cell pellets for example, mutacin B-Ny266 from S. mutans (Mota-Meira, et 
al., 1997) and bacteriocins produced by different genera of lactic acid bacteria (Yang, et al., 
1992).   
 
Limited success in detection of these substances may be due to inactivation of the 
bacteriocin by proteolytic enzymes present in the culture supernate. Therefore the final 
attempt to extract bacteriocin used culture media supplemented with agar and this method 
proved successful. Similar problems had been described by Kelstrup and Gibbons (1969). 
They explained that the recovery of the bacteriocin produced by non-group A streptococci 
was dependent on the viscosity of the media which could be manipulated by the amount of 
agar, starch, glycerol or dextran in the culture medium. In culture on solid media, the 
bacteriocins may diffuse ahead of the active proteinase and would be protected from 
inactivation.   
Results from this study showed that a non-pathogenic bacterium found in cow’s milk, 
Macrococcus caseolyticus 2042-4, had inhibitory activity against S. uberis. Since 
Macrococcus caseolyticus was isolated from the same niche as S. uberis, this raises the 
possibility that the inhibitory substance produced by this organism could be used to 
regulate pathogenic species in the same environment. This newly found antibiotic, 
therefore has the potential for beneficial use as a method of natural control of bovine 
mastitis caused by S. uberis. 
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The next chapter describes further characterization of this bacteriocin as well as 
investigation of an extraction method suitable for scale up of production in sufficient 
amounts for purification and identification of this molecule. 
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Chapter 5 Bacteriocin characterization and purification 
5.1 Introduction 
The previous chapter presented results showing that a crude bacteriocin produced by 
Macrococcus caseolyticus has antibacterial activity against all isolates of S. uberis that 
were tested. Characteristics of bacteriocins, which include a narrow inhibitory spectrum, 
thermostability and pH stability, could make them attractive as chemotherapeutic agents. In 
particular, antibacterial activity against mastitis pathogens makes them attractive 
candidates for the treatment of clinical mastitis or protection against from mastitis. Each 
bacteriocin is unique; therefore characterization of this bacteriocin is necessary. The aim of 
this chapter was to report on the characterization of purified bacteriocin from culture 
supernate.  
 
5.2 Material and methods 
5.2.1 Bacteriocin characterization  
Characterization of the bacteriocin involved determining the spectrum of activity against a 
variety of Gram-positive and Gram-negative bacteria, thermostability, pH stability and rate 
of killing. These tests used concentrated crude bacteriocin that was prepared by extraction 
from semi-solid agar followed by ammonium sulphate precipitation as described in 5.2.3.2 
and 5.2.3.3. 
5.2.1.1 Spectrum of inhibitory activity 
Indicator strains from stock cultures held by the Microbiology Laboratory, RMIT University 
were used in this experiment. The strains included varieties of Gram-positive, Gram-
negative bacteria and spiral bacteria (Appendix B, Table 4). The strains were stored at -
80°C in Protect Bacterial Preservers. They were retrieved from storage at -80°C by 
aseptically transferring the bacterial preserver beads onto horse blood agar (HBA, Appendix 
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C) or brain heart infusion agar (BHA, Appendix C), streaking and incubating for 24 hours 
for further testing. Determination of the spectrum of activity of the bacteriocin culture was 
performed by spot on lawn method (4.2.4.2) using a culture of the producer strain. The 
bacteriocin precipitate (80 AU/mL) obtained by ammonium sulphate precipitation (5.2.3.3) 
was examined for its spectrum of activity by the agar diffusion assay (4.2.4.3).   
5.2.1.2 Thermostability 
Thermostability of the ammonium sulphate precipitate (5.2.3.3) was determined by 
incubating the precipitate (160 AU/mL) in PBS at room temperature, 37°C, 60°C, 80°C and 
100°C. Samples were removed at intervals of 15, 30, 60, 120, 180 min and 24 h (only in 
the case of the sample held at 37°C). The ammonium sulphate precipitate was also 
incubated at 121°C for 15 min. After exposure to different temperatures, samples were 
cooled to 4°C and assayed for the remaining inhibitory activity by the agar diffusion 
method. 
5.2.1.3 pH stability 
The ammonium sulphate precipitate (5.2.3.3) (320 AU/mL) in PBS was adjusted to pH 2, 3, 
4, 5, 6, 7, 8, 9, 10, 11 and 12 with 1M HCl or 1 M NaOH. Samples were incubated in a 
waterbath at 37°C for 1 h. The samples were then adjusted to pH 7.0 with 1 M HCl or 1 M 
NaOH before testing for the remaining inhibitory activity by the agar diffusion assay. 
5.2.1.4 Kill curves 
The effect of the ammonium sulphate precipitate (5.2.3.3) on indicator cells using S. uberis 
796-2 was determined. After the indicator strain was grown on BHA at 37°C overnight, it 
was inoculated into 10 mL of brain heart infusion broth (BHB, Appendix C) with agitation at 
37°C until the OD reached 0.15 – 0.20 at wavelength 600 nm. Five mL of culture broth was 
transferred into each of two tubes. Five mL of BHB was added to the first tube as a control. 
Five mL of the ammonium sulphate precipitate (80 AU/mL in PBS) was added to the 
second tube to treat the indicator cells. The control and treated cells were incubated at 
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37°C with agitation. Viable cell counts were performed at hourly intervals, by plating 
aliquots of appropriate dilutions of broth culture onto BHA and incubating at 37°C overnight.  
Colonies were counted and the CFU/mL was calculated. 
5.2.2 Electron microscopy 
The cell morphology of S. uberis treated with ammonium sulphate precipitate (160 AU/mL) 
was examined by scanning and transmission electron microscopy and compared with the 
morphology of control cells incubated under the same conditions but without bacteriocin.    
5.2.2.1 Scanning electron microscopy 
Scanning electron microscopy was employed to observe bacterial surfaces. Fresh cultures 
of S. uberis and S. uberis treated with the ammonium sulphate precipitate (160 AU/mL) for 
6 h were prepared as described under 5.2.1.4 above. The bacterial sample was prepared 
by pipetting the cells onto a 0.45 µm membrane and the cells with the membrane were air-
dried overnight. After the sample was coated with gold (Magnetron sputter coater, 
Dynavac, SC100M), the cells were viewed on a scanning electron microscope (XL30, 
Philips).  
5.2.2.2 Transmission electron microscopy 
The method of specimen preparation for transmission electron microscopy was modified 
from Almeida and Oliver (1993) and Bellemann et. al (1994). Fresh cultures of S. uberis 
and S. uberis treated with the ammonium sulphate precipitate (160 AU/mL, refer to 5.2.3.3) 
for 6 h were prepared as described in section 5.2.1.4. The cells were harvested by 
centrifugation at 10,000 × g for 3 min to attain approximately 50 µl of bacterial pellet, then 
washed once in PBS. The washed cells were fixed in 200 µl of 3% (v/v) glutaraldehyde in 
0.1 M cacodylate buffer (pH 7.0) for 2 h at room temperature. Fixed bacteria were 
suspended in 200 µl of 1 mg/mL cationized ferritin in 0.1 M cacodylate buffer, pH 7.0 for 30 
min. The reaction was stopped by adding 2 mL of 0.1 M cacodylate buffer, pH 7.0. The 
bacteria were washed three times in 0.1 M cacodylate buffer, pH 7.0 then immobilized in 
4% (w/v) agar. Agar cubes containing the bacterial specimen were washed five times in 0.1 
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M cacodylate buffer, pH 7.0 and post-fixed in 200 µl of 1% (v/v) osmium tetroxide for 2 h, 
then washed again in cacodylate buffer. The cubes were dehydrated by exposure to 1 mL 
of the following increasing concentrations of acetone in Milli Q water: 25% (v/v), 50% (v/v), 
70% (v/v), 90% (v/v) and 100% (v/v). Each dehydration step was performed for 30 min and 
the final step (100% acetone) was performed three times for 30 min, 30 min and 1h 
respectively. Dehydration was continued in propylene oxide three times, each for 30 min. 
 
The sample was gradually infiltrated with embedding medium using a rotary mixer at room 
temperature by the following three steps. First, the sample was infiltrated by placing it in 1 
mL of a 1:1 solution of propylene oxide and embedding medium for 1 h. Embedding 
medium contained 20 mL of Procure 812, 16 mL of DDSA, 8 mL of NMA and 1.1 mL of 
BDMA (Appendix A). Second, the sample was infiltrated in 1 mL of a 2:1 solution of 
propylene oxide and embedding medium overnight. Finally, the sample was placed in 1 mL 
of 100% embedding medium for 1 h. 
 
After infiltration, each sample was transferred to an embedding capsule and the capsule 
was filled with embedding medium. The medium was cured in an oven at 50°C for 24 h. 
Blocks of sample were returned to room temperature then trimmed with a blade and 
sectioned with an ultratome (Reichert-Jung, Austria). The sections were placed on copper 
grids.  
 
The final step of specimen preparation consisted of uranyl acetate followed by lead citrate 
staining. First, uracetate-saturated solution was prepared by adding aliquots of uranyl 
acetate to a mixture of methanol and distilled water (1:1) until saturated, then filtering 
through a 0.45 µm filter membrane before use. A drop of saturated solution of uranyl 
acetate was placed on dental wax in a Petri dish. A copper grid containing the specimen 
was placed on the drop of uranyl acetate and left for 20 min at room temperature. The grid 
was rinsed with distilled water three times and allowed to air dry. The second staining was 
performed with lead citrate in a CO2-free chamber. The chamber was prepared by dipping 
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filter paper in 0.1 M NaOH and placing on dental wax in a Petri dish. Five NaOH pellets 
were placed on the filter paper and the Petri dish was covered with a lid. Lead citrate 
solution was prepared by dissolving 0.02 g of lead citrate in 0.1 mL of 10 M NaOH and 10 
mL of CO2-free distilled water. The solution was filtered through a 0.45 µm filter membrane 
before use. Lead citrate solution was rapidly dropped on the dental wax, and the grid with 
specimen was stained in the solution for 7 min. The grid was rinsed in CO2-free distilled 
water then blotted with filter paper and allowed to air-dry. The samples were ready to view 
in the transmission electron microscope (JEM-1010, JEOL).  
5.2.3 Bacteriocin purification 
Purification of the bacteriocin from the supernate was required in order to study the 
properties of the bacteriocin. The bacteriocin purification scheme developed used several 
different chromatography techniques. First, crude bacteriocin was concentrated by 
ammonium sulphate precipitation. Secondly, the bacteriocin precipitate was purified by gel 
filtration, cation exchange chromatography and extraction from SDS-PAGE. Finally, the 
active fractions were purified by reverse phase-chromatography. The purification scheme 
of the bacteriocin is shown in Figure 5.1. After each stage of the purification process, the 
product was assayed for protein concentration (5.2.3.1) and for antibiotic activity by the 
diffusion method (4.2.4.3). This data was used to calculate the activity in AU units (4.2.4.3) 
and the specific activity.             
 
 
 
 
Crude bacteriocin 
↓ 
Ammonium sulphate precipitation 
↓ 
Gel filtration 
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↓ 
Cation exchange chromatography 
↓ 
Extraction from SDS-PAGE 
↓ 
RP-HPLC 
Figure 5.1 Purification scheme of the bacteriocin 
 
 
 
 
 
 
 
 
 
 
5.2.3.1 Protein determination   
Absorbance assay  
Proteins have two major absorbance peaks in the ultraviolet region; one between 210 and 
230 nm where peptide bonds absorb, and another at about 280 nm due to light absorption 
by tyrosine and tryptophan content (and to a very small extent on the amount of 
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phenylalanine and disulfide bonds). Monitoring the absorbance at 214 nm is fast and 
convenient for peptide determination and is commonly used for determining the protein 
concentration of fractions from chromatography columns (Aitken and Learmounth, 2002, 
The biotechnology project, 2007) 
 
The spectrophotometer was switched on for about 15 min before adjusting the wavelength 
at 214 nm. The buffer solution was placed in a quartz cuvette for zero calibration. After 
cleaning the cuvette with distilled water, the first sample was placed in the cuvette and the 
absorbance value was read. The cuvette was cleaned with distilled water before each new 
sample was assayed (Bollag & Edelstein, 1991).  
Bicinchoninic (BCA) assay (Bollag & Edelstein, 1991) 
The BCA assay is a variation of the Lowry method. The reaction is simpler to perform and 
has fewer interfering substances and is more sensitive than the Lowry method (Hansen, 
2007). The BCA protein assay kit (Pierce, USA) consisted of BCA reagent A and B. 
Working BCA reagent was prepared by mixing 50 parts of BCA reagent A and 1 part of 
BCA reagent B. The mixture was stable in a closed container at room temperature for at 
least one day.  
 
A fresh set of protein standards, using bovine serum albumin (BSA), was prepared by 
diluting 1mg/mL of BSA as shown in Table 5.1. Twenty-five microlitres of each BSA 
standard or sample was transferred into the wells of a microtiter plate, then 200 µl of 
prepared BCA reagent was added into each well and mixed appropriately. The plate was 
incubated at 37°C for 30 min then at room temperature for 15 min. The absorbance of wells 
containing standards and test samples were determined at 600 nm with a microplate 
reader (Dynatech MR7000, Germany).    
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Table 5.1 Protein standard preparation 
1 mg/mL BSA 
(µl) 
Milli Q water (µl) Final BSA concentration 
(µg/mL) 
0 200 0 
10 190 50 
20 180 100 
30 170 150 
40 160 200 
50 150 250 
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70 130 350 
100 100 500 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.3.2 Extraction of crude bacteriocin from BHA plates 
The bacteriocin was successfully detected by extracting from semi-solid agar cultures 
(4.2.6.2). The optimal concentration of agar for maximum bacteriocin production was 
determined using the same procedures as in 4.2.6.2 with agar concentrations ranging from 
0.1% to 1.0%. 
5.2.3.3 Ammonium sulphate precipitation   
Ammonium sulphate precipitation is a method for concentrating and fractionating a mixture 
of proteins. Proteins tend to aggregate in high concentrations of salt and precipitate out of 
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solution. Ammonium sulphate is the salt of choice because it is effective, highly soluble, 
dissolves at low temperatures and at a range of pH values and is cheap (Bollag & 
Edelstein, 1991).  The crude bacteriocin was initially concentrated by ammonium sulphate 
precipitation. The following procedures were performed at 4°C. Solid ammonium sulphate 
was slowly added to the crude bacteriocin solution. A range of concentrations of 
ammonium sulphate was added to the bacteriocin solution to optimize precipitation. 
Ammonium sulphate reaches 40% (w/v), 50% (w/v), 60% (w/v), 70% (w/v), 80% (w/v) and 
90% (w/v) saturation when 242, 314, 390, 472, 561 and 657 g of this salt is added to 1 L of 
salt-free crude bacteriocin solution respectively (Bollag & Edelstein, 1991). The system was 
held with constant stirring overnight. The precipitate was recovered by centrifugation at 
10,000 × g for 30 min. The precipitate was then solubilized in 30 mL of 20 mM sodium 
phosphate buffer (pH 5.5) and dialyzed in the same buffer using dialysis tubing with a 
3,500 Dalton cut-off to eliminate ammonium sulphate residue. After dialyzing, the solution 
was filtered through a 0.45 µm membrane. The product of this stage of purification process 
was designated ammonium sulphate precipitate. The protein concentration and inhibitory 
activity against S. uberis were determined as described in 4.2.4.3. Sodium phosphate 
buffer was used as negative control. The precipitate was stored at -20°C until use.  
5.2.3.4 Gel filtration chromatography 
Gel filtration separates a mixture of proteins based on their differences in molecular size 
(Wu, 2004). Gel beads have pores in them which allow smaller molecules to enter but 
exclude molecules larger than the pore diameter. As a result, the smaller molecules are 
retained in the column longer and pass through slower than the larger molecules.      
 
Sephadex G-100 was mixed slowly and degassed to remove air bubbles prior to packing 
into a 10 × 1 cm column (Pharmacia). The resin was washed with at least 100 mL of 20 
mM sodium phosphate buffer, pH 5.5, at a flow rate of 0.5 mL/min. Three milliliters of the 
bacteriocin precipitate was loaded onto the column followed by the same buffer and 
fractions were collected (1 mL/tube). The column was washed again before each new run. 
 117
The peptide concentration of each fraction was assayed manually by determining the 
absorbance at 214 nm (5.2.3.1), then the chromatogram was developed. Every fraction 
was also analyzed for inhibitory activity against S. uberis by the agar diffusion assay 
(4.2.4.3). The fractions with inhibitory activity were then further purified by cation 
chromatography. Sodium phosphate buffer was used as a negative control. 
5.2.3.5 Cation exchange chromatography 
The stationary phase in ion exchange chromatography is made of porous polymer to which 
anionic or cationic exchange groups have been attached. The retention and separation of 
solutes are performed according to the degree of ionization of the solute and its affinity to 
the ionic sites on stationary phase. The eluent is usually an aqueous buffer and the 
retention controlled by changes in ionic strength  (Hansen, et al., 1984). 
 
The SP Sepharose Fast Flow (strong cation exchange) media was mixed and packed in a 
10 × 1 cm column (Pharmacia). There were five steps for ion exchange chromatography; 
equilibration, sample loading, washing unbound material, gradient elution and regeneration 
of the column. 
 
One hundred milliliters of 20 mM sodium phosphate buffer at the desired pH was used to 
equilibrate the column at a flow rate of 6 mL/min. The sample and a starting buffer were 
maintained at the same pH. An aliquot of 3 mL of sample or buffer was applied to the 
column at a flow rate of 0.5 mL/min. The column was washed with 20 mL of buffer to 
remove unbound material.  Gradient mixtures consisting of equal volumes of buffer and 1 
M NaCl in a gradient maker (Bio-Rad) were used for elution. At the end of elution, 50 mL of 
1 M NaCl was applied to the column to elute any remaining bound material. One milliliter of 
each fraction was collected and the protein content was determined manually by 
absorbance at 214 nm (5.2.3.1) then the chromatogram was observed.  Every fraction was 
also analyzed for inhibitory activity against S. uberis 796-2 by the agar diffusion assay 
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(4.2.4.3). A new cycle of cation exchange chromatography was started by repeating the 
equilibration step. Buffer alone and buffer with NaCl were used as negative controls. 
5.2.3.6 Protein gel electrophoresis, bioassay and purification 
Gel electrophoresis was not only a tool to determine the size and assess the purity of the 
protein, but it was also used for purification of the protein of interest from the gel.  
Polyacrylamide gel electrophoresis under denaturing conditions (Laemmli, 1970)  
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) separates 
proteins based on their differences in molecular weight. SDS binds along the polypeptide 
chain, and the length of the reduced unfolded SDS-protein complex is proportional to its 
molecular weight. The composition of the stacking and resolving gels are given in Table 
5.2. The gel sandwich of the Mini-PROTEAN® II System (Bio-Rad) with gel plates was 
assembled (Figure 5.2). The resolving gel solution was pipetted to the gel sandwich until it 
reached 1.5 cm from the top of the front plate. Distilled water was gently layered on top of 
the resolving gel solution to keep the gel surface flat. After polymerization of the gel for 1 h, 
the water was decanted and the stacking gel solution was added until the solution again 
reached the top of the front plate. Then, the comb was carefully inserted into the gel 
sandwich. After the gel was allowed to polymerize for 30 min, the comb was removed. 
Analysis by SDS-PAGE was performed using a discontinuous buffer system. 
Electrophoresis was conducted at 150 V for 1 h under denaturing or reducing conditions. 
The bacteriocin sample was prepared for loading by mixing four volumes of protein sample 
and one volume of 5 X sample buffer in a microcentrifuge tube and heating at 100 °C for 2 
min. The sample buffer (5 X) consisted of 0.6 mL of 1 M Tris-HCl, pH 6.8, 5 mL of 50% 
glycerol, 2 mL of 10% SDS, 0.5 mL of 2-mercaptoethanol, 1 mL of 1% bromophenol blue 
and 0.9 mL of distilled water. Samples were loaded into wells with a syringe, ensuring all 
lanes were loaded, to keep samples running in straight lines. The electrophoresis buffer 
consisted of 0.3% (w/v) Tris, 1.44% (w/v) glycine and 0.1% (w/v) SDS.    
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Table 5.2 The composition of the acrylamide mixtures to make two mini SDS-PAGE gels 
Gel components Stacking gels (mL) 12% resolving gel (mL) 
H2O 2.1 3.3 
30% (w/v) acrylamide mix 0.5 4.0 
1.5 M Tris, pH 8.8 - 2.5 
1.0 M Tris, pH 6.8 0.38 - 
10% (w/v) SDS 0.03 0.1 
10% (w/v) APS 0.03 0.1 
TEMED 0.003 0.004 
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Figure 5.2 Bio-Rad Mini-Protean apparatus (Laemmli, 1970) 
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Coomassie blue R-250 staining (Laemmli, 1970) 
The gel was stained on a slow shaker for 5-10 min in a solution of 0.1% Coomassie blue R-
250, 45% (w/v) methanol and 10% (w/v) glacial acetic acid. The stain was decanted and the 
gel was rinsed with two changes of water. The Coomassie blue destaining solution, 
consisting of 10% (w/v) methanol and 10% (w/v) glacial acetic acid, was added to the gel 
which was destained for 1 h. To destain completely, the solution was changed and the 
destaining was continued overnight.   
Assay of inhibitory activity from electrophoresis gel (Crupper, et al., 1997) 
The protein marker (Mark 12, Invitrogen) and duplicate samples were loaded into wells of a 
native gel. After running the gel, the second sample lane was excised using a clean razor 
blade and the remainder was stained. The unstained section of the gel was assayed for 
inhibitory activity. It was first soaked in a solution consisting of 20% (v/v) isopropanol and 
10% (v/v) acetic acid for 2 h to eliminate SDS, then the gel was rinsed in distilled water for 
4 h. The washed gel was placed on a BHA plate which was overlaid with BHI soft agar 
(0.7% agar) containing an indicator strain of S. uberis 796-2 at a concentration of 106 
CFU/mL. The plate was incubated at 37°C overnight, examined for zones of inhibition and 
aligned with the stained gel to determine the approximate molecular weight of the inhibitory 
activity. 
Protein purification from polyacrylamide gel (Retamal, et al., 1999) 
Protein purification by SDS-PAGE gel is used to resolve individual components of complex 
mixtures. The protein of interest was extracted from the gel as follows: after the bands of 
interest on the unstained gel were localized by alignment with the stained gel, they were 
cut with a clean razor blade and transferred to a sterile tube. The gel slices were then 
washed three times for 5 min with a solution consisting of 250 mM EDTA in 250 mM Tris 
(pH 7.4) then followed by three rinses of 5 min with distilled water. After removing the 
water, the elution buffer, which consisted of 50 mM Tris-HCl, 150 mM NaCl, 0.1 mM EDTA 
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and 0.1% (w/v) SDS (pH 7.5), was added. The sample was sonicated (6 passes of 30 s) in 
an ice bath then incubated in a rotary shaker at 30°C overnight. After centrifugation at 
10,000 g for 10 min, the supernatant fluid containing the bacteriocin was carefully removed 
and stored at -20°C until use. This bacteriocin preparation was dialyzed with PBS and 
further purified by RP-HPLC.  
5.2.3.7 Reversed phase-high performance liquid chromatography (RP-HPLC) (Lough & 
Wainer, 1995) 
Reversed phase chromatography separates proteins and peptides with differing 
hydrophobicity based on their reversible interaction with the hydrophobic surface of a 
chromatographic medium. The stationary phase is non-polar (hydrophobic) and the mobile 
phase is polar. After loading, non-polar components are more attracted to the non-polar 
stationary phase, while the polar compounds tend to remain in the polar mobile phase and 
move faster. The length of carbon chains in the stationary phase of the column are 
expressed as the number of carbon atom such as C4, C8 and C18  
 
The samples with inhibitory activity were further purified by RP-HPLC on a C4 column 
(Brownlee Labs, USA., 7 µM, 30 x 4.6 mm., Butyl C4 300) using a gradient of 0 to 60% 
(v/v) acetronitrile. Buffer A was composed of 0.1% (v/v) TFA and buffer B was composed of 
60% (v/v) acetronitrile in 0.1% (v/v) TFA. These mobile phase solutions were filtered 
through a 0.45 µm membrane and degassed before use. Each run consisted of 3 min of 
buffer A, a 30 min of linear gradient of 0-100% buffer B and 3 min of 100% buffer B. The 
detector was set at 214 nm. One ml of each fraction was collected, lyophilised (Dynavac 
FD12, Australia) and resuspended in 20 µl of PBS. The total activity of each fraction was 
measured by the agar diffusion assay (4.2.4.3) and protein content was determined by the 
BCA assay (5.2.3.1). Buffer A and buffer B were used as negative controls. 
RP-HPLC fractions were cleaned with a C18 Zip tip (Millipore) to minimize salt 
contamination before processing by mass spectrometry. The Zip tip (C18) was pre-wet with 
100% methanol and equilibrated by 10 aspirations in wash solution, which contained 5% 
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(v/v) methanol in 0.1% (v/v) formic acid. The peptides were absorbed to the Zip tip matrix 
by aspirating 10 µl aliquots through the Zip tip and transferring to another eppendorf tube. 
The aspiration step was repeated so that each aliquot was aspirated through the Zip tip 
twice. The Zip tip was washed with two aliquots of wash solution to remove unbound 
peptides. The peptides were eluted by aspirating through the Zip tip 10 times with 10 µl of 
elution buffer (80% (v/v) methanol in 0.1% (v/v) formic acid). The eluted peptides were 
transferred to an Eppendorf tube.    
5.2.3.8 Mass Spectrometry 
An analysis of purified bacteriocins by matrix assisted laser desorption ionization-time-of-
flight mass spectrometry (MALDI-TOF-MS) was performed by Frank Antolasic at Applied 
Chemistry, RMIT university. The results were analyzed by Bruker Data Analysis Software 
for TOF 1.6 g. 
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5.3 Results 
5.3.1 Bacteriocin characterization 
5.3.1.1 Spectrum of inhibitory activity 
Both the producer culture (Macrococcus caseolyticus 2042-4) and the ammonium sulphate 
precipitate (80 AU/mL) showed the same inhibitory profiles (Appendix B, Table 4). An 
inhibitory effect was detected against all species of streptococci tested (n = 12) including all 
isolates of S. uberis, and there was partial inhibition against Enterococcus faecium. No 
inhibitory activity was detected against other gram-positive bacterial strains. None of the 
gram-negative and spiral bacteria examined were inhibited by producer cells or the 
ammonium sulphate precipitate. The producer strain was resistant to its own bacteriocin.    
5.3.1.2 Bacteriocin thermostability 
The ammonium sulphate precipitate (160 AU/mL) showed 100% residual activity after 
incubation for 60 min at 37°C and 60°C and 15 min at 80°C (Figure 5.3). The activity 
gradually decreased when longer incubation periods were used.  Some inhibitory activity 
still remained after one day of exposure at 37°C. The bacteriocin activity decreased by 50% 
when incubated at 100°C for 15 min.  The bacteriocin was inactive after autoclaving at 
120oC for 20 min. 
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Figure 5.3 Effect of temperatures on the bacteriocin activity (three repetitions)  
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5.3.1.3 Bacteriocin pH stability 
The ammonium sulphate precipitate (320 AU/mL) showed great stability over a wide pH 
range when incubated at 37°C for 1h (Figure 5.4). The bacteriocin had optimum activity at 
relatively acidic and neutral pH and the activity decreased after incubation with strong acid 
(pH 2) and in basic conditions (pH 8 and 9). No activity was detected at very strong basic 
pH values of 10, 11 and 12.  
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Figure 5.4 Effect of pH on the bacteriocin inhibitory activity (three repetitions) 
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5.3.1.4 Kill curves 
Addition of 80 AU/mL ammonium sulphate precipitate to S. uberis 796-2 resulted in a 
dramatic decrease in the number of viable cells (Figure 5.5). The viability was reduced 4 
log in 1 h and approximately 6 log when incubated further for 6 to 7 h. After 7 and 24 h of 
treatment, only 1,000 and 100 CFU/mL of cells survived. Prolonged incubation beyond 24 h 
did not result in any further killing (data not shown). S. uberis 796-2 without bacteriocin 
showed a normal growth pattern.  
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Figure 5.5 Effect of ammonium sulphate precipitate bacteriocin of Macrococcus caseolyticus 2042-4 on 
cells of Streptococcus uberis 796-2. ▲: no bacteriocins added, ■: 80 AU/mL ammonium sulphate 
precipitate added.  Means and standard errors of two replical assays are presented. 
 
 
 
 
 
 
 
 
 
5.3.2 Electron microscopy 
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Streptococcus uberis cells treated with ammonium sulphate precipitate (160 AU/mL) 
showed differences from control cells when examined by SEM (Figure 5.6a and b). Figure 
5.6c showed pore formation of Porphyromonas gingivalis treated with bacteriocin from 
Lactobacillus paracasei (Pangsomboon, et al., 2006). Cells treated with the ammonium 
sulphate precipitate bacteriocin of M. caseolyticus for a period of 6 h were collapsed into 
irregular shapes. On examination using TEM (Figure 5.7), untreated S. uberis showed 
coccal and coccobacilliary forms with a diameter of about 0.5 µm. Cells exposed to 
bacteriocin appeared to show a defect in cell division, rather than at the level of single cells 
with cell wall apparently tearing off and being destroyed at the division site.  
 
 
 
 
 
 
 
 
 
 a 
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Figure 5.6 Scanning electron microscopy of S. uberis in presence of bacteriocin. a: S. uberis control, b: S. 
uberis with bacteriocin, c: pore formation of Porphyromonas gingivalis (Pangsomboon, et al., 2006) 
presented for comparison.  
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Figure 5.7 Transmission electron microsopy of S. uberis treated with bacteriocin (8000X). a, b: 
untreated cell, c, d and e: bacteriocin treated cell. Arrows showed cells defect. 
 
 
 
 
 
 
 
 
 
 
 
5.3.3 Bacteriocin purification  
Some antibiotic activity was detected in BHI containing 0.5% of agar (Table 5.3). BHI 
containing 0.7% agar resulted in the maximum levels of bacteriocin production and the 
activity level remained stable with further increases in agar concentration. Increasing the 
incubation time from overnight to 24 or 48 h or increasing the number of thawing cycles up 
to 5 times did not increase or reduce bacteriocin recovery.  One liter of 0.7% agar in BHI 
provided 600 mL of extracted liquid containing bacteriocin (Table 5.5), which was 
designated as crude bacteriocin.  The activity of the crude bacteriocin was 10 AU/mL and 
yield was arbitrarily defined as 100%. 
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Table 5.3 Bacteriocin activity in semi-solid BHI agar 
Agar (%) in BHI Diameter of inhibition zone 
(mm) 
Bacteriocin activity (AU/mL) 
0 0 0 
0.1 0 0 
0.2 0 0 
0.3 0 0 
0.4 0 0 
0.5 7 (partial) 10 
0.6 8 10 
0.7 9.5 10 
0.8 9.5 10 
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0.9 9.5 10 
1.0 9.5 10 
partial: partial inhibition 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Proteins began to precipitate at 50% (w/v) ammonium sulphate saturation. The activity 
gradually increased when more ammonium sulphate was added and reached the maximum 
at 80% (w/v) saturation (Table 5.4). Table 5.5 shows that ammonium sulphate precipitation 
reduced the volume of the bacteriocin solution from 600 to 30 mL. The yield was 40% and 
approximately 10-fold concentration (80 AU/mL) was achieved. In all subsequent assays, 
the bacteriocin was precipitated at 80% saturation of ammonium sulphate.  
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Table 5.4 The bacteriocin activity of M. caseolyticus 2042-4 extract obtained by ammonium sulphate 
precipitation 
% Saturation of 
(NH4)2SO4 
Diameter of inhibition zone 
(mm) 
Bacteriocin activity 
(AU/mL) 
Crude bacteriocin 8 10 
40 0 0 
50 8 10 
60 8.8 10 
70 9.5 40 
80 10 80 
90 10 80 
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Following ammonium sulphate precipitation and gel filtration chromatography with 
Sephadex G100, the elution profile showed several fractions (Figure 5.8). Examination of 
each fraction for biological activity by the diffusion assay demonstrated three fractions with 
activity. Comparison of stained and unstained gels overlayed with S. uberis 796-2 showed 
that the molecular mass of the active fraction was less than 6,000 Da (Figure 5.9). Both 
denaturing and non-denaturing conditions of the PAGE gel demonstrated inhibition activity. 
Examination of PAGE gel prepared from samples at different stages of purification showed 
that significant amounts of contaminating proteins of similar molecular weight to the 
bacteriocin were removed by the gel filtration step (Figure 5.9). The yield of bacteriocin 
following gel filtration was 33% and there was a 38-fold increase in concentration of the 
bacteriocin (Table 5.5). 
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Figure 5.8 Elution profile of the bacteriocin activity on gel filtration. Arrow showed inhibitory activity. 
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Figure 5.9 Coomassie blue stained SDS-PAGE gel of bacteriocin purification. M: Unstained standard 
(Mark 12, Invitrogen), lane 1: bacteriocin from ammonium sulphate precipitation, lane 2: active 
fractions from gel filtration, lane 3: active fractions from cation exchange electrophoresis component I, 
lane 4 active fractions from cation exchange electrophoresis component II, lane 5: Bioassay of PAGE gel 
of ammonium sulphate precipitate with overlay of S. uberis 796-2 (arrow).  
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Passage of the active fractions obtained from the Sephadex G-100 gel filtration system 
through a column of SP-Sepharose Fast Flow resulted in separation of two components 
that eluted at pH 4 to 6.5 (Figure 5.10). The first component (Figure 5.10) did not bind to 
the cation exchange column. Attempts to retain this component in the cation media by 
decreasing the pH were not successful due to precipitation of proteins in the column at very 
low pH. The second component (Figure 5.10) was retained in the column and was eluted 
by increasing the ionic strength of the buffer with a continuous gradient of sodium chloride 
in 20 mM phosphate buffer at pH 5.5. The most active component was eluted in the range 
of 0.15 to 0.25 M sodium chloride. Those two components showed inhibitory activity 
independently. The specific activity of components I and II significantly increased to 153 
and 444 AU/mg, respectively (Table 5.5). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Absorbance at 214 nm NaCl (M)
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Figure 5.10 Elution profile of the active fractions from gel filtration to cation exchange chromatography 
at pH 5.5. Arrows showed inhibitory activity  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The RP-HPLC step of the purification procedure was unable to isolate the two active 
components from cation exchange chromatography (Figure 5.10) due to complex impurity 
in these two peaks. However, extraction of the active bands from the gel electrophoresis 
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prior to RP-HPLC provided the purest bacteriocin. Active component I was eluted by RP-
HPLC using the C4 column at fraction 19 (Figure 5.11) in 32% (v/v) acetronitrile. Active 
component II did not bind to the C4 column (Figure 5.12) since it was eluted in fraction 1 
before the acetronitrile gradient started. The concentration of the component I and II 
markedly increased to 370 and 741 fold respectively (Table 5.5) 
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    Retention time (min) 
 
Figure 5.11 PR-HPLC chromatogram of the bacteriocin component I from cation exchange 
chromatography, C4 column. Arrow: active fraction  
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Figure 5.12 PR-HPLC chromatogram of the bacteriocin component II from cation exchange 
chromatography, C4 column. Arrow: active fraction 
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Table 5.5 Purification  scheme of the bacteriocin 
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5.3.4 Mass spectrometry 
The purified bacteriocin component I was analyzed by MALDI-TOF-MS (Figure5.13). 
MALDI could not identify an individual peptide and there was no regular pattern of mass. 
The spectrum showed mixtures of molecules ranging between 1640 to 3169 m/z. Analysis 
of the purified bacteriocin component II showed three sets of peptide that had regular 
patterns (Figure 5.14). The first set consisted of three peaks (1852, 1875 and 1897). The 
second set consisted of four peaks (1940, 1962, 1983 and 2006). The third set consisted of 
four peaks (2039, 2060, 2082 and 2106). After desalting purified bacteriocin component II 
with the Zip tip (C18), no peptide peak was observed by MALDI-TOF-MS.  
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Figure 5.13 Mass spectrometric analysis of purified the bacteriocin component I.  
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Figure 5.14 Mass spectrometric analysis of purified the bacteriocin component II.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purification steps Results 
 147
Crude bacteriocin  
          ↓  
Ammonium sulphate precipitation  
          ↓  
Gel filtration 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33
Fractions
O
D
(A
21
4)
 
          ↓  
Cation exchange chromatography 
 
Component I   Component II  
0
0.5
1
1.5
2
2.5
3
3.5
1 6 11 16 21 26 31 36 41
Fractions
O
D
 (A
21
4)
0
0.2
0.4
0.6
0.8
1
1.2
Na
C
l (
M
)
OD214
NaCl gradient  
 
          ↓  
Extracted bacteriocin from SDS-PAGE  
          ↓  
RP-HPLC 
 
Component I              Component II 
-50
0
50
100
150
200
250
300
350
400
8 10 12 14 16 18 20 22 24 26 28 30 32 34 36
0
200
400
600
800
1000
1200
1400
1600
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36
 
Figure 5.15 Summary of purification of the bacteriocins from Macrococcus caseolyticus 2042-4 
 
5.4 Discussion   
In this study, a bacteriocin from Macrococcus caseolyticus 2042-4 that was characterized 
and purified, showed highly specific inhibition of strains of the genus Streptococcus 
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including all isolates of S. uberis that were examined. Generally, bacteriocins produced by 
Gram-positive bacteria have a relatively broad inhibitory spectrum (Jack, et al., 1995). By 
contrast a bacteriocin from Staphylococcus warneri showed activity only against members 
of the Legionella genus (Hechard, et al., 2005). Other bacteriocins of staphylococci have 
been reported to inhibit a broader range of Gram-positive species such as warnericin RB4 
from S. warneri RB4 (Minamikawa, et al., 2005), staphylococcin 1580 from S. epidermidis 
(Jetten & Vogels, 1972b) and various bacteriocins from S. aureus (Hale & Hinsdill, 1975, 
Nakamura, et al., 1983, Crupper & Iandolo, 1996, Crupper, et al., 1997). Although most 
bacteriocins are restricted in their action to other closely related strains, Bac201 from S. 
aureus AB201 was found to inhibit both Gram-positive and Gram-negative bacteria. The 
bacteriocin described in this chapter that was isolated from the non-mastitis pathogen, 
Macrococcus caseolyticus 2042-4 and showed specific activity against streptococci, could 
provide highly specific treatment of mastitis caused by streptococci including S. uberis. 
 
Consistent with other bacteriocins, which are generally heat stable and active in a wide 
range of pH values (Jack, et al., 1995), the bacteriocin described in this chapter was fully 
active over the range, pH 3 to 7 and resistant to heat up to 80°C. The degree of heat 
stability among bacteriocins from staphylococci may vary slightly. Most tolerate 
temperatures up to 90-100°C for 15 min without loss of activity but the activity decreases 
when the temperature reaches 121°C (Nakamura, et al., 1983, Crupper & Iandolo, 1996, 
Iqbal, et al., 1999, Hechard, et al., 2005, Minamikawa, et al., 2005). Similarly, bacteriocins 
from staphylococci, such as Bac 201 and warnericin RB4, have activity over a wide range 
of pH (Iqbal, et al., 1999, Minamikawa, et al., 2005). The bacteriocin of Macrococcus 
caseolyticus thus is highly stable, similar to staphylococcal bacteriocins and could therefore 
be advantageous for use in field conditions. 
 
Like staphylococcal bacteriocins (Nakamura, et al., 1983, Crupper & Iandolo, 1996, Iqbal, 
et al., 1999), the bacteriocin studied here showed bacteriocidal activity, killing target cells 
and causing rapid loss of viability of the indicator strain, S. uberis 796-2.  Damage inflicted 
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on the cell envelope showed tearing of the cell on examination by TEM. The observation of 
collapsed cells on examination by SEM was in agreement with other studies that showed 
similar morphological changes to the foodborne pathogens, Listeria monocytogenes, 
Salmonella typhimurium and Escherichai coli, exposed to nisin and pediocin 
(Kalchayanand, et al., 2004). The collapsed cells observed in this study were different in 
appearance from the pore formation observed when Porphyromonas gingivalis was 
exposed to a bacteriocin produced by Lactobacillus paracasei (Figure 5.6c). Examination of 
S. uberis following exposure to the bacteriocin suggested that the bacteriocin attacked cells 
during their division. These findings are supported by other studies that reported 
bacteriocins showed activity on log-phase cells (Nakamura, et al., 1983, Crupper & Iandolo, 
1996, Iqbal, et al., 1999).  
 
The laboratory purification protocols for bacteriocins tend to be cumbersome procedures, 
usually including precipitation followed by various combinations of chromatographic steps 
that normally vary from two to three stages (Nakamura, et al., 1983, Crupper & Iandolo, 
1996, Crupper, et al., 1997, Crupper & Iandolo, 1997, Minamikawa, et al., 2005). For each 
bacteriocin, an optimized purification scheme has to be developed. During purification of 
the bacteriocin described in this chapter, several different strategies were applied. Liquid 
containing bacteriocin was obtained by extraction from semi-solid agar. The purest active 
preparations were obtained by ammonium sulphate precipitation, gel filtration, cation 
exchange chromatography, extraction from SDS-PAGE and RP-HPLC. 
 
The prolonged stability of the bacteriocin in culture was similar to that of other bacteriocins 
(Nakamura, et al., 1983, Crupper & Iandolo, 1996, Crupper, et al., 1997). Stability of the 
bacteriocin during freezing and thawing extraction was beneficial and it allowed the culture 
to be harvested and stored for later use without loss of activity. The bacteriocin was 
precipitated from the culture supernate by adding solid ammonium sulphate to reach 80% 
(w/v) saturation. No increase in activity was observed at higher salt concentration and this 
precipitation provided a convenient way to concentrate large volumes of the sample.  
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Using the gel filtration chromatography performed on the Sephadex G100 column, almost 
all the activity was eluted early (fraction 4-6), indicating that the bacteriocin was possibly in 
the form of aggregates or was associated with higher molecular weight substances. The 
bacteriocin bands appeared with larger proteins but smaller proteins were eluted from the 
column in later fractions which showed no activity (data not shown). In ultrafiltration studies, 
all the activity was retained by membranes, with molecular mass exclusion sizes of 10 kDa 
and 30 kDa (data not shown). These findings support the hypothesis that the bacteriocins 
produced by M. caseolyticus are associated with higher molecular weight proteins. 
 
Two antibiotic peptides with similar molecular weight (less than 6.5 kDa) were observed 
after cation exchange chromatography. These two peptides showed different profiles on 
RP-HPLC. These findings suggested that these two bacteriocins had independent activity, 
different pI values and hydrophobicity by RP-HPLC retention.  
 
Attempts to separate and extract active bacteriocin fractions following ion exchange 
chromatography by SDS-PAGE, prior to applying to HPLC, resulted in low recovery of 
product, probably due to loss during extraction from SDS-PAGE. The extraction of target 
peptides from SDS-PAGE by electroelution may have improved the yield, but suitable 
equipment was not available.    
 
In contrast to the bacteriocins from Macrococcus caseolyticus 2042-4, many bacteriocins 
are very hydrophobic in nature (Jack, et al., 1995). The chromatogram obtained by RP-
HPLC (Figure 5.11), indicated that the bacteriocin component II was not retained in the C4 
column as it was detected in the first fraction.  Component I was purified by the same 
column and was eluted at 32% (v/v) acetronitrile. Both bacteriocins were therefore 
hydrophilic.    
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Mass spectrometry was used to determine the exact molecular mass of each peptide. 
Identification of the individual mass of component I was not feasible as no regular spectrual 
pattern could be obtained. This could be due to the molecule degrading during 
lyophilization or transportation. The three sets of peptides of the purified bacteriocin 
component II shared a common base mass. The difference in mass between the major 
peak of the first set (1875) and the second set (1962) was 87. The different of mass 
between the major peak of the second set (1962) and the third set 2060 was 98. These 
could imply that the second set and the third set of peptides consisted of extra serine 
(mass = 87) and valine (mass = 99) respectively. Each peak of the same set of peptides 
showed approximately a 23 mass interval. This could reveal that the purified bacteriocin 
component II was contaminated with sodium. No peptide was detected by MALDI-TOF-MS 
after attempts to remove salt contamination using the Zip tip (C18). This could be explained 
if the purified bacteriocin component II was not retained in the Zip Tip. This result is also 
supported by the observation that the peptide did not retain in the RP-HPLC column (C4 
column), which was thought to be because of the hydrophilic character of the peptide. The 
complete identification of the bacteriocin components (I and II) was beyond the scope of 
this study.  
 
Five steps as described above, were involved in the purification of the two bacteriocin 
compounds. Consequently, a massive reduction in yield was obtained. Media used for 
bacteriocin production may affect the purification procedures required due to the presence 
of contaminants arising from the media. Barefoot and Klaenhammer (1984) used a semi-
defined medium for bacteriocin production from Lactobacillus and suggested that this 
media eliminated excessive levels of medium contaminants compared with MRS. The 
authors suggested the evaluation of the most suitable media for bacteriocin production 
should include studies aimed to reduce contaminating proteins in order to reduce the steps 
required for purification. Further development of culture media formulations to optimise 
production of the bacteriocin described in this thesis may improve and assist the 
purification scheme.  
 152
 
The two bacteriocin components I and II that were identified in this study had independent 
inhibitory activity but inhibitory spectra was not preformed due to the limit of those 
components available. Taking these biochemical characteristics into consideration, the 
bacteriocin compounds from M. caseolyticus 2042-4 are likely to be monomers or multimer 
pairs or they could have been formed as a result of post-translational modification that has 
changed the charge and hydrophobicity of portion of the primary translation product.   
 
The use of bacteriocins as mastitis biological control agents is expected to increase in the 
future as a result of consumer awareness of the potential risks derived from pathogens as 
well as from the extensive use of antibiotics to control mastitis. Because bacteriocin 
treatment is effective and non-toxic to animals and humans, it has been already proposed 
as an alternative strategy for disease control (Sears, et al., 1992, Ryan, et al., 1998, Ryan, 
et al., 1999, Twomey, et al., 2000). The specific activity of the bacteriocins from 
Macrococcus caseolyticus 2042-4 against S. uberis could be very beneficial to the dairy 
industry if prepared as an antibiotic substance for the prevention and treatment of bovine 
mastitis. It is anticipated that bacteriocins will prove to be valuable alternative therapies 
against this emerging pathogen.  
 
In summary, Macrococcus caseolyticus is a normal inhabitant of the teat flora and milk of 
dairy cows. Strain 2042-4 produces antibacterial substances against an important bovine 
mastitis pathogen, S. uberis. No bacteriocin from Macrococcus has been described so far 
in the literature. Activity was restricted to the genus Streptococcus. The possibility of 
controlling S. uberis mastitis with these bacteriocins should be investigated. Studies should 
also be commenced to increase the yield of the bacteriocins, possibly by improving culture 
conditions and purification methods, in order to obtain sufficient quantities of the two 
components for pharmacology tests, toxicology tests, and to further evaluate their stability 
and efficacy. Studies are also required to determine the mechanisms of action and genetic 
determinants of the two bacteriocins produced by Macrococcus caseolyticus 2042-4. For 
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example, a gene of enterocin P from Enterococcus faecium P13 a was cloned into the 
yeast, Pichia pastoris, and it has proven valuable for protein production at high level 
(Gutierrez, et al., 2005). A construct of E. coli  produced recombinant dysgalacticin that 
provided a good yield of purified product after purification by affinity chromatography 
(Heng, et al., 2006). The gene coding for bacteriocin production by M. caseolyticus 2042-4 
could be identified and this information used to construct strains that express larger 
quantities of the peptides. 
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Final discussion 
In this study, identification, antibiotic susceptibility and biological control of bovine mastitis 
caused by S. uberis were studied. 
 
Infection with contagious mastitis pathogens has been markedly reduced over the past 
three decades due to the implementation of mastitis controls but this has had little effect on 
the incidence of environmental mastitis pathogens. As a result S. uberis has become a 
major streptococci mastitis problem worldwide. 
 
The inadequacy of the current identification methods of bovine mastitis caused by S. uberis 
in diagnostic veterinary laboratories has lead to the search for additional measures to 
better identify this organism. Four biochemical tests (hippurate hydrolysis, inulin and 
mannitol fermentation and growth tolerance in 6.5% NaCl) were established for esculin 
degrading streptococci. Accuracy in S. uberis identification was 91.4%.  The set of four 
tests provided a simple and cost effective method for use in veterinary diagnostic 
laboratories. The set of four tests could not distinguish S. uberis and S. parauberis which 
are similar in phenotype. These two species can only be distinguished by genotypic 
methods. Pulsed field gel electrophoresis analysis showed that S. parauberis is a diverse 
species that is most likely acquired from the environment, not by cow to cow transmission. 
Samples from a greater number and variety of sites (including farm environments) are 
required to confirm the mode of transmission for this bacterium. 
 
Antibiotic treatment of cows infected with S. uberis is unavoidable. To have prudent use of 
antibiotics, regular examination of antibiotic susceptibility patterns is required. A very low 
level of antibiotic resistance was found in this study compared with studies of S. uberis 
isolates from other countries. This is likely to be due to the strict regulations for antibiotic 
use in animals in Australia. Regulation monitoring of susceptibility patterns is 
recommended as S. uberis is a major problem in the Australian dairy industry. It is 
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important to report susceptibility patterns of individual streptococcal species rather than 
reporting all streptococci as a group. 
 
Biological control of bovine mastitis caused by S. uberis is an attractive possible addition to 
antibiotic treatment. Antibacterial protein (bacteriocin) from a strain of a non-pathogenic 
bacterium, M. caseolyticus, isolated from bovine milk produced active substances that were 
active against the genus Streptococcus including all S. uberis isolated in this study (n = 68). 
This species has not been previously reported to produce bacteriocins. Although, further 
work is required to improve the yield and purity to define the structure of the bacteriocins 
from Macrococcus, the exceptional characteristics of bacteriocins may make it possible to 
use the product for mastitis control. These bacteriocins appear highly specific to 
streptococci, and they have the potential to be used in field conditions because they are 
heat stable and active over a wide range of pH values. Moreover, bacteriocins are 
generally regarded as safe to use as a natural food preservative because of their low 
toxicity and because they are digested by many proteolytic enzymes. However, if used 
commercially, toxological investigations of any new product would need to be undertaken 
for regulatory approval.  To determine whether the bacteriocins described in this study, 
which inhibit mastitis pathogens in vitro, would also be inhibitory in vivo, it would be 
necessary to undertake a clinical trial of the bacteriocins as a teat dip. If in vivo inhibition 
occurs, they may be a useful addition for mastitis control. 
 
The yield of purified bacteriocins was low (component I 0.03% and component II 0.06%) 
and improved production and purification methods will be necessary to facilitate further 
characterization. Optimization of the broth media formulations may result in improved 
bacteriocin production and would be more efficient than extraction of the bacteriocins from 
semi-solid media. To improve purity, suitable equipment (HPLC columns for hydrophilic 
proteins) for purification is necessary for the hydrophilic bacteriocins decribed in this study. 
Also, reduction in the number of the purification steps could be examined in order to 
improve the yield. Determination of the structure would lead to a better understanding of 
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the bacteriocins. Furthermore, improvement of production and purification methods of the 
bacteriocin based on genetic engineering could lead to improved yields of more pure 
product. 
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Appendix A List of equipment, reagents and their 
manufacturers   
       
 Equipment Manufacturers 
96-well microtiter plate, round bottom Techno-Plas, St. Mary, South Australia, 
Australia 
Butyl C4 300 Brownlee, USA 
Copper grid ProScitech, Queensland, Australia 
Dialysis tube, molecular weight cut off 3,500 
dalton 
Cellu-Sep, Membrane Filtration Products, 
Inc., USA 
Disposable syringe filter unit, pore size 0.45 
µm 
Advantec MFS, Inc., USA 
Embedding capsule ProScitech, Queensland, Australia 
Freeze-drier Dynavac FD12, Australia 
Gel Documentation  Imaging system BioRad, CA, USA 
High Performance Liquid Chromatography 
(HPLC), series 200 LC pump 
Perkin Elmer, USA 
Knifemaker LKB 7800 B, Sweden 
Magnetron sputter coater, Dynavac SC 100, Australia 
Microplate reader  Dynatech MR7000, Germany 
Mini-PROTEAN® II System Bio-Rad, CA, USA 
PCR Thermal cycler Corbett Research GP001, Sydney, Australia 
Protect bacterial preservers Technical service consultants Ltd., 
Lancashire, UK 
Rotary evaporator Rotavapor-R Büchi, Switzerland 
Rotary mixer, R2 Pelco Ted Pella Inc, CA, USA 
Scanning electron microscope  XL30, Philips 
Sephadex G-100 GE-Healthcare Bio-Sciences AB, Sweden 
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Sonicator Branson, USA 
SP Sepharose Fast Flow GE-Healthcare Bio-Sciences AB, Sweden 
Spectrophotometer Varian, Cary 50 Bio, Australia 
Transmission electron microscope  JEM-1010, JEOL 
Ultratome Reichert-Jung, Austria 
Vortex mixer Vortex Genie-2, Scientific Industries, USA  
Zip tip  Millipore, USA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   Reagents  Manufacturer 
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2-mercaptoethanol Bio-Rad, USA 
40% Acrylamide/Bis solution Bio-Rad, CA, USA 
Acetronitrile Mallinckrodt, USA 
Aesculin hydrate  Sigma, UK 
Agar bacteriological (Agar No. 1) Oxoid, Hampshire, England 
Ampicillin Sigma, UK 
API 20 Strep  Bio Merieux, France 
BCA Protein Assay Kit Pierce, Illinois, USA  
Benzyldimethylamine (BDMA) ProSciTech, Queensland, Australia 
Brain heart infusion Oxoid, Hampshire, UK 
Catalase    Sigma, St. Louise MO, USA 
Cationized ferritin (11mg/mL) Sigma, Steinheim, Germany 
Cephalothin Sigma, USA 
CHEF DNA size standards lambda ladder Bio-Rad, CA, USA 
Chymotrypsin  SIGMA, St. Louise MO, USA 
Columbia agar base Oxoid, Hampshire, UK 
Defibrinated horse blood Oxoid, Australia 
Deoxyribonuclease (DNase) test agar Oxoid, Hampshire, UK 
DNA grade agarose Progen Industries Limited, Australia 
Dodecenyl succinic anhydride (DDSA) ProSciTech, Queensland, Australia 
Edwards medium (modified) Oxoid, Hampshire, UK 
Erythromycin   Sigma, USA 
erythromycin disc15 µg Becton Dickinson, MD, USA 
Gentamicin Sigma, USA 
Glutaraldehyde 25% solution Electronmicroscopy Science, PA, USA 
Lipase   SIGMA, St. Louise MO, USA 
Broad range resolution 
of fragments from 1-20 kb 
Progen industries limited, Australia 
Low-melting temperature agarose Progen industries limited, Australia 
Lyophilized rabbit plasma bioMérieux®, Marcy-I’Etoile, France 
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Mark 12 TM Unstained standard Invitrogen, CA, USA 
MassRulerTM DNA ladder, Low range Fermentas, USA 
Milk agar Oxoid, Hampshire, England 
MRS Oxoid, Hampshire, England 
Mueller-Hinton broth Oxoid, Hampshire, England 
N,N,N′N′-Tetra-methylethylenediamine Bio-Rad, CA, USA 
Nadic methyl anhydride (NMA) ProSciTech, Queensland, Australia 
Ninhydrin  Sigma, USA 
Novobiocin   Sigma, USA 
Nutrient agar broth No.2 Oxoid, Hampshire, UK 
Oxacillin     Sigma, USA 
Penicillin       Sigma, USA 
Phosphate buffer saline (PBS) Oxoid, Hampshire, UK 
Procure 812 ProSciTech, Queensland, Australia 
Propylene oxide ProScitTech, Queensland, Australia 
Protease inhibitor cocktail tablets RocheDiagnostics GmbH, Mannheim, 
Germany 
Protect Bacterial Preservers Technical Service Consultants Ltd, UK 
Proteinase K     SIGMA, St. Louise MO, USA 
Rabbit plasma Bio Merieux, France 
SmaI Fermentas, USA 
Sodium cacodylate trihydrate ProSciTech, Queensland, Australia 
Sodium hippurate hydrate Sigma, USA 
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Sodium phosphate dibasic, anhydrous 
(Na2HPO4) 
AnalaR® , BDH, Victoria, Australia 
Sodium phosphate monobasic, monohydrate 
(NaH2PO4.H2O) 
AnalaR® , BDH, Victoria, Australia 
SP Sepharose TM Fast Flow GE Healthcare, Uppsala, Sweden 
Tango buffer Fermentas, USA 
Taq polymerase Roche, USA 
Tetracycline Sigma, USA 
Todd Hewitt broth Oxoid, Hampshire, UK 
Trifluoroacetic acid (TFA) Auspep, Australia 
Trypsin  Sigma, St. Louise MO, USA 
Trypticase soy agar Oxoid, Hampshire, UK 
Vancomycin    Sigma, USA 
 
 167
Appendix B Strains data 
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Table 2 Biochemical test patterns obtained with esculin-degrading streptococci isolated from bovine milk  
Pattern
Isolate 
number esculin hippurate inulin mannitol 
6.5% 
NaCl API 
16S rRNA 
sequencinga
Disease 
statusb 
Qualitative 
levelc 
Other 
pathogens 
1 2042-5 + + + + - ND  S. uberis SC +++ - 
1 2042-8 + + + + - ND S. uberis SC +++ - 
1 2169-2 + + + + - ND S. uberis C ++ - 
1 2285-1 + + + + - ND S. uberis C + - 
1 
2407-5 + + + + - S. uberis 
S. 
parauberis 
SC + S. uberis 
1 2407-7 + + + + - ND S. uberis SC + - 
1 2407-8 + + + + - ND S. uberis SC + - 
1 2481-1 + + + + - ND S. uberis C +++ - 
1 2520-1 + + + + - ND S. uberis C + - 
1 2530-2 + + + + - ND S. uberis C ++ - 
1 2530-4 + + + + - ND S. uberis C ++ - 
1 2530-5 + + + + - ND S. uberis C ++ - 
1 2565-2 + + + + - ND S. uberis C + - 
1 2575-3 + + + + - S. uberis S. uberis L ++ - 
1 2655-5 + + + + - S. uberis S. uberis SC +++ - 
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1 2655-6 + + + + - ND S. uberis SC +++ - 
1 2655-8 + + + + - ND S. uberis SC +++ - 
1 2690-3 + + + + - S. uberis S. uberis SC ++ - 
1 2730-1 + + + + - S. uberis S. uberis C + - 
1 2730-5 + + + + - ND S. uberis C + - 
1 2874-4 + + + + - ND S. uberis C + - 
1 2893-1 + + + + - S. uberis S. uberis C ++ - 
1 2893-2 + + + + - ND S. uberis C ++ - 
1 2893-3 + + + + - ND S. uberis C ++ - 
1 
2893-7 + + + + - S. uberis 
S. 
parauberis 
C ++ S. uberis 
1 2907-1 + + + + - S. uberis S. uberis C ++ - 
1 2956-4 + + + + - ND S. uberis C ++ - 
1 2988-1 + + + + - ND S. uberis C +++ - 
1 3064-1 + + + + - S. uberis S. uberis C + - 
1 
3147-1 + + + + - 
ND S. uberis L + Corynebacterium 
spp. 
1 
3147-4 + + + + - 
ND S. uberis L + Corynebacterium 
spp. 
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1 3147-5 + + + + - S. uberis S. uberis L +++ - 
1 3209-4 + + + + - ND S. uberis C + - 
1 3209-5 + + + + - ND S. uberis C + - 
1 684-1* + + + + - ND S. uberis SC +++ - 
1 684-10* + + + + - ND S. uberis SC +++ - 
1 
684-2* + + + + - 
ND S. uberis SC +++ Corynebacterium 
spp. 
1 
684-3* + + + + - 
ND S. uberis SC +++ Corynebacterium 
spp. 
1 
684-6* + + + + - 
ND S. uberis SC +++ Corynebacterium 
spp. 
1 
684-7* + + + + - 
ND S. uberis SC +++ Corynebacterium 
spp. 
1 684-8* + + + + - ND S. uberis SC +++ - 
1 684-9* + + + + - ND S. uberis SC +++ - 
1 686-2* + + + + - ND S. uberis SC ++ - 
1 686-4* + + + + - S. uberis S. uberis SC ++ - 
1 686-5* + + + + - S. uberis S. uberis SC ++ - 
1 698-4* + + + + - S. uberis S. SC + - 
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parauberis 
1 796-1* + + + + - ND S. uberis SC +++ - 
1 796-2* + + + + - S. uberis S. uberis SC +++ - 
1 816-2* 
+ + + + - 
ND  S. uberis SC +++ Corynebacterium 
spp. 
1 816-3* + + + + - S. uberis S. uberis SC +++ - 
1 816-5* + + + + - ND S. uberis SC +++ CoNS 
1 
819-2* + + + + - S. uberis 
S. 
parauberis 
SC + - 
1 883-4* + + + + - ND S. uberis C + S. aureus 
1 893-6* + + + + - S. uberis S. uberis SC ++ CoNS 
1 
923-4* + + + + - S. uberis 
S. 
parauberis 
SC +++ S. aureus 
1 Clinical853-3* + + + + - ND S. uberis C +++ - 
1 Clinical853-4* + + + + - S. uberis S. uberis C +++ - 
1 Clinical853-9* + + + + - S. uberis S. uberis C +++ - 
1 clinical883-6* + + + + - ND S. uberis C + - 
1 Clinical883-7* + + + + - ND S. uberis C + - 
1 H2581-2 + + + + - ND S. uberis SC +++ - 
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1 H2581-3 + + + + - ND S. uberis SC +++ - 
1 
H3133-1 + + + + - 
ND S. uberis L ++ Corynebacterium 
spp. 
1 H3133-3 + + + + - ND S. uberis L ++ - 
1 
H3133-5 + + + + - S. uberis 
S. 
parauberis 
L ++ S. uberis 
1 H3217-1 + + + + - ND S. uberis L + - 
1 H3217-2 + + + + - S. uberis S. uberis L + - 
1 
H3217-5 + + + + - S. uberis S. uberis 
L + Corynebacterium 
spp. 
1 H3327-3 + + + + - ND S. uberis L + CoNS 
1 H3333 a + + + + - S. uberis S. uberis L +  - 
                    
2 H3217-3 + + - + - S. uberis S. uberis L + - 
2 
868-3* + + - + - S. uberis 
S. uberis SC + Corynebacterium 
spp. 
2 
868-4* + + - + - S. uberis S. uberis 
SC + Corynebacterium 
spp. 
2 2690-2 + + - + - S. uberis S. uberis SC ++ - 
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2 
2655-10 + + - + - A. viridans 
S. 
parauberis 
SC + S. uberis 
2 2655-2 + + - + - A. viridans A. viridans SC + CoNS 
2 3162-2 + + - + - A. viridans A. viridans L +++ CoNS 
2 3162-4 + + - + - A. viridans A. viridans L +++ CoNS 
2 
3218-1 + + - + - A. viridans 
S. 
parauberis 
L + CoNS 
2 H2601-1 + + - + - A. viridans A. viridans L ++ - 
2 H3175-1 + + - + - A. viridans A. viridans L + - 
2 116-3 + + - + - A. viridans A. viridans L + - 
                    
3 780-4* + + - - - A. viridans S. iniae SC ++ - 
3 2042-9 + + - - - A. viridans A. viridans SC ++ - 
3 2893-4 + + - - - S. bovis S. iniae SC + - 
3 3162-1 + + - - - A. viridans A. viridans L +++ CoNS 
3 H3133-8 + + - - - A. viridans A. viridans L ++ - 
3 2407 + + - - - A. viridans A. viridans SC + - 
3 2655-1 + + - - - A. viridans A. viridans SC + CoNS 
3 3147-2 + + - - - S. bovis S. bovis L + Corynebacterium 
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spp. 
3 
3218-9 + + - - - A. viridans 
S. 
parauberis 
L + Corynebacterium 
spp. 
3 
3218-10 + + - - - A. viridans 
S. 
parauberis 
L + Corynebacterium 
spp. 
3 
H2490-1 + + - - - A. viridans A. viridans 
L + Corynebacterium 
spp. 
3 H2601-2 + + - - - A. viridans A. viridans L ++ - 
3 3209-3 + + - - - A. viridans A. viridans C + CoNS 
                    
4 H3333-1 + + - - + E. faecium E. faecium L + - 
                    
5 684-5* + - + - - ND S. bovis SC +++ - 
5 780-8* + - + - - S. bovis  ND SC ++ - 
5 893-4* + - + - - ND S. bovis SC ++ CoNS 
5 H3333-3 + - + - -  S. bovis ND L ++ - 
5 2042-2 + - + - - S. bovis ND SC ++ - 
5 2042-10 + - + - - ND ND SC ++ - 
5 3084-4 + - + - - S. bovis  ND L + CoNS 
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5 H2329-1 + - + - - S. bovis  ND L + - 
5 H3133-6 + - + - - ND ND L ++ - 
5 H3133-4 + - + - - S. bovis  ND L ++ - 
5 
H3133-2 + - + - - 
ND ND L ++ Corynebacterium 
spp. 
5 H3175-2 + - + - - ND ND L + - 
5 H3217-4 + - + - - ND ND L + - 
5 H3333-2 + - + - - ND ND L + - 
                   
6 2534-3 + - - + - ND ND L + - 
                    
7 864-15* + - - - - S. bovis  S. bovis SC + - 
7 684-3* + - - - - ND ND SC +++ - 
7 2693-2 + - - - - S. bovis  ND L + - 
7 
H3133-1 + - - - - ND 
ND L ++ Corynebacterium 
spp. 
 S. uberis  
700407 + + + + -  S. uberis 
 
S. uberis 
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-: negative 
+: positive 
ND: not determined 
*: isolates were from Timboon farm and the others from Newry farm 
CoNS: Coagulase negative staphylococci 
a Results of S. uberis sequencing were from Takehiro Tomita (PhD. Student). Isolates that were not S. uberis were characterized in this study.   
b Disease status is indicated as follow: C, clinical mastitis; SC, subclinical mastitis; L, low somatic cell count 
c Quantitative growth of S. uberis is defined as follow: +, 1-10 colonies; ++, 11-50 colonies; +++, more than 50 colonies 
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Table 3 Streptococcus uberis susceptibility 
 
Antibiotics (µg/mL)  Source 
  
Isolate number
  Amphicillin Penicillin Oxacillin Erythromycin Tetracycline Novobiocin Cephalothin Vancomycin Gentamicin 
Newry H3333 a 0.5 <0.03 0.25 0.5 0.12 1 0.12 0.5 2 
Newry H3327-3 0.5 <0.03 0.25 0.5 0.12 1 0.12 0.5 2 
Newry H3217-5 2 <0.03 0.25 0.12 0.25 1 0.5 0.5 8 
Newry H3217-3 0.5 0.06 0.25 0.12 0.12 1 0.25 0.5 8 
Newry H3217-2 0.25 <0.03 0.12 0.25 0.25 1 0.12 0.25 4 
Newry H3217-1 0.25 <0.03 0.12 0.25 0.25 4 0.12 0.5 8 
Newry H3133-3 1 0.06 0.25 0.25 0.25 1 0.25 0.5 8 
Newry H3133-1 1 0.06 0.25 0.25 0.25 1 0.25 0.5 4 
Newry H2581-3 1 <0.03 0.06 0.25 1 2 0.12 0.5 8 
Newry H2581-2 0.25 <0.03 0.06 0.25 1 2 0.12 0.5 8 
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Timboon   Clinical883-7 0.25 <0.03 0.12 0.12 0.25 2 0.12 1 4 
Timboon clinical883-6 0.25 <0.03 0.25 0.5 0.25 4 0.12 0.5 8 
Timboon Clinical853-9 0.25 0 0.12 0.25 0.5 4 0.12 0.5 8 
Timboon Clinical853-4 0.25 0.06 0.12 0.25 0.5 4 0.25 0.5 8 
Timboon Clinical853-3 0.25 0.06 0.12 0.25 0.5 4 0.12 0.25 4 
Timboon 893-6 0.12 <0.03 0.12 0.25 1 4 0.25 0.5 4 
Timboon 883-4 0.25 <0.03 0.25 0.12 0.25 4 0.12 0.5 4 
Timboon 868-4 0.25 <0.03 0.25 0.25 0.5 2 0.12 0.5 4 
Timboon 868-3 0.06 <0.03 0.06 0.25 0.25 4 0.12 0.5 8 
Timboon 816-5 0.12 <0.03 0.06 0.12 0.25 2 0.06 0.5 8 
Timboon 816-3 0.05 <0.03 0.12 0.12 0.5 2 0.06 0.5 4 
Timboon 816-2 0.25 <0.03 0.12 0.12 0.5 4 0.12 0.5 8 
Timboon 796-2 0.12 <0.03 0.12 0.5 0.25 2 0.06 0.5 2 
Timboon 796-1 0.25 <0.03 0.12 0.5 0.5 2 0.06 0.25 2 
Timboon 686-5 0.25 <0.03 0.12 0.12 0.5 2 0.12 0.5 4 
Timboon 686-4 0.12 <0.03 0.12 0.12 0.25 1 0.12 0.5 4 
Timboon 686-2 0.12 <0.03 0.12 0.12 0.25 2 0.12 0.5 4 
Timboon 684-9 0.25 <0.03 0.06 0.25 0.25 4 0.12 0.5 8 
Timboon 684-8 0.06 <0.03 0.06 0.5 0.12 1 0.06 0.5 8 
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Timboon 684-7 0.12 <0.03 0.06 0.5 0.12 1 0.12 0.5 8 
Timboon 684-6 0.12 <0.03 0.06 0.25 0.25 1 0.06 0.5 4 
Timboon 684-3 0.12 <0.03 0.12 0.12 0.25 2 0.12 0.5 4 
Timboon 684-2 0.12 <0.03 0.06 0.25 0.25 2 0.12 0.5 8 
Timboon 684-10 0.25 <0.03 0.06 0.25 0.25 4 0.12 0.5 8 
Timboon 684-1 0.12 <0.03 0.06 0.25 0.25 4 0.12 0.5 8 
Newry 3209-5 0.25 <0.03 0.12 0.12 0.5 2 0.12 0.5 8 
Newry 3209-4 0.25 <0.03 0.12 0.12 0.5 2 0.12 0.5 8 
Newry 3147-5 0.25 0.06 0.25 0.12 0.5 2 0.25 0.5 4 
Newry 3147-4 0.25 <0.03 0.12 0.12 0.5 2 0.12 0.5 8 
Newry 3147-1 2 0.12 0.25 0.25 1 4 0.5 0.5 8 
Newry 3064-1 0.12 <0.03 0.06 0.25 0.25 2 0.12 0.5 2 
Newry 2988-1 0.12 <0.03 0.06 0.25 0.25 2 0.12 0.5 2 
Newry 2956-4 0.12 <0.03 <0.03 0.25 0.25 2 0.12 0.5 4 
Newry 2907-1 0.5 <0.03 0.25 0.25 0.12 2 0.12 0.5 4 
Newry 2893-3 0.12 <0.03 0.06 0.25 0.25 2 0.12 0.5 2 
Newry 2893-2 0.12 <0.03 0.06 0.25 0.25 2 0.12 0.5 2 
Newry 2893-1 0.12 <0.03 <0.03 0.25 0.25 2 0.12 0.5 4 
Newry 2874-4 0.25 <0.03 0.12 0.25 0.5 4 0.12 0.5 8 
 180
Newry 2730-5 0.12 <0.03 0.06 0.12 0.5 1 0.12 0.5 8 
Newry 2730-1 0.12 <0.03 0.06 0.12 0.5 1 0.12 0.5 8 
Newry 2690-3 0.5 <0.03 0.25 0.25 0.12 2 0.12 0.5 4 
Newry 2690-2 0.5 <0.03 0.25 0.25 0.12 2 0.12 0.5 4 
Newry 2655-8 0.5 0.12 0.25 0.5 0.12 1 0.25 0.25 2 
Newry 2655-6 0.5 0.06 0.25 0.12 0.25 1 0.25 0.25 2 
Newry 2655-5 0.5 <0.03 0.25 0.06 0.25 1 0.25 0.25 4 
Timboon   2575-3 0.06 <0.03 0.06 0.5 0.12 1 0.06 0.5 8 
Newry 2565-2 0.12 <0.03 0.06 0.25 0.25 2 0.12 0.5 2 
Newry 2530-5 0.5 <0.03 0.25 0.25 0.12 2 0.12 0.5 4 
Newry 2530-4 0.5 0.12 0.25 0.5 0.12 1 0.25 0.25 2 
Newry 2530-2 0.5 0.06 0.25 0.12 0.25 1 0.25 0.25 2 
Newry 2520-1 2 0.12 0.25 0.25 1 4 0.5 0.5 8 
Newry 2481-1 0.12 <0.03 0.06 0.25 0.25 2 0.12 0.5 2 
Newry 2407-8 0.25 <0.03 0.12 0.25 0.5 4 0.12 0.5 8 
Newry 2407-7 0.12 <0.03 0.06 0.12 0.5 1 0.12 0.5 8 
Newry 2285-1 2 0.12 0.25 0.25 1 4 0.5 0.5 8 
Newry 2169-2 0.12 <0.03 0.06 0.25 0.25 2 0.12 0.5 2 
Newry 2042-8 1 0.06 0.25 0.25 0.5 4 0.25 0.5 8 
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Newry 2042-5 0.5 0.06 0.25 0.12 0.5 4 0.5 0.5 8 
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Table 4 Coagulase negative staphylococci isolates with inhibitory spectra against Streptococcus 
uberis strains by spot on lawn method 
Number of indicator strains of S. uberis with 
active spectra against CoNS  (annular radius 
of inhibition) 
No. Source Isolate 
number of 
CoNS 
1-2 (mm) 3-4 (mm) 5-6 (mm) 
1 Newry 2042-3 0 0 0 
2 Newry 2042-4 58 9 1 
3 Newry 2042-6 0 0 0 
4 Newry 2042-7 0 0 0 
5 Newry 2407-3 0 0 0 
6 Newry 2407-4 0 0 0 
7 Newry 2534-1 0 0 0 
8 Newry 2534-2 0 0 0 
9 Newry 2534-4 0 0 0 
10 Newry 2648-1 0 0 0 
11 Newry 2648-2 0 0 0 
12 Newry 2655-11 0 0 0 
13 Newry 2655-12 0 0 0 
14 Newry 2655-4 0 0 0 
15 Newry 2655-7 0 0 0 
16 Newry 2669-2 0 0 0 
17 Newry 2690-1 0 0 0 
18 Newry 2702-1 0 0 0 
19 Newry 2702-2 0 0 0 
20 Newry 2755-1 0 0 0 
21 Newry 2755-2 0 0 0 
22 Newry 2825-1 0 0 0 
23 Newry 2825-2 0 0 0 
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24 Newry 2832-2 0 0 0 
25 Newry 2832-3 0 0 0 
26 Newry 2832-4 0 0 0 
27 Newry 2839-6 0 0 0 
28 Newry 3009-1 0 0 0 
29 Newry 3010-1 0 0 0 
30 Newry 3084-1 0 0 0 
31 Newry 3084-2 0 0 0 
32 Newry 3084-3 0 0 0 
33 Newry 3084-5 0 0 0 
34 Newry 3084-6 0 0 0 
35 Newry 3136-1 0 0 0 
36 Newry 3136-2 0 0 0 
37 Newry 3147-3 0 0 0 
38 Newry 3162-3 0 0 0 
39 Newry 3218-2 0 0 0 
40 Newry 3218-3 0 0 0 
41 Newry 3218-5 0 0 0 
42 Newry 3218-6 0 0 0 
43 Newry 3218-7 0 0 0 
44 Newry 3218-8 0 0 0 
45 Newry H2936-1 0 0 0 
46 Newry H3290-1 0 0 0 
47 Newry H3290-2 0 0 0 
48 Newry H3290-3 0 0 0 
49 Newry H3290-4 0 0 0 
50 Newry H3327-1 0 0 0 
51 Timboon 2574-1 0 0 0 
52 Timboon 2575-1 0 0 0 
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53 Timboon 2575-2 0 0 0 
54 Timboon 2618-1 0 0 0 
55 Timboon 2627-1 0 0 0 
56 Timboon 2627-2 0 0 0 
57 Timboon 2659-1 0 0 0 
58 Timboon 2659-2 0 0 0 
59 Timboon 2725-1 0 0 0 
60 Timboon 2741-1 0 0 0 
61 Timboon 2741-2 0 0 0 
62 Newry 2169-1 0 0 0 
63 Newry 2530-1 0 0 0 
64 Newry 2565-1 0 0 0 
65 Newry 2730-1 0 0 0 
66 Newry 2730-2 0 0 0 
67 Newry 2730-3 0 0 0 
68 Newry 2730-4 0 0 0 
69 Newry 2874-1 0 0 0 
70 Newry 2874-2 0 0 0 
71 Newry 2874-3 0 0 0 
72 Newry 2956-1 0 0 0 
73 Newry 2956-2 0 0 0 
74 Newry 2956-3 0 0 0 
75 Newry 3209-1 0 0 0 
76 Newry 3209-2 0 0 0 
77 Newry 2907-2 0 0 0 
78 RMIT 10 0 0 0 
79 RMIT 18 0 0 0 
80 RMIT 19 0 0 0 
81 RMIT 31W 0 0 0 
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82 RMIT 31Y 0 0 0 
83 RMIT 33W 0 0 0 
84 RMIT 33Y 0 0 0 
85 RMIT 35 0 0 0 
86 RMIT 37 0 0 0 
87 RMIT 30W 0 0 0 
88 RMIT 30Y 0 0 0 
89 RMIT 41 0 0 0 
90 RMIT 42W 0 0 0 
91 RMIT 42Y 0 0 0 
92 RMIT 43 0 0 0 
93 RMIT 45W 0 0 0 
94 RMIT 45Y 0 0 0 
95 RMIT 46DY 0 0 0 
96 RMIT 50LW 0 0 0 
97 RMIT 50SW 0 0 0 
98 RMIT 51 0 0 0 
99 RMIT 68 0 0 0 
100 RMIT 70 0 0 0 
101 RMIT 75 0 0 0 
102 RMIT 76 0 0 0 
103 RMIT 77 0 0 0 
104 RMIT 83 0 0 0 
105 RMIT 84W 0 0 0 
106 RMIT 84Y 0 0 0 
107 RMIT 86 0 0 0 
108 RMIT 82 0 0 0 
109 RMIT 95 0 0 0 
110 RMIT 103 0 0 0 
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111 RMIT 104 0 0 0 
112 RMIT 106 0 0 0 
113 RMIT 108W 0 0 0 
114 RMIT 108Y 0 0 0 
115 RMIT 109W 0 0 0 
116 RMIT 109Y 0 0 0 
117 RMIT 110W 0 0 0 
118 RMIT 110Y 0 0 0 
119 RMIT 111 0 0 0 
120 RMIT 112 0 0 0 
121 RMIT 114 0 0 0 
122 RMIT 115 0 0 0 
123 RMIT 1 0 0 0 
124 RMIT 3 0 0 0 
125 RMIT 4 0 0 0 
126 RMIT 5 0 0 0 
127 RMIT 6 0 0 0 
128 RMIT 7 0 0 0 
129 RMIT 9 0 0 0 
130 RMIT 11 0 0 0 
131 RMIT 12 0 0 0 
132 RMIT 13 0 0 0 
133 RMIT 14W 0 0 0 
134 RMIT 15 0 0 0 
135 RMIT 16W 0 0 0 
136 RMIT 16Y 0 0 0 
137 RMIT 17 0 0 0 
138 RMIT 21 0 0 0 
139 RMIT 22 0 0 0 
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140 RMIT 23 0 0 0 
141 RMIT 24W 0 0 0 
142 RMIT 24Y 0 0 0 
143 RMIT 25 0 0 0 
144 RMIT 27 0 0 0 
145 RMIT 28W 0 0 0 
146 RMIT 36 0 0 0 
147 RMIT 37Y 0 0 0 
148 RMIT 39 0 0 0 
149 RMIT 40 0 0 0 
150 RMIT 46LY 0 0 0 
151 RMIT 47Y 0 0 0 
152 RMIT 48G 0 0 0 
153 RMIT 48 0 0 0 
154 RMIT 49 0 0 0 
155 RMIT 50Y 0 0 0 
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Table 5 Spectrum of inhibitory activity by Macrococcus caseolyticus 2042-4   
Indicator strains Inhibitory activity in 
deferred antagonism 
of M. caseolyticus 
2042-4 
Inhibitory activity of 
ammonium sulfate 
precipitate from M. 
caseolyticus 2042-4 
Gram positive bacteria 
Micrococcus caseolyticus 2042-4   - - 
Streptococcus uberis ATCC 
700407 
+ + 
S. salivarius 345/11 + + 
S. bovis 345/5 + + 
S. cremoris 345/6 + + 
S. agalactiae 345/2 + + 
S. agalactiae ATCC 13813 + + 
S. agalactiae NSB 40 + + 
S. dysgalactiae NSB 41 + + 
S. mitis 345/9 + + 
S. group G 345/4 + + 
S. pyogenes 345/1-2 + + 
S. group C 345/3 + + 
Enterococcus faecium ATCC 
35667 
+ partial + partial 
E. faecium 345/19 + partial + partial 
E. faecalis ATCC 27959 - - 
Listeria monocytogenes 192/1 - - 
L. innocua - - 
Staphylococcus aureus ATCC 
29213 
- - 
S. aureus NCTC 6571 - - 
 189
S. aureus 344/2-4 - - 
S. aureus 344/2-22 - - 
S. epidermidis 344/1-4 - - 
Bacillus cereus 30/2-2 - - 
B. cereus 30/2 - - 
B. subtilis 30/7 - - 
Clostridium sporogenes S2/4 - - 
C. perfringens S2/6-1 - - 
C. perfringens S2/6-4 NCTC 8237 - - 
Gram negative bacteria 
Escherichia coli 103/1-1 - - 
E. coli 103/1-41 - - 
E. coli 103/1-22 - - 
Proteus mirabilis 281/1-4 - - 
P. vulgaris 281/3 - - 
Salmonella typhimurium 340/4-3 - - 
S. typhimurium 340/4 - - 
Klebsiella oxytoca 180/4 - - 
K. pneumoniae 180/2-6 - - 
Pseudomonas aeruginosa 283/1-
19 
- - 
P. aeruginosa 281/1 - - 
Shigella flexneri 343/1 - - 
Enterobacter aerogenes 100/1-6 - - 
Spiral bacteria 
Brachyspira hyodysentriae 2897 ND - 
B. hyodysentriae 2515 ND - 
 
+: clear inhibition zone between 7 and 10 mm in diameter, + partial: small colonies of 
test organisms, -: no inhibition 
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Appendix C Bacteriological media 
Brain heart infusion broth/agar/soft agar (BHB/BHA/BHI soft 
agar) 
This medium was prepared according to the manufacturer’s instructions, and 
sterilized by autoclaving at 121°C for 15 min. Bacteriological agar was added 1.5% 
(w/v) for BHA and 0.7% (w/v) for BHI soft agar prior to autoclaving and poured in 
Petri dishes.    
De Man Rogosa Sharpe agar medium (MRS), DNase agar, 
Edwards Milk agar (MA), Muller Hintion (MH), Nutrient agar 
(NA) and Trypticase soy agar (TSA)  
This medium was prepared according to the manufacturer’s instructions, and 
sterilized by autoclaving at 121°C for 15 min and poured in Petri dishes.     
Horse blood agar (HBA) 
Horse blood was prepared by incorporating 5% horse blood in Columbia agar base. 
The medium was prepared according to the manufacturer’s instruction, and sterilized 
by autoclaving at 121°C for 15 min and cooled down to 50°C. Finally, 5% of 
defibrinated horse blood was added aseptically and mixed gently before pouring into 
Petri dishes.  
The medium was prepared according to the manufacturer’s instruction, and sterilized 
by autoclaving at 121°C for 15 min and poured in Petri dishes.     
Todd Hewitt broth (THB)  
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The medium was prepared according to the manufacturer’s instruction, and 
transferred to 16 × 150 mm tubes and sterilized by autoclaving at 121°C for 15 min.
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